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A soluble fluorous palladacycle complex that promotes the Heck coupling and can be 
recovered and reused is reported herein. This complex promoted the Heck coupling of acrylates 
and haloarenes in high yields and with high turnover numbers.  
Passifloricin A, a natural product isolated from the tree Passiflora foetida is a polyol δ-
lactone containing four stereocenters. The fluorous mixture synthesis (FMS) of all eight 
diastereomers of passifloricin A is reported herein. Utilizing a multiple-tag FMS strategy we 
successfully obtained the eight quasiisomers from the natural product. The spectroscopic data for 
synthetic passifloricin A matched the spectroscopic data for natural passifloricin A.  
The ene-diene cross-metathesis reaction was succesfully applied to a wide variety of enes 
and dienes in high yields and streoselectivities. This reaction was applied for the synthesis of 10 
grams of the bottom fragment of dictyostatin.  
Dictyostatin, a marine sponge-derived macrolactone has been extensively studied in the 
Curran group because of its high potency as a microtubule-stabilizing agent. Based on SAR 
studies it was synthesized the 6-epimer (four times more potent). We successfully coupled the 
fragments via dimethylsilaketal formation and ring closing metathesis reaction of the silaketal 
intermediate. The final steps led to the synthesis of 30 mg of 6-epi-dictyostatin for the testing of 
its antiploriferative activity in vivo.    
APPLICATION OF FLUOROUS METHODOLOGIES FOR THE TOTAL 
SYNTHESIS OF EIGHT DIASTEREOMERS OF PASSIFLORICIN A AND 6-EPI-
DICTYOSTATIN 
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1.0  A SOLUBLE PALLADIUM COMPLEX THAT PROMOTES HECK REACTIONS 
AND CAN BE RECOVERED AND REUSED 
1.1 INTRODUCTION 
Palladium-catalyzed C-C bond formation reactions have emerged as powerful tools in 
organic synthesis due to their mild reaction conditions and high yields.1,2 Among these, the Heck 
reaction,3 coupling of readily available olefins with aryl or alkenyl halides or triflates, offers 
enticing possibilities for obtaining a wide range of vinylic products used as intermediates in 
pharmaceutical and fine chemical synthesis.4  
The development of efficient methods to assist the recovery and recycling of palladium 
complexes remains an important goal.5 Thus, several reports in the literature have described new 
recycling techniques involving the binding of the catalyst to an insoluble support, facilitating 
catalyst separation after reaction completion.6 Moreover, the development of soluble polymer 
supported catalysts to achieve high levels of recycling have increased palladacycles 
applicability.7  
The concept of catalyst recycling was extended by the introduction of fluorous biphasic 
catalysis.8 This well established technique exploits the temperature dependent miscibility of 
organic and fluorous phases.9 The reaction of organic substrates promoted by a heavy fluorous 
catalyst can be conducted under homogeneous conditions at high temperature. The resulting 
 2 
mixture at RT will separate into a fluorous phase (containing the heavy fluorous catalyst) and an 
organic phase (containing the organic product). This technique has great applicability in large 
scale process chemistry but lacks the generality that is so important in small scale discovery 
chemistry.10 This is because introducing large numbers of fluorines to ligands, or catalysts, as 
“ponytails” conveys unusual physical and chemical properties (lack of solubility in organic 
solvents, high molecular weight, little reactivity under standard organic reaction conditions).11       
1.1.1  Light fluorous chemistry 
 Fluorous reagents, reactants, catalysts and protecting groups are primed to move from a 
relatively small community into standard organic synthesis.12 Light fluorous compounds (less 
than 21 fluorines) are usually soluble in standard organic reaction solvents, though they still can 
be separated from organic products by fluorous silica gel solid phase extraction (FSPE).13 The 
Curran group pioneered light fluorous catalysis14 by using fluorous phosphines as ligands for 
platinum- and palladium-catalyzed reactions. In those experiments, the fluorous residue was 
collected by FSPE, but the intact catalyst was not recovered because it was unstable to the 
reaction conditions. As a consequence, the development of a light fluorous palladium catalyst 
that can be recovered and reused would be of great advantage for the continuously growing field 
of light fluorous chemistry. 
1.1.2  Palladacycles 
 Palladacycles have been known for over 20 years, although they have not been used as 
catalysts until recently.15 Nitrogen-, phosphorus-, and sulfur-containing palladacycles are 
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emerging as a new family of palladium complexes, and they have become the most simple and 
efficient complexes to promote palladium coupling reactions.16 The robustness, recycling, and air 
stability of palladacycles17 makes them good candidates for catalysis.   
The general structure of palladacycles complexes is represented in Figure 1. The class of 
compounds in the palladacycles family that is commonly used as promoters for palladium 
coupling reactions is the so-called “pincer” complex (3). 
PdLn
Y L
PdLn
Y L
PdLn
Y L
Y L Y L
1                                         2                                            3
L = donor, Y = linker  group  
Figure 1. Classes of palladacycles 
 
There are many examples of different types of pincer-palladacycles that promote the 
Heck reaction; nitrogen-18, oxygen-,19 and sulfur-contaning20 pincer-palladacycles (4, 5 and 6, 
respectively) are among the most important examples of this type of complexes. Sulfur-
containing palladacycles like 6a and 6b are known to promote Heck couplings with high yields 
and high catalyst turnover.   
Most textbooks describe the mechanism for the Heck reaction as a Pd(0)/Pd(II) based 
mechanism.21 However, it has been proposed that a Pd(II)/Pd(IV) mechanism may be operative 
in the case of pincer PCP complexes 3.22 The issue of having Pd(IV) intermediacy is surprising 
due to the high reactivity of the Pd-C bond in palladacycles towards electrophiles and 
nucleophiles.23 In turn, sulfur-containing palladacycles have one of the most stable Pd-C bonds 
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in this class of organopalladium complexes, supporting a possible Pd(II)/Pd(IV) mechanism 
(Figure 3).24 The postulated mechanism starts with the oxidative addition of the olefin to Pd(II) 
complex 7 to obtain Pd(IV) complex, followed by reductive elimination to Pd(II), oxidative 
addition of the aryl halide, and final reductive elimination to provide the Heck product and Pd(II) 
complex 7. Although this mechanism is valid for standard Pd(IV) species, there is no 
experimental evidence that proves or disproves this mechanism for cross coupling reactions 
mediated by palladium pincer-type of complexes.25  
Pd
N
N
R
Me
Me
R
Cl Pd
X
X
PR2
PR2
Cl Pd
S
S
Cl
R2
R2
R1
4                                              5                                                       6
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R
Me
PEG4b
X R
C,C
O,O
O,C
iPr
iPr
tBu
5a
5b
5c
R1 R2
NHAc
OPEG
Ph
Ph
tBu
6a
6b
6c H
Pd
S
S
Cl
C6F13
C6F13
7  
Figure 2. Palladium pincer complexes 
 
More recently, it has been suggested that these palladacycles are not catalysts but instead 
reservoirs of highly catalytic palladium nanoparticules.23b Literature reported measured 
formation of palladium nanoparticules during palladacycle-promoted Heck coupling reactions by 
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transmission electron microscopy (TEM).26 However, there is no record of complete 
characterization of these palladium nanoparticules. Therefore, it is still not clear if this is the 
general mechanism for palladacycle-promoted Heck couplings.27   
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R
(i)
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(i) Oxidative addition of a vinylic C-H bond, (ii) rate-determining HX reductive elimination,
(iii) aryl chloride oxidative addition, (iv) reductive elimination.  
Figure 3. Mechanism for the palladacycle promoted Heck reaction  
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1.1.3 Synthesis of fluorous palladacycle complex 7 
The synthesis of fluorous palladacycle 7 started with the lithium-halogen exchange of 
commercially available bromide 8, followed by thionation and then treatment with acetyl 
chloride to furnish crystalline compound 9 in 52% yield after silica gel flash chromatography. 
Deacylation with MeLi followed by reaction of the thiolate with α,α-dibromo-m-xylene provided 
light fluorous ligand 10 in 58% yield. An equimolar mixture of light fluorous ligand 10 and bis-
acetonitrile palladium dichloride (Cl2Pd(CH3CN)2) was heated for 48 h in a mixture of 
ACN/BTF.28 Cooling of the reaction mixture and the filtration of precipitate furnished the first 
batch of 7 (between 65-75% of mass before recrystalization). The mother liquor was 
concentrated and allowed to cool for 1 h and the precipitate was filtrated to furnish a second 
batch of complex 7 (30% of mass before recrystalization). Both batches were mixed and then 
recrystalized in a mixture of ACN/hexanes to obtain pure complex 7 in 71% yield, as fine yellow 
crystals, with a mp of 224 oC (Scheme 1).   
C6F13Br
1) tBuLi
2) S8
3) AcCl
C6F13AcS
8 9, 52%
9
1) MeLi
2) Br
Br
S
S
C6F13
C6F13
10, 58%
Cl2Pd(CH3CN)2
ACN/BTF
7
71%
 
Scheme 1.  Synthesis of fluorous palladacycle complex 7 
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1.2 RESULTS AND DISCUSSION 
1.2.1 Characterization of a light fluorous palladacycle complex 
 The first task in this project was to complete the characterization of complex 7. We 
obtained 1H, 13C, and 19F NMR spectra for complex 7 along with crystals suitable for X-ray 
analysis (The crystals were grown from recrystalization in hexanes and X-ray analysis was done 
by Dr. Steven Geib).  
Pd-C(Å)
Pd-Cl(Å)
Pd-S(Å)
1.97 1.98
2.41 2.39
2.30 2.30
S
S
Pd
C6F13
C6F13
Cl
S
S
Pd Cl
H
N
OO
HO
Fluorous palladacycle
complex 7
Bergbreiter SCS-Pd
Complex 6a
Bond lenghts SCS-Pd complex 7 Fluorous Palladacycle complex 6a
 
Figure 4. ORTEP diagrams for fluorous palladacycle complex 7 and Bergbreiter SCS-Pd complex 6a 
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Complex 7 crystallizes in the space group P21/n with three crystallographically independent 
but chemically similar molecules per asymmetric unit. The symmetry suggests an orthorombic 
arrangement of the asymmetric unit and the environment around the palladium center is slightly 
distorted square-planar. The Bergbreiter SCS-Pd complex 6a showed a similar symmetry 
pattern.29 Figure 4 shows both ORTEP diagrams and selected bond lengths for complexes 6a and 
7.  Palladacycle 7 showed a retention time (TR) of 8.4 min in a FluofixTM HPLC column under 
80/20 ACN/H2O to 100% ACN gradient elution, and a melting point of 224 oC with immediate 
an decomposition.  
1.2.2  Application of the fluorous palladacycle complex to Heck coupling reactions  
The application of complex 7 was investigated by studying Heck couplings under thermal 
conditions, as is summarized in Table 1. In a typical reaction, iodobenzene was mixed with 
methyl acrylate, triethylamine, and 3 mol% of complex 7 in DMA under ambient atmosphere. 
The reaction was heated at 140 oC in an oil bath for 48 h, and then an aliquot of the crude 
mixture was injected in the GC using iodotoluene as an internal standard. The ratio of the 
integrated peaks in the chromatogram indicated that we obtained methyl cinnamate in 45% yield 
(Entry 1).  
A similar reaction using styrene and iodobenzene provided stilbene in 60% yield by GC 
integration (Entry 2). The reaction using DMF as a solvent with methyl acrylate and iodobenzene 
for 52 h provided methylcinnamate in 35% yield (Entry 2). Styrene and iodobenze under the 
same reaction conditions reacted for 54 h to provide stilbene in 30% yield (Entry 3). The thermal 
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reaction conditions along with the long reaction times did not provide the product in good yields 
when 3 mol% of catalyst 7 was used. 
    
Table 1. Preliminary results in Heck couplings with fluorous palladacycle complex 
I
+ R
NEt3,solvent
3 mol% 7 R
Entry R Solvent Temp. (oC) Yield(%)a Rx time (h)
1 COOMe DMA 140 45 48
2 Ph DMA 140 60 46
3 COOMe DMF 120 35 52
4 Ph DMF 120 30 54
a) Yields were calculated from the integration of peaks in GC chromatogram using iodotoluene as internal
standard  
 
Because of the low yields under thermal conditions, and the reported advantage of using 
microwave irradiation for Pd-mediated coupling reactions.30 Next, we investigated the cross-
coupling reaction mediated by microwave irradiation. These results are summarized in Table 2.  
In a typical reaction, iodobenzene was mixed with styrene, tributylamine and complex 7 
in DMA under ambient atmosphere and in a sealed microwave reaction tube. The reaction 
mixture was heated at 110 oC for 15 min, and then an aliquot of the crude mixture was injected in 
the GC using iodotoluene as an internal standard. The ratio of the integrated peaks in the 
chromatogram indicated that we obtained stilbene in 8% yield (Entry 1).  
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Moreover, the reaction in DMF at 110 oC and for 10 min provided stilbene in 40% yield 
by GC integration (Entry 2). The reaction using DMA at 150 oC for 10 min provided stilbene in 
74% yield and, when the reaction was run for 15 min provided stilbene in 80% yield (Entries 3 
and 4). Finally, the same reaction but at 140 oC was run for 30 min and the crude mixture 
product was purified by silica gel flash chromatography to provide stilbene in 82% isolated yield 
(Entry 5).  
 
Table 2. Optimization results for the microwave mediated Heck coupling with complex 7 
I
+ R
NBu3, solvent
7 (3 mol%) R
Entry R Solvent Temp. (oC) Yield(%)a Rx time (min)
1 Ph DMA 110 8 15
2 Ph DMF 120 40 10
3 Ph DMA 150 74 10
4 Ph DMA 150 80 15
a) Yields were calculated from the integration of peaks in GC chromatogram using iodotoluene as internal standard
b) Isolated yield.
5 Ph DMA 140 82b 30
 
 
We also tested different coupling substrates to expand the scope and applicability of 
fluorous palladacycle complex 7, as summarized in Table 3. The reactions were set up the same 
way as the reactions reported in Table 2, and the organic product was isolated initially by 
fluorous solid phase extraction (FSPE), followed by silica gel flash chromatography. The scale 
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of the reaction (0.3 mmol) did not allow complex 7 to be recovered by FSPE in measurable 
amounts. The reaction of 4-iodo-anisole and methyl acrylate under the optimized conditions 
provided (E)-methyl-3-(4-methoxyphenyl) acrylate in 89% isolated yield (Entry 1). Similarly, 4-
bromo-benzonitrile and methyl acrylate provided (E)-methyl 3-(4-cyanophenyl) acrylate in 84% 
yield (Entry 2).  
 
Table 3. Heck reactions with fluorous palladacycle complex 7 
X
R1
+ R2
Bu3N, DMA
140o C
2) FSPE
R1
R2
Entry R1 X R2 Time (min) Yield (%)
1 MeO
CN
COMe
COMe
NO2
H
MeO
CN
MeCO
MeCO
MeO
COMe
2
3
4
5
6
7
9
10
12
I
Br
I
Br
OTf
I
I
I
Br
I
Br
I
CO2Me
CO2Me
CO2Me
CO2Me
CO2Me
CO2Me
Ph
Ph
Ph
Ph
Ph
CO2Me
45
45
30
30
30
30
30
45
45
45
45
45
89
84
90
94
87
79
82
76
78
89
92
89
1) 3 mol% 7
a) Isolated yields.
8
11
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The reactions with 4-iodo, 4-bromo and 4-trifluoromethanosulfonate acetophenones and 
methyl acrylate provided (E)-methyl 3-(4-acetylphenyl) acrylate in 90, 94 and 87% yield 
respectively (Entries 3-5). The reaction of electron-deficient 4-iodo-nitrobenzene and methyl 
acrylate provided (E)-methyl 3-(4-nitrophenyl) acrylate in 79% isolated yield (Entry 6). Next, the 
reaction of iodobenzene and styrene was found to provide stilbene in a very good 82% yield 
(Entry 7). Similarly, 4-iodo-anisole, 4-bromo-benzonitrile, 4-iodo-acetophenone and 4-bromo-
acetophenone provided the respective Heck products in very high yields (76, 78, 89 and 92% 
isolated yield, Entries 8-11).  
1.2.3  Recycling experiments with fluorous palladacycle complex 7 
The next step was to evaluate the recycling of complex 7. Previous work done in the 
Curran laboratory showed that FSPE is an excellent method for separating organic compounds 
from fluorous compounds.31 When using FSPE, the first elution with 80-90% MeOH/H2O gives 
the organic product and the second elution with ethyl ether, or THF, provides the fluorous 
compound. Based on the reliability of FSPE, a larger scale experiment was designed to obtain an 
accurate recovery percentage of complex 7 through several cycles. The reaction of 
bromoacetophenone (1.25 mmol) and methyl acrylate was promoted by complex 7 (41.5 mg, 3 
mol%) in DMA (4 mL) at 140oC for 30 min. After cooling, the reaction mixture was loaded on a 
20 g FSPE cartridge and compound 12 was isolated in 94% yield from the fractions eluted with 
90% MeOH/H2O. The fractions eluted with diethyl ether were concentrated and the residue was 
recrystalized from a 1/1 mixture of ACN/hexanes, providing complex 7 in 76% yield (31.4 mg).  
The recrystalized complex was reused for another 1.25 mmol scale coupling reaction. Three 
cycles of recovery and reuse of complex 7, were performed with very good results (Table 4). The 
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1H NMR spectrum of recovered 7 showed the expected peaks with no trace of free ligand after 
recrystalization. The 1H NMR spectra of all three recovered samples were identical to the 
spectrum of the original sample of complex 7, and to each other, proving that in each cycle the 
same complex was recovered and reused as new. 
 
Table 4. Recovery experiments with fluorous palladacycle complex 7 
Br + CO2Me
3 mol% 7
Bu3N, DMA
140o C, 30 min
Cycle Amount 7 used mol% 7 Yield (%) Amount recov. 7a
O O
1 41.5 mg 94 31.4 mg
2 31.4 mg 97 26.0 mg
3 26.0 mg 98 19.6 mg
a) Mass of complex 7 recovered af ter recrystalization in 1/1 mixture of ACN/hexanes.
11, 1.25 mmol/cycle 12
3
2
1
CO2Me
 
 
 The recovery experiments showed clearly that most of fluorous palladacycle 7 survived 
the reaction conditions. These results indicated that either 7 catalyzes the Heck coupling reaction 
or functions as a source of small amounts of highly active palladium nanoparticules that are the 
true catalyst of the reaction. It was noted that the reaction mixture changes from a clear yellow to 
a dark red color, which is evidence for palladium nanoparticules in polar solvents.32  
Finally, a large scale experiment was performed wherein 1 g of bromoacetophenone was 
coupled with methyl acrylate in 3 mol% of complex 7 (167 mg). Product 12 was obtained in high 
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yield (951 mg), and was tested for traces of palladium (by elemental analysis with resolution as 
low as parts per billion).33 Only 74 ppm of palladium was found in the organic product, 
corresponding to 0.45% of the original amount of palladium that was added. If it is assumed that 
all of the palladium nanoparticules eluted together with the organic product during purification 
and that indeed those nanoparticules are the true catalyst, then the Heck reaction was promoted 
by 0.01 mol% of 7. 
1.3 CONCLUSIONS 
 The air stable light fluorous palladacycle complex 7 was synthesized and used to promote 
the Heck reaction with a variety of substrates in very high yields and in short reaction times. The 
highly convenient microwave irradiation technology was used to facilitate the reaction.34                                      
 High levels of recycling (75% recovered each cycle) of the light fluorous palladacycle 
complex was uncovered. The complex showed high stability to the reaction conditions allowing 
us to recover, recrystalize and reuse it “as good as new”, reproducing the yields cycle by cycle. 
 The reaction was successfully scaled-up to 1 g of bromoacetophenone without any loss in 
yield of the product or of the recovered catalyst. Regardless whether complex 7 is a precursor of 
highly catalytic palladium nanoparticules or a true catalyst, it is an attractive new kind of 
palladacycle that is soluble under standard palladium coupling reaction conditions, can be 
recovered very easily by FSPE, and can be reused for future  small or big scale experiments. 
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1.4 EXPERIMENTAL 
General  
All reactions were performed under an atmosphere of argon unless otherwise specified or 
the reaction solvent contained water. The reaction times reported are dictated by TLC analysis of 
the reaction mixture in comparison to the starting material. Reaction solvents were freshly dried 
either by distillation or passing through an activated alumina column. Methylene chloride 
(CH2Cl2) was distilled from CaH2 and toluene, benzene, diethyl ether, and tetrahydrofuran (THF) 
were distilled from Na/benzophenone. All other commercially available solvents and reagents 
were used without further purification. 
 Products were analyzed by 1H NMR, 13C NMR,   19F NMR, LC-MS, FT-IR, high and low 
resolution mass spectrometry, and HPLC. NMR spectra were recorded on a Bruker WH-300, an 
IBM AF-300, an AM-500, or a Bruker AvanceTM 600 NMR spectrometer. Spectra were recorded 
at room temperature in the indicated deuterated solvents and chemical shifts were reported in 
parts per million (ppm) from the residual solvent signal of the deuterated solvent. In the case of 
19F NMR spectroscopy no internal standard was used or any special care was taken to measure it. 
IR spectra were recorded on an IBM IR/32 spectrometer and ran as chloroform solutions. Low 
resolution mass spectra were obtained on a Hewlett Packard-9000 GC-MS, and high resolution 
spectra were recorded on a Varian MATCH-5DF instrument. HPLC analysis was performed on a 
Waters 600E system with UV detector. LC-MS spectra were obtained on a Hewlett Packard-
1100 LC-MS using APCI positive mode. All MS peaks were reported in units of m/z. Melting 
points were measured on a MEL-TEMP II apparatus and were not corrected.  
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Pd
S
S
Cl
C6F13
C6F13
 
Fluorous palladacycle complex (7): In a 10 mL dry round bottom flask Cl2Pd(ACN)2 (65 mg, 
0.25mmol) was dissolved in acetonitrile (3 mL). Then 1,3-bis((4-(perfluorohexyl) phenylthio) 
methyl)benzene (235 mg, 0.25 mmol) was added followed by the addition of BTF (3 mL). The 
reaction mixture was refluxed and stirred for 2 days, cooled to 0o C and then the yellow 
precipitate was filtrated with cold acetonitrile. The crude product was recrystalized from a 1:1 
mixture of acetonitrile/hexanes to give pure 7 (178 mg, 71% yield) as fine light yellow crystals 
(Mp: 224˚ C): 1H NMR (300 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 4H), 7.59 (d, J = 8.3 Hz, 4H), 
7.08 (m, 4H), 4.68 (s, 3H); 19F NMR (282.4 MHz, CDCl3) δ -79.57 (3F), -109.86 (2F), -120.32 
(4F), -121.59 (2F), -124.96 (2F); 13C NMR (75 MHz, CDCl3) δ 161.8, 149.0, 136.8, 130.7, 
130.2, 128.3, 125.6, 122.8, 50.3; LCMS (APCI, positive mode): m/z = 1063 (M − Cl); EIMS: 
m/e = 1100 (M+), 1063 (M − Cl), 958 (M − PdCl).  
General procedure for the Microwave-Mediated Heck Reaction: The haloarene (0.3 mmol) 
was mixed with catalyst 7 (10 mg, 3 mol%) in a microwave tube with a stirring bar. To this was 
added DMA (1 mL), tributylamine (39 mg, 0.3 mmol) and methyl acrylate or styrene (0.38 
mmol). The reaction tube was sealed and reacted in a CEM Discover Microwave reactor for 30 
to 45 min at 140oC with continuous stirring. After 5 min of cooling, the reaction mixture was 
loaded on a 10 g FluoroFlashTM cartridge that had been preconditioned with 9:1 MeOH-H2O. 
The cartridge was eluted with 60 mL of the solvent mixture to give the non-fluorous compounds, 
followed by elution with 30 mL of Et2O to give fluorous complex 7. The non-fluorous 
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compounds were purified by a quick column chromatography to afford the Heck product in high 
yields. The products are known compounds that were analyzed by 1H NMR spectroscopy and 
GC.  
Gram-scale reaction and complex recovery experiments: Bromoacetophenone (1.0 g, 5.05 
mmol) was mixed with palladacycle 7 (167 mg, 3 mol%). To the resulting mixture was added 
DMA (8 mL), tributylamine (652 mg, 5.05 mmol), and methyl acrylate (6.3 mmol). The reaction 
tube was sealed and reacted in a CEM Discover Microwave reactor for 30 min at 140oC with 
continuous stirring. After 5 min of cooling, the reaction mixture was loaded on a 50 g 
FluoroFlashTM cartridge that had been preconditioned with 9:1 MeOH-H2O. The cartridge was 
eluted with 100 mL of the mentioned solvent mixture to give the non-fluorous compound, 
followed by elution with 80 mL of Et2O, to give fluorous complex 7 (160 mg). The ethereal 
solution was concentrated and recrystalized from hexanes, giving light yellow crystals (116 mg, 
60%).  
Stability experiments with fluorous palladacycle complex: In a round bottom flask fluorous 
palladacycle 7 (20 mg, 0.018mmol) was dissolved in THF (5 mL). TBABr or TBAI (0.036 
mmol) was then added. The reaction mixture was stirred or refluxed for 24h and the solvent was 
removed and the crude was analyzed by 1H NMR, HPLC, LCMS, and melting point. The results 
indicated the lack of formation of any halogen-exchanged complex (no standard compound was 
prepared to measure the formation of exchanged complex).     
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2.0  APPLICATION OF FLUOROUS MIXTURE SYNTHESIS (FMS) FOR THE 
SYNTHESIS OF NATURAL PRODUCT STEREOISOMER LIBRARIES: TOTAL 
SYNTHESIS OF EIGHT DIASTEREOMERS OF PASSIFLORICIN A. 
2.1 INTRODUCTION 
A natural product stereoisomer library is a family or a group of stereoisomers from a 
natural product that may present a similar biological profile. The synthesis and biological activity 
of natural product stereoisomer libraries have become progressively more important because of 
the fundamental relationship between different stereostructures and the specific active site for the 
respective natural product. Furthermore, their synthesis is relevant because it allows the 
unequivocal structural assignments of natural products whose stereoisomers may have similar 
spectra.1 However, literature on stereoisomers library synthesis has been for the most part limited 
to compounds with a core structure that is available from nature or compounds with only a single 
functional group or stereocenter that is modified.2 This shortage surely is not because there is a 
lack of interest. Stereostructure is an important target for variation in any structure-activity 
study.3 Moreover, stereoselective methods in synthesis are available for most transformations; 
therefore, it is clear that stereoisomer libraries represent a difficult challenge for current solution 
phase synthesis.4       
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To streamline the synthesis of multiple stereoisomers, the technique of fluorous mixture 
synthesis (FMS) was developed.5 FMS has emerged as a general and powerful alternative to 
traditional solution-phase synthesis and to solid-phase synthesis because it fuses many of the 
most attractive features of both types of approaches.6 This technique exploits the simplicity and 
velocity of working with mixtures of compounds, yet still permits a systematic separation of the 
mixtures to provide individual pure stereoisomers or analogs.7  
FMS has three main stages: 1) premix, 2) mixture synthesis, and 3) postmix. The premix 
stage involves tagging of individually synthesized substrates with homologous fluorous 
protecting groups (e.g., fluorous silanes, PMBs, or MOMs),8 followed by the mixing of the 
tagged substrates. The mixture synthesis stage involves the stepwise construction of the 
molecules through standard synthetic reactions. This stage ends with the demixing, where each 
mixture is separated over fluorous silica gel into its individual fluorous-tagged components based 
on their fluorous content (i.e., the number of fluorine atoms in a single compound). In the final 
postmix stage, the fluorous tags are removed in parallel providing the target compounds.9  
Early FMS work used only a single fluorous tag per component of the mixture. A recent 
project in the Curran group demonstrated that components with fluorinated scaffolds and 
fluorous tags showed longer retention times on fluorous HPLC than the components without the 
fluorinated scaffold. This redundant tagging, based on the accumulated fluorine content of each 
component of a mixture, gave birth to the idea of multiple-tag FMS.10 This technique permits the 
systematic fluorous tagging of N stereocenters in each component of a single mixture. The steps 
are in the following sequence: 1) split the substrate into two batches, 2) diastereoselective 
reaction with the reagent of opposite chirality for each batch, and 3) individual tag and mix of the 
components. This sequence of steps is repeated as many times as stereocenters to be tagged 
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(Figure 5). Multiple-tag FMS becomes doubly attractive because it saves steps over linear, or 
parallel, approaches and it allows the use of fewer fluorous tags than the number of 
stereoisomers in the library.11      
The number of components in a fluorous mixture is limited by the number of tags; in 
turn, multiple-tag FMS for a library of n components is distinctively encoded with n/2 + 1 tags. 
For example: encoding a mixture of four components where two stereocenters are tagged 
requires three fluorous tags (P1, P2 and P3, in order of increasing fluorine content). This strategy 
provides a mixture of four fluorous compounds in the following order of accumulated fluorous 
content: P1P1 < P1P2 < P1P3 < P2P3. This rationale can be extended to larger libraries if we 
assume that the minimal requirement to achieve fluorous demixing is one fluorine atom between 
each component of a mixture. 
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Figure 5. Schematic representation of a multiple-tag FMS for stereoisomer library synthesis 
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FMS has been applied successfully to the synthesis of natural products, their isomers, and 
libraries. The Curran group pioneered the field with the synthesis of a 560-compound library of 
mappicine analogs.10a Next, the Curran group developed the first stereoisomer library FMS with 
the synthesis of all sixteen isomers of the pinesaw fly pheromone;10b followed by the 
development of an orthogonal tagging strategy using fluorous tags and OEG (olygoethylene 
glycol) tags with the synthesis of the acetogenin murisolin.10c More recently, the Curran group 
completed the synthesis of four diastereomers of lagunapyrone, four diastereomers of cytostatin, 
and four diastereomers of (−)-dictyostatin, all by fluorous mixture synthesis (Figure 6).10d-f  
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Figure 6. Recently completed FMS projects 
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2.1.1 Passifloricin A and its isomers 
 Passifloricin A was isolated from the tree Passiflora foetida (a member of the passion 
flower family) in the tropical regions of Colombia.14 Passifloricin A has moderate to good levels 
of cytotoxicity (LC50 = 2.3 μg/mL) and antifungal activity (LC50 = 5.61 μg/mL);17 and a recent 
paper shows that this natural product also displays activity against parasites (EC50 = 0.36 
μg/mL).13 Pasifloricin A was characterized as either structure 1 or 2 by the Echeverri group 
(Scheme 2). Triols 1 and 2 were synthesized by Marco15 and later by Cossy.16 However, the 
spectroscopic data from synthetic samples 1 and 2 did not match that of the natural product. 
These results indicated that the initial structure assigned for the natural product was not correct.  
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 26 
Comparison of the mass spectra of natural passifloricin A and synthetic 1 and 2 exposed 
differences in the mass fragmentation pattern. Based on the observed fragmentation, Marco 
postulated that passifloricin A was the constitutional isomer 3a with the left most hydroxyl group 
in the C12 instead of the C11.  
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Scheme 3. Marco's synthesis of passifloricin A 
 
In a second synthetic effort, Marco’s group made 3a and found that its 1H NMR, 13C 
NMR, and mass spectra matched the spectroscopic data for natural passifloricin A. Along with 
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constitutional isomer 3a, they synthesized three other diastereomers (3b, 3c and 3d).17 Marco’s 
synthetic approach to 3a relied on iterative diastereoselective allylation reactions to set the 
stereocenters. The construction of each stereocenter was obtained by a “cycle” of 
diastereoselective allylation, protection, and oxidative cleavage reactions, as summarized in 
Scheme 3.  
Each stereocenter was obtained by using Brown’s diastereoselective allylation reaction 
with the commercially available allyldiisopinocampheylborane (+)-10. The synthesis began with 
the allylation of 4 with (+)-10 to obtain homoallylic alcohol (S)-5 in 80% yield and 92% ee. 
Homoallylic alcohol (S)-5 was protected as a TBS ether, followed by the hydroboration of the 
olefin with 9-BBN, and the final oxidation to obtain aldehyde (S)-6 in 66% overall yield. 
Aldehyde (S)-6 was subjected to cycle 1 (allylation with (+)-10, protection as a TBS ether, and 
ozonolysis) to provide aldehyde (SS)-7 in 42% overall yield and 90% de. Moreover, aldehyde 
(S,S)-7 after cycle 2 provided aldehyde (SSS)-8 in 55% overall yield and 90% de. Final 
diastereoselective allylation of (SSS)-8 provided homoallylic alcohol (RSSS)-9 in 68% yield and 
90% de. The construction of the δ-lactone was achieved by reacting (RSSS)-9 with acryloyl 
chloride, followed by ring closing metathesis (RCM) of the resulting ester with Grubbs second 
generation catalyst 11, and final global deprotection with HCl 1M in MeOH; to obtain 
passifloricin A (3a) in 64% yield from (RSSS)-9. The same synthetic pathway was used to 
prepare diastereomers 3b, 3c and 3d. 
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2.1.2 Multiple-tag FMS strategy 
 It was envisioned for this project that the application of a multiple-tag FMS for the 
synthesis of all eight diastereomers of passifloricin A would be achievable. This synthesis is 
important for the complete stereochemical assignment due to the potential similarity of the 
diastereomers spectroscopic data. It is even more important as a proof of principle for the 
proposed multiple-tag FMS strategy. Because of the mixture nature of this technique, 
purification of diastereomeric impurities during the mixture synthesis stage becomes 
cumbersome. Therefore, this technique requires that each stereocenter is built with complete 
reagent control and no influence of the inherited chirality of the substrate (substrate control). To 
fulfill this requirement, diastereoselective allylation reactions were chosen to establish the 
stereocenters.  
The synthetic approach chosen has three similar iterative sequences of reactions or cycles 
(Figure 7). The first cycle is done on a single compound and starts with: 1) allylation of aldehyde 
4 with (R)-chiral reagent, 2) protection as a silyl ether, 3) hydroboration, and 4) oxidation to 
obtain aldehyde (R)-12. The second cycle is done on a single compound but produces a fluorous 
mixture and starts with: 1) the split of (R)-12, followed by the allylation of one half of (R)-12 
with (R)-chiral reagent and the allylation of the other half of (R)-12 with (S)-chiral reagent, 2) 
the protection of each allylated product with a different fluorous tag, followed by mixing of both 
fluorous tagged compounds and 3) the oxidative cleavage of the resulting mixture to obtain 
aldehyde M13. The final cycle will provide, in the same fashion as the second cycle, aldehyde 
M14 now as a mixture of 4 quasiisomers. The final steps involve the split of M14, followed by 
the allylation of one half of M14 with (R)-chiral reagent and the allylation of the other half of 
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M14 with (S)-chiral reagent, and the acylation of each mixture to provide (R)-M15 and (S)-M15. 
Lastly, the RCM reaction of each mixture will provide (R)-M16 and (S)-M16, followed by the 
demixing and the individual global deprotection of each quasiisomer to provide the eight 
diastereomers of passifloricin A.   
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Figure 7. Multiple-tag FMS strategy for the synthesis of eight diastereomers of passifloricin A 
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The next goal was to design the tagging strategy for this multiple-tag FMS. Previous 
FMS developed in the Curran lab has shown that components of a mixture with redundant 
tagging have an order of elution directly proportional to the accumulated fluorine content.10 
Based on those results, it was decided to use diisopropyl fluoroalkyl silanes as the tags for our 
multiple-tag FMS.18 It was proposed that to unambiguously separate two mixtures of four 
quasiisomers each, three different fluorous groups would be needed to tag two stereocenters. 
Therefore, binary combinations of P1 (seven fluorine atoms), P2 (nine fluorine atoms) and P3 
(thirteen fluorine atoms) diisopropyl fluoroalkyl silanes were used (Figure 7). 
2.1.3 Diastereoselective allylation reactions 
Addition of chiral allyl-metal reagents to aldehydes is one of the most important approaches 
for the construction of stereocenters in open-chain systems. 19 Enantioselecive allylations can be 
catalytic or stoichiometric in terms of the amount of chiral reagent and also can be classified as 
type I (closed transition state) or type II (open transition state) depending on the metal that bears 
the allyl group.20 Most common reagents and catalysts for diastereoselective allylation reactions 
use one or more of the following metals to transfer allyl groups to aldehyde electrophiles:  boron, 
titanium, silicon, silver, zirconium, and chromium.21 
 Allyl-boron reagents are classified as type I and are among the most efficient 
diastereoselective allylation reagents.22 H. C. Brown discovered that the allylation of achiral 
aldehydes with allyl-boranes, like allyldiisopinocampheylborane (+)-10, yields homoallylic 
alcohols with very good enantioselectivities. In a typical Brown allylation reaction, (+)-10 at 
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−100 oC in diethyl ether was reacted with benzaldehyde for 6 h at the same temperature. The 
reaction was quenched with basic H2O2 and the crude product was purified to provide 
homoallylic alcohol 17 in 81% yield and 96% ee (Scheme 4). Similarly, Brown found that (+)-10 
reacted with n-butyraldehyde under the same conditions to provide homoallylic alcohol 18 in 
72% yield and 93% ee.23 Similarly, the allylation of α-chiral aldehydes was found to provide 
homoallylic alcohols with poor levels of reagent control stereoselectivity. The reaction of 19 
with (+)-10 provided homoallylic alcohol 20 in 68% yield and 96% de; and the allylation of 19 
with (−)-10 provided 21 in 71% yield and 34% de.24  
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Scheme 4. Allyl-boron reagents for stereoselective allylations 
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Roush found that the reaction of allyl-boronates like (S,S)-22 and aldehydes provides 
homoallylic alcohols in high yields and moderate stereoselectivities.25a The reaction of  (S,S)-22 
with benzaldehyde at −78 oC in toluene provided 17 in 78% yield and 72% ee, and the reaction 
with n-butyraldehyde provided 18 in 97% yield and 87% ee (Scheme 4).25b However, the 
synthesis of (S,S)-22 requires six steps from commercially available (S,S)-diethyl tartrate; in 
turn, reagent (+)-10 is commercially available. 
Duthaler and Hafner found that strained allyl-titanium type I allylation reagents react 
with aldehydes to provide homoallylic alcohols with high levels of stereoselectivity. In a typical 
reaction, a solution of allyltitanocene (S,S)-23 in diethyl ether was cooled to −78 oC, and 
benzaldehyde was added. After 3 h, the reaction was quenched with a 45% NH4F aqueous 
solution and then the crude mixture was purified to provide 17 in 93% yield and 95% ee. 
Correspondingly, the reaction with n-butyraldehyde provided 18 in 94% yield and 94% ee 
(Scheme 5).26 Moreover, the allylation of α-chiral aldehyde 19 with (R,R)-23 provided 
homoallylic alcohol 20 in 91% yield and 90% de; and the reaction with (S,S)-23 provided 
homoallylic alcohol 21 in 94% yield and 98% de. The allylation of chiral aldehyde 19 with 
allyltitanocenes 23 was shown to provide good levels of reagent control diastereoselectivity.27 
Allyltitanocene (S,S)-23 was obtained by the reaction of (S,S)-Taddol and CpTiCl3, followed by 
the addition of allylMgCl.  
The Keck reaction, using titanium-based Lewis acids as type II allylation reagent, 
promotes the reaction of allylstannanes and aldehydes with good levels of stereocontrol (Scheme 
5). In a typical Keck allylation reaction, Ti(i-OPr)4 and (R,R)-BINOL were dissolved in CH2Cl2 
to form catalyst (R,R)-24. The resulting solution containing 10 mol% of catalyst was added at 
RT to benzaldehyde and after 30 min to allyltributyltin. The reaction was stirred for 20 h and 
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quenched by adding water, then the crude mixture was purified to provide 17 in 98% yield and 
92% ee. The reaction using n-butyraldehyde provided 18 in 95% yield and 92% ee.28 Keck’s 
catalyst promoted the allylation of chiral aldehydes with low levels of reagent control 
stereoselectivity. Thus the reaction of β-chiral aldehyde 25, allyltributyltin, and (S,S)-24 
provided homoallylic alcohol 26 in 79% yield and 88% de and the reaction with (R,R)-24 
provided 27 in 65% yield and 50% de.29  
Maruoka further improved the allylation reaction of aldehydes with allyltributyltin and 
titanium-based chiral Lewis acids by developing more enantioselective μ-oxo-type chiral Lewis 
acid (R,R)-28.30 In a typical reaction, Ti(i-OPr)Cl3 was dissolved in CH2Cl2 and at RT was added 
Ag2O followed by (R,R)-BINOL to provide catalyst (R,R)-28. A solution containing 10 mol% of 
(R,R)-28 at 0 oC was treated with benzaldehyde then allyltributyltin, and after 48 h the reaction 
was quenched with water and the crude mixture was purified to provide 17 in 90% yield and 
96% ee. The reaction with n-butyraldehyde provided 18 in 85% yield and 99% ee (Scheme 5).31  
Chiral allylsilanes, as type I allylation reagents, were initially developed by Kira.32 He 
found that a tartrate-derived allylsilane added to aldehydes with high levels of conversion and 
stereoselectivity. Leighton found that strained chiral allylsilacycles reacted with aldehydes to 
provide homoallylic alcohols in excellent ee and yields (Scheme 6).33 In a typical reaction, a 
solution of allylcyclohexylbisaminosilacycle (S,S)-29 in CH2Cl2 was cooled to −10 oC and 
benzaldehyde was added. After stirring for 20 h, the reaction was quenched with aqueous 1 M 
HCl, and then the crude mixture was purified to provide 17 in 69% yield and 98% ee. The 
reaction with n-butyraldehyde provided 18 in 80% yield and 96% ee.34a 
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Scheme 5. Allyl-titanium reagents for stereoselective allylations 
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Leighton proved that allylsilacycles reacted with aldehydes with high levels of reagent 
control stereoselectivity. For example; β-chiral aldehyde 30 reacted with (R,R)-29 to provide 
homoallylic alcohol 31 in 86% yield and 90% de, and the reaction with (S,S)-29 provided 32 in 
86% yield and 96% de.34b Reagent (S,S)-29 was obtained by reacting (S,S)-N,N′-di-p-
bromobenzylcyclohexane-1,2-diamine with allyltrichlorosilane and DBU in CH2Cl2. 
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Scheme 6. Allyl-silicon reagents for stereoselective allylations 
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2.2 RESULTS AND DISCUSSION 
As shown in the multiple-tag FMS strategy, allylations are the key reactions for the 
planned synthesis of passiflorcins. Three different types of allylations must be executed; a first 
allylation on an achiral substrate (aldehyde 4), a second allylation on a substrate with a 
stereocenter at the γ-position (aldehyde (R)-13) and a third allylation and fourth allylation on a 
substrate with a stereocenter at the β-position (aldehyde M13 and M14). FMS requires reactions 
with very high levels of reagent-controlled stereoselectivity. To evaluate this crucial aspect, the 
following range of commonly used asymmetric allylation reagents and catalysts were selected 
for the different substrates: Brown’s allyldiisopinocampheylborane 10, Keck’s catalyst 24, 
Duthaler-Hafner’s allyltitanocene 23, Leighton’s allylcyclohexylbisaminosilacycle 29, and 
Maruoka’s catalyst 28. 
2.2.1 First allylation 
The initial task was to develop an efficient and reliable analytical tool to determine the 
enantioselectivity of each reagent and catalyst tested for the allylation reaction of aldehyde 4 to 
create the C12 stereocenter. Initially, pentadecanal (4) was reacted with allylMgBr to provide 
alcohol rac-5 in 100% yield. Direct analysis of rac-5 by chiral HPLC or GC did not show 
evidence of a mixture of enantiomers. Therefore, the derivatization of rac-5 with (S)-O-methyl-
mandelic acid was attempted. Mandelate mixture 33 was obtained in 95% yield by DCC-
mediated coupling of rac-5 and (S)-O-methylmandelic acid in CH2Cl2 and DMAP.35 The 
spectroscopic analysis of 33 clearly showed a 1:1 mixture of diastereomers and the HPLC 
analysis of 33 (normal phase Silicapak column, eluted with 99:1 Hex:EtAc) also showed two 
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peaks in a 1:1 ratio of mandelates 33 (Scheme 7). HPLC analysis of the mandelate derivatives 
became the analytical tool of choice to measure the enantioselectivities of the different allylation 
reagents and catalysts for the allylation of aldehyde 4.  
The synthesis of diastereopure mandelate (SR)-33 from enantiopure (R)-5 (obtained from 
the allylation reaction of 4 with (R,R)-23, Table 5) and further HPLC analysis of the 
diastereopure sample proved that the peak at 7.5 min corresponded to (SR)-33 and the peak at 
8.5 min corresponded to (SS)-33. The optical rotation measured in CHCl3 for (R)-5 matched the 
literature values for this compound in CHCl3.36 Therefore, it was confirmed that 5 had the 
desired (R) configuration. Based on these results, it was decided to use the allylation reagents 
and catalysts which predict the R configuration in the allylation of aldehydes. The HPLC traces 
for pure (SR)-33 and mixture 33 are in Appendix A. 
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Scheme 7. O-Methyl mandelates for the determination of the stereoselectivities 
 
With a quick analytical tool to measure stereoselectivities, the reaction of aldehyde 4 with 
the allylation reagents and catalysts was tested. The reagents and catalystswere available using 
the procedures described in the introduction. The results of these experiments are summarized in 
Table 5. Brown’s allyldiisopinocampheylborane (−)-10 reacted with 4 to give (R)-5 in 97.5:2.5 
er and 82% yield (Entry 1). Catalyst (S,S)-24 promoted the reaction of 4 and allyltributyltin to 
provide (R)-5 in 53% yield and 98:2 er (Entry 2). Commercially available allyltitanocene (R,R)-
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23 reacted with aldehyde 4 to provide (R)-5 in a very encouraging 99:1 er and 86% yield. This 
result was reproducible with freshly prepared (R,R)-23 (Entry 3). The reaction of 
allylcyclohexylbisaminosilacycle (R,R)-29 with aldehyde 4 provided (R)-5 in a similar 99:1 er 
but a disappointing 52% isolated yield (Entry 4). Similarly, Maruoka’s catalyst (S,S)-28 
promoted the reaction of 4 and allyltributyltin to obtain (R)-5 in 91% yield and 99.5:0.5 er (Entry 
5). Maruoka’s catalyst gave the best results in terms of yield and enantioselectivity for the 
synthesis of (R)-5. 
 
Table 5. Enantioselective allylation of achiral aldehyde 4 
C14H29
O
4 (R)-5
C14H29
OH
Entry reagent/catalyst conditions Time Yield of(R)-5 (%)a er of (R)-5b
1 (−)-10 diethylether/−100 oC 6h 82 97.5:2.5
2 (S,S)-24 (20mol%) allyltributyltin/toluene/RT 20h 53 98:2
3 (R,R)-23 diethylether/−78 oC 3h 86 99:1
4 (R,R)-29 CH2Cl2/−10 oC 20h 51 99:1
5 (S,S)-28 (20 mol%) allyltributyltin/CH2Cl2/RT 48h 91 >99.5:5
reagent
a) Isolated yields.
b) Measured by HPLC analysis of O-methyl mandelates.  
2.2.2 Second allylation 
The construction of the C9 stereocenter requires a diastereoselective allylation on a chiral 
substrate with a γ-stereocenter (aldehyde (R)-12). There is little background on substrate 
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induction due to γ-stereocenters. However, to minimize the chance of substrate control, it was 
decided to protect the hydroxyl group in C12 with a well known non-chelating group (TBDPS).37 
The reaction of (R)-4-(tert-butyldiphenylsilyloxy)octadecanal ((R)-12) with allylMgBr provided 
alcohol 34 in 100% yield. Although we expected a 1:1 mixture of diastereomers, direct analysis 
of 34 by 1H NMR spectroscopy, chiral HPLC, or chiral GC did not show any evidence for a 
mixture. However, derivatization of alcohol 34 with (S)-O-methyl-mandelic acid provided 
separable mandelates 35. 1H NMR analysis of 35, prior to separation, showed a 1:1 mixture of 
diastereomers and HPLC analysis of 35 (normal phase Silicapak column, eluted with 99:1 
Hex:EtOAc) showed also a 1:1 ratio of mandelates 35 (Scheme 8). This initial result indicated 
that allylMgBr adds to aldehyde (R)-12 without any substrate control. Mandelate mixture 35 was 
obtained in 93% yield using the same conditions as for mandelate’s 33 (Scheme 8).  
The synthesis of diastereopure mandelate (SSR)-35 from enantiopure (SR)-34 (obtained 
from the allylation of (R)-12 with reagent (S,S)-23, Table 6) and further HPLC analysis of the 
diastereopure sample proved that the peak at 10.2 min corresponded to (SSR)-35 and the peak at 
12.6 min corresponded to (SRR)-35. The individual synthesis and HPLC analysis of 
diastereopure (SRR)-35 confirmed the assignment by providing the isomer with a retention time 
(TR) = 12.6 min. HPLC analysis of mandelate derivatives became the analytical tool of choice to 
measure the diastereoselectivity of different allylation reagents and catalysts for the allylation of 
aldehyde (R)-12. The HPLC traces for pure (SSR)-35 and (SRR)-35 and mixture 35 are in 
Appendix A. 
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The results for the reaction of aldehyde (R)-12 with allylation reagents and catalysts to 
provide homoallylic alcohol (SR)-34 and (RR)-34 are summarized in Table 6. The 
diastereomeric ratios are shown as the ratio of (SR)-34:(RR)-34, which are determined by 
conversion of the product to the mandelate 35 and HPLC analysis. Reagent (−)-10 reacted with 
(R)-12 to give (RR)-34 in 78% yield and 5:95 dr. However, the reaction with (+)-10 produced 
(SR)-34 in 72% yield and 99:1 dr (entries 1a and 1b). This difference in the diastereoselectivity 
indicated a small influence of chiral aldehyde (R)-12 on the stereochemical outcome of the 
reaction.  
Keck’s catalyst (S,S)-24 promoted the reaction of allyltributyltin with aldehyde (R)-12 in 
35% yield and 88:12 dr. Catalyst (R,R)-24 promoted the reaction in a similar 30% yield and 
12:88 dr (entries 2a and 2b). The reactions of allyltitanocene (S,S)-23 and (R,R)-23 with (R)-12 
provided (SR)-34 and (RR)-34 in good yields (75 and 73% yield) and nearly complete reagent 
control diastereoselectivity (99:1 dr and 1:99 dr, entries 3a and 3b). Leighton’s silacycles (S,S)-
29 and (R,R)-29 reacted with (R)-12 to provide (SR)-34 and (RR)-34 in low yields but high dr 
(50/31% and 98:2/1:99, Entries 4a and 4b respectively). Unexpectedly, the reaction of 
Maruoka’s catalysts (R,R)-28 and (S,S)-28 with (R)-12 provided (SR)-34 and (RR)-34 in low 
yields but high dr (48%, 99:1 and 55%, 1:99; entries 5a and 5b). Optimization of the reaction by 
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increasing the catalyst load to 40% led to similar yields for homoallylic alcohols (SR)-34 and 
(RR)-34 (42 and 49% yield, entries 6a and 6b). In summary, Duthaler-Hafner allyltitanocenes 23 
gave the best results in terms of yield and diastereoselectivity for the synthesis of (SR)-34 and 
(RR)-34. 
 
a) Isolated yields.
b) Measured by HPLC analysis of O-methyl mandelates.
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Table 6. Diastereoselective allylation of chiral aldehyde (R)-12 
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2.2.3 Third allylation 
The construction of the C7 stereocenter requires a diastereoselective allylation using a 
chiral substrate with a β-stereocenter (aldehyde M13). There are two issues to consider for this 
reaction: first, the influence of the substrate chirality on the stereochemical outcome and second, 
the effect that the fluorous tags may have on reactivity and selectivity.38 The model aldehyde 
substrate (M13, mixture of two quasiisomers) that has fluorous TIPS ethers in the β position was 
designed. Aldehyde M13 reacted with allylMgBr in THF and provided M36 in 100% yield. 
Since M13 was a mixture of two quasiisomers and little to no selectivity was expected in the 
allylation, M36 should have been a mixture of four isomers. Fluorous HPLC analysis and further 
demixing of a small sample provided a 1:1 mixture of alcohols 36A and 36B in 88% yield. 
Analysis of 36A or 36B by 1H NMR spectroscopy and HPLC did not show evidence of a mixture 
of two diastereomers.  
However, the deprotection reaction of alcohols 36A and 36B with 0.5N HCl in ethanol 
provided diols 37A and 37B that were shown to be equimolar mixtures of diastereomers by 
HPLC analysis (normal phase Silicapak column, eluted wit 9:1 Hex:EtOAc). The retention times 
for diol mixtures 37A and 37B were the following: 11.7 min for (SRR)-37A, 14.8 min for 
(RRR)-37A, 11.8 min for (RSR)-37B, and 14.9 min for (SSR)-37B (Scheme 7). The HPLC 
analysis of diols 37A and 37B was a very efficient analytical tool to determine the 
stereoselectivities for the allylation reaction of aldehyde M13. The determination of which diol 
was syn or anti was achieved by obtaining the acetonides derivatives of diastereopure diols 
(SRR)-37A and (SSR)-37B (Scheme 10). The HPLC traces for (SRR)-36A and (SSR)-36B and 
mixtures 36A and 36B are in Appendix A. 
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Scheme 9. Analysis of diastereoselectivities for the allylation of aldehyde M13 
 
The results for the reaction of aldehyde M13 with the allylation reagents and catalysts 
provided homoallylic alcohols M36; the results are summarized in Table 7. Diastereomer ratios 
are shown as the ratio of homoallylic alcohols after demixing and HPLC analysis as follows: 
(SRR)-36A:(RRR)-36A and (RSR)-36B:(SSR)-36B. Because of the unknown influence of the 
fluorous tags on reactivity, it was decided to use Walsh’s conditions using tetraallyltin instead of 
allyltributyltin for the allylation reaction with catalyst (R,R)-24.39 The reaction with catalyst 
(R,R)-24, aldehyde M13, and tetraallyltin provided alcohol M36 in 83% yield but only fair 
diastereomeric ratios: 45:55 for 36A and 55:45 for 36B (Entry 1). The reaction was next tested 
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using FC-72 as a cosolvent and M36 was obtained in 86% yield and 40:60 dr for 36A and 55:45 
dr for 36B (Entry 2). It was hypothesized that the background reaction might be faster than the 
asymmetric reaction at RT, so the reaction was tried at −78 oC and alcohol M36 was isolated in 
25% yield with no improvement in the dr (45:55 dr for 36A and 55:45 dr for 36B, Entry 3). The 
reaction of allyltitanocene (S,S)-23 and aldehyde M13 provided M36 in 65% yield with almost 
complete reagent control diastereoselectivities: 5:95 dr for 36A and 97:3 dr for 36B (Entry 4). 
The reaction with Maruoka’s catalyst (R,R)-28, aldehyde M13, and allyltributyltin provided 
M36 in trace amounts (Entry 5). However, replacing allyltributyltin with tetraallyltin provided 
M36 in 91% yield and low dr (45:55 dr for 36A and 70:30 dr for 36B, entry 6). Attempts were 
made to optimize the selectivity for the reaction with catalyst (R,R)-28 by decreasing the 
reaction temperature (0 oC and −15 oC, entries 7 and 8), but the results did not improve (91% 
yield and 45:55 dr for 36A and 75:25 dr for 36B, 69% yield and 45:55 dr for 36A and 75:25 dr 
for 36B). Allyldiisopinocampheylborane (−)-10 reacted with aldehyde M13 to provide M36 in 
74% yield with good levels of reagent control diastereoselectivity: 87:13 dr for 36A and 14:86 dr 
for 36B (Entry 9).  
Next, the reaction with FC-72 as a cosolvent was tried. M36 was obtained in 86% yield 
and 96:4 dr for 36A and 25:75 dr for 36B (Entry 10). The reaction with 
allylcyclohexylbisaminosilacycle (R,R)-29 and aldehyde M13 provided M36 in less than 10% 
yield (Entry 11). The reaction with 5 equiv of (S,S)-29 gave M36 in 55% yield and 10:90 dr for 
36A and 90:10 dr for 36B (Entry 12). Moreover, the reaction at RT provided M36 in a similar 
58% yield and 10:90 dr for 36A and 74:26 dr for 36B (Entry 13). The reaction with 
allyltitanocene (S,S)-23 gave the best results in terms of yield and reagent control 
diastereoselectivity for the synthesis of M36. As a consequence, 23 became the reagent of choice 
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for the allylation of aldehydes M13 and M14. The fourth allylation (aldehyde M14) is very 
similar to the third, so no further studies were needed.   
 
Table 7. Yields and diastereoselectivities for the third allylation 
OTBDPS
OP2,1
reagentO
H
C14H29
M13
OTBDPS
(R)
OP1
(S)
OH
(R)C14H29
OTBDPS
OP2 OH
C14H29
OTBDPS
OP1 OH
C14H29
OTBDPS
OP2 OH
C14H29
(SRR)-36A (RRR)-36A
(RSR)-36B (SSR)-36B
a) Reaction conditions and reagents are the same as previous allylations unless specified.
b) Isolated yields for homoallylic alcohols 36 before demixing.
c) Measured by HPLC analysis of desilylated products of (SRR)-36A:(RRR)-36A and (RSR)-36B:(SSR)-36B.
d) Entries were done by Dr. Mathias Pholman.
P1 = (i-Pr)2SiC2H4C3F7
P2 = (i-Pr)2SiC2H4C4F9
Entry Reagenta yield%b conditions RT T (oC) (SRR)-36A:(RRR)-36Ac (RSR)-36B:(SSR)-36B
1 (R,R)-24 83 (allyl)4Sn 10 h rt 45:55 55:45
2 (R,R)-24 86 (allyl)4Sn/FC-72 10h rt 40:60 55:45
3 (R,R)-24 25 (allyl)4Sn 12h −78 45:55 55:45
4 (S,S)-23 65 1.2 equiv/Ether 6h −78 95:5 3:97
5 (R,R)-28 traces allyl(Bu)3Sn 48 h rt - -
6 (R,R)-28 91 (allyl)4Sn 16 h rt 45:55 70:30
7 (R,R)-28 91 (allyl)4Sn 16 h 0 45:55 75:25
8 (R,R)-28 84 (allyl)4Sn 16 h −15 45:55 75:25
9 (-)-10 74 1.2 equiv/Ether 8 h −100 87:13 14:86
10d (-)-10 86 1.2 equiv/Ether/FC-72 8 h −100 96:4 24:76
11 (R,R)-29 <10 2 equiv/CH2Cl2 20 h −10 96:4 6:94
12d (S,S)-29 55 5 equiv/CH2Cl2 20 h −10 10:90 90:10
13d (S,S)-29 58 5 equiv/CH2Cl2 20 h rt 10:90 74:26
 
 46 
The reaction in entry 4 produced the set of homoallylic alcohols (SRR)-36A and (SSR)-
36B with the best selectivity. To confirm the configuration in the stereocenter formed during this 
allylation, the individual alcohols (SRR)-36A and (SSR)-36B were deprotected with 0.5 N HCl 
in ethanol to provide diastereopure diols (SRR)-37A and (SSR)-37B in 82 and 78% yield, 
respectively.  
 
OTBDPS
OH OH
C14H29
OTBDPS
OH OH
C14H29
OTBDPS
(R) (S)
(R)C14H29
O O
OTBDPS
C14H29
O O
19.7 30.2 ppm
24.7 24.8 ppm
DMP, Acetone
CSA, 95 %
DMP, Acetone
CSA, 92 %
38
39
(SRR)-37A
(SSR)-37B
OTBDPS
OP1 OH
C14H29
OTBDPS
OP2 OH
C14H29
(SRR)-36A
(SSR)-36B
0.5 N HCl
Ethanol, 82%
0.5 N HCl
Ethanol, 78%
 
Scheme 10. Formation of the acetonide derivatives for 37A and 37B 
 
The crude diols reacted individually with excess 2,2-dimethoxypropane and catalytic 
CSA to provide their respective dimethyl acetonides (38 in 95% yield for 2 steps and 39 in 92% 
yield for 2 steps, Scheme 10).40 syn-Acetonide 38, made from (SRR)-37A, displayed the 13C 
NMR resonances of the acetal methyls at 19.7 and 30.2 ppm and the acetal quaternary carbon 
resonance at 98.3 ppm. Moreover, anti-acetonide 39, made from (SSR)-37B, displayed the acetal 
methyls’ 13C NMR resonances at 24.7 and 24.8 ppm and the acetal quaternary carbon resonance 
at 100.1 ppm. These results corroborated that the relative configuration for alcohol (SRR)-36A is 
syn and for alcohol (SSR)-36B is anti.40 
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2.2.4 Model studies on the acylation and ring closing metathesis (RCM) reactions  
Ring closing metathesis reactions (RCM) to form six membered ring carbocycles are a 
common approach in natural product synthesis.41 Cossy and Marco used the RCM reaction to 
form the δ-lactone moiety in their synthetic approaches to passifloricin A.15,16  
Based on those results, it was decided to investigate the RCM reaction of (R)-40 and (R)-
41 using Grubbs I 11B and Grubbs II 11A ruthenium catalysts. The reaction of (R)-5 with 
acryloyl chloride and DIPEA in CH2Cl2 at 0 oC provided model acryloyl ester (R)-40 in 78% 
yield. Moreover, the reaction of (R)-5 with cinnamoyl chloride and DMAP in CH2Cl2 at 0 oC 
provided model cinnamoyl ester (R)-41 in 89% yield (Scheme 11). The RCM reaction of (R)-40 
and 10 mol% of 11A, in refluxing toluene, provided (R)-42 in 79% yield (Entry 1, Scheme 11). 
When the reaction was done with refluxing CH2Cl2, (R)-42 was isolated in 82% yield (Entry 2). 
When the RCM reaction of (R)-40 was promoted by 10 mol% of 11B in refluxing CH2Cl2, (R)-
42 was isolated in 35% yield; and when the RCM reaction was done at RT, (R)-42 was isolated 
only in 15% yield (Entries 3 and 4).  
The RCM reaction of cinnamoyl ester (R)-41 and 10 mol% of 11A in refluxing toluene or 
CH2Cl2 provided (R)-42 in high yields (89 and 87% yield respectively, entries 5 and 6). Similar 
results were obtained when the RCM reaction of (R)-41 was done with 10 mol% of 11B catalyst 
in refluxing toluene or CH2Cl2 (81 and 75% yield respectively, entries 7 and 8). However, when 
the RCM reaction of (R)-41 was promoted by 10 mol% of 11B at RT, (R)-42 was isolated in 
only 36% yield (Entry 9).  
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Scheme 11. RCM and acylation reactions 
 
Although both catalysts promoted the reaction in similar yields, purification of (R)-42 
was easier when the reaction was promoted with catalyst 11A. The yield was higher when using 
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cinnamoyl ester (R)-41 as the RCM substrate. Therefore, acylation with cinnamoyl chloride and 
RCM reaction with catalyst 11A are the best reactions to achieve the final steps of this FMS.    
2.2.5 Fluorous mixture synthesis of passifloricin A diastereomers 
2.2.5.1 Pre-mix stage 
The synthesis began with the enantioselective allylation of aldehyde 4 using Maruoka 
catalyst (S,S)-28 to furnish homoallylic alcohol (R)-5 in 91% yield and er >99.5:0.5. Alcohol 
(R)-5 was protected with TBDPS chloride in 92% yield to furnish silyl ether (R)-43. The 
resulting silylether (R)-43 was hydroborated with 9-BBN and the resulting borane was oxidized 
with H2O2 to furnish alcohol (R)-44 in 79% yield.42 Primary alcohol (R)-44 was then oxidized in 
the presence of catalytic TEMPO and 2 equiv of commercial bleach43 to provide aldehyde (R)-12 
in 91% yield. Other oxidations provided (R)-12 in similar yields but were not easy to scale-up.44  
Aldehyde (R)-12 was split in half. The first batch was reacted with allyltitanocene (S,S)-
23 to produce (SR)-34 in 83% yield and 98.5:1.5 dr. The second batch was reacted with 
allyltitanocene (R,R)-23 to produce (RR)-34 in 82% yield and 1.5:98.5 dr (Scheme 12). The 
yields and diastereoselectivities for the scale-up reactions with allyltitanocenes (S,S)-23 and 
(R,R)-23 were similar to the small-scale test reactions. Homoallylic alcohol (SR)-34 was 
protected using TfOSi(iPr)2C2H4C4F9 (P2) and 2,6-lutidine in CH2Cl2 to provide (SR)-45 in 81% 
yield. Accordingly, homoallylic alcohol (RR)-34 was also protected using TfOSi(iPr)2C2H4C3F9 
(P1) and 2,6-lutidine in CH2Cl2 to provide (RR)-46 in 95% yield. The two single tagged 
compounds were mixed in an equimolar ratio to produce M47.  
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Scheme 12. Pre-mix stage of the FMS 
2.2.5.2 Mixture synthesis stage 
The mixture synthesis stage started with the oxidative cleavage of M47 to obtain 
aldehyde M13. The reaction of M47 and catalytic amounts of OsO4 with 2 equiv of NaIO4, as a 
cooxidant, produced aldehyde M13 in 50% yield together with 45% of recovered olefin M47. 
This result prompted a stepwise oxidation/diol cleavage sequence. Oxidation of M47 with 5 
mol% of OsO4 and 1 equiv of NMO provided a crude diol. The resulting crude mixture was 
dissolved in THF/H2O and reacted with 3 equiv of NaIO4 to give aldehyde M13 in 73% isolated 
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yield. M13 was carefully analyzed by 1H NMR, 19F NMR, fluorous HPLC, and fluorous LCMS 
before the next step.45  
  
a) Ratios are for HPLC traces of diols after removal of f luorous tag. Ratios = (SRR)-37:(RRR)-37 and
(SSR)-37:(RSR)-37.
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Scheme 13. Mixture synthesis stage 
 
The batch of aldehyde M13 was split in half. The first batch was subjected to another 
diastereoselective allylation with (S,S)-23 to produce (RMR)-36 in 88% yield after silica gel 
flash chromatography. Homoallylic alcohol (RMR)-36 was demixed and fractions (RRR)-36A 
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and (RSR)-36B were selectively desilylated to discover that diastereoselective ratios were 
97.5:3.5 and 95.5:4.5, respectively. The second batch of aldehyde M13 reacted with 
allyltitanocene (R,R)-23 to produce (SMR)-36 in 91% yield and 5:95/4.5:95.5 dr for compounds 
(SRR)-36A/(SSR)-36B respectively (Scheme 13). Homoallylic alcohol (RMR)-36 was protected 
using TfOSi(iPr)2C2H4C3F9 (P1) and 2,6-lutidine in CH2Cl2 to provide 48 in 94% yield. 
Furthermore, homoallylic alcohol (SMR)-36 was protected using TfOSi(iPr)2C2H4C6F13 (P3) and 
2,6-lutidine in CH2Cl2 to provide 49 in 97% yield. 
Both double tagged mixtures 48 and 49 were mixed to obtain a mixture of four 
quasiisomers M50A (P1P1, P2P1, P1P3, P2P3). HPLC analysis of M50A only showed two peaks 
(compounds with P1P1 and P2P1 fluorous tags combinations) when eluting with 100% ACN. The 
other two compounds (P1P3 and P2P3) only came off the column when they were eluted with a 
1:1 mixture of THF/ACN. Because of the high retention time showed by compounds with P1P3 
and P2P3 fluorous tags in M50A, it was hypothesized that the introduction of a tag with no 
fluorines P0 (Si(iPr)3) in replacement of P3 (Si(iPr)2C2H4C6F13) will decrease the retention time 
of the compounds on the fluorous HPLC column enough so they will be demixed under standard 
conditions. Homoallylic alcohol (RMR)-36 was then protected using TfOTIPS (P0) and 2,6-
lutidine in CH2Cl2 to provide 51 in 90% yield. Olefins 49 and 51 were mixed to form M50B. 
HPLC analysis of this four compound mixture showed four peaks using 100% ACN as solvent. 
The synthesis was continued using M50B. The oxidative cleavage reaction, under the conditions 
for M13, provided the mixture of four aldehydes M14 in 73% isolated yield (Scheme 13).  
 The construction of the last stereocenter started when the batch of aldehyde M14 was 
split in half. The first half was reacted with allyltitanocene (R,R)-23 to produce (S)-M52 in 80% 
yield. The second half of M14 reacted with allyltitanocene (S,S)-23 to produce (R)-M52 in 93% 
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yield (Scheme 14). The diastereoselectivities for homoallylic alcohols 52 were assumed to be the 
same as for homoallylic alcohols 36. The HPLC traces for M14 and alcohols M52 are in 
Appendix A. 
 
C14H29
OTBDPS
OP1,2OP0,1OH
Grubbs II,
toluene, ref lux
Cinnamoyl chloride,
DMAP, DCM, 0 oC
M14
(S,S)-23
split
C14H29
OTBDPS
OP1,2OP0,1OH
(R)-M52, 93%a
(S)-M52, 80%
P2 = (i-Pr)2SiC2H4C4F9
P1 = (i-Pr)2SiC2H4C3F7
P0 = (i-Pr)3Si
C14H29
OTBDPS
OP1,2OP0,1O
O
Ar
(R)-M15, 83%
Cinnamoyl chloride,
DMAP, DCM, 0 oC
(S)-M52 C14H29
OTBDPS
OP1,2OP0,1O
O
Ar
(S)-M15, 78%
C14H29
OTBDPS
OP1,2OP0,1O
OGrubbs II,
toluene, ref lux
C14H29
OTBDPS
OP1,2OP0,1O
O
(R)-M16, 85%
(S)-M16, 92%
a) HPLC traces for samples 52, 15 and 16 are in appendix A.
(R,R)-23
(R)-M52
(R)-M15
(R)-M15
 
Scheme 14. Mixture synthesis stage for final mixtures 
 
Homoallylic alcohols (R)-M52 and (S)-M52 were individually reacted with cinnamoyl 
chloride at 0 oC and DMAP in CH2Cl2 to provide mixtures (R)-M15 and (S)-M15 in 83 and 78% 
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yield, respectively. Finally, RCM reaction of mixtures (R)-M15 and (S)-M15 under conditions 
developed for model system (10 mol% of Grubbs II in refluxing toluene) provided final mixtures 
(R)-M16 and (S)-M16 in 85 and 92% isolated yield respectively.  
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Scheme 15. Demixing of final mixtures 16 
 
Analytical HPLC analysis of mixtures (R)-M16 and (S)-M16 showed 4 peaks for each 
mixture with the following retention times 30.9, 45.1, 53.2, and 69.7 min for (S)-M16 and 33.5, 
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47.0, 54.3, and 68.6 min for (R)-M16 (Scheme 15). The HPLC traces for mixtures M15 and 
M16 are in Appendix A. 
2.2.5.3 Post-mix stage 
After a careful analysis of mixtures (S)-M16 and (R)-M16 (19F NMR, 1H NMR, fluorous 
HPLC and fluorous LCMS), each mixture was demixed using a gradient elution on the fluorous 
semi-preparative HPLC (95:5 ACN:H2O to 100% ACN in 30 min plus another 30 min of 100 % 
ACN), as is shown in Scheme 15. The 384 mg of (S)-M16 was demixed in 39 mg/mL aliquots,  
to obtain, eluting in order of increasing fluorine content, the following quasidiastereomers: 61 
mg of (SRRR)-16, 72 mg of (SRSR)-16, 73 mg of (SSRR)-16, and 80 mg of (SSSR)-16. The 
overall yield for the demixing was 85%.  
The 378 mg of (R)-M16 was demixed in 38 mg/mL aliquots, to obtain, eluting in order of 
increasing fluorine content, the remaining quasidiastereomers: 56 mg of (RRRR)-16, 70 mg of 
(RRSR)-16, 69 mg of (RSRR)-16, and 75 mg of (RSSR)-16. The overall yield for the demixing 
was 82%. Each quasiisomer was carefully characterized by 19F NMR, 1H NMR, 13C NMR, 
HPLC and HRMS, showing a unique spectrum for each isomer. The demixing also allowed 
collection of some small impurities (shoulders in the HPLC trace) from each mixture: (S)-M16 
produced three impurities and (R)-M16 produced two. 
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Figure 8. Fluorous HPLC traces of mixtures (R)-M16 and (S)-M16 
 
Figure 8 shows a representative preparative HPLC trace for each mixture of 
quasidiastereomers (S)-M16 and (R)-M16. These HPLC traces also show the shoulder impurities 
isolated from the demixing of each mixture. Five diastereomeric impurities (16a (5 mg), 16b (7 
mg), 16c (8 mg), 16d (6 mg), and 16e (6 mg)) were isolated. Each impurity’s 1H NMR spectrum 
16b
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95:5 ACN:H2O to 100% ACN, then
isocratic ACN for 60 min
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95:5 ACN:H2O to 100% ACN, then
isocratic ACN for 60 min
16e
(SRRR)-16
(SSRR)-16
(SSSR)-16
(RRRR)-16
(RRSR)-16
(RSRR)-16
(RSSR)-16
(SRSR)-16
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matched a 1H NMR spectrum of quasiisomer 16. However, each 19F NMR spectrum matched a 
different quasiisomer spectrum, allowing determination of which diastereoselective allylation the 
impurity was formed (Figure 8). The spectroscopic data from impurities 16a, 16c, and 16e 
matched the 1H NMR and 19F NMR of the following quasiisomer ((RRSR)-16, (RSSR)-16, and 
(SSSR)-16 respectively), but were isolated from the opposite mixture. For example: 16e matched 
spectroscopic data for (SSSR)-16 but was isolated from (R)-M16, not from (S)-M16. These 
results indicated that these compounds were the diastereomeric impurities formed in the 
allylation of aldehyde M14 (4th allylation). Accordingly, 19b and 19d spectroscopic data 
matched the 1H NMR of quasiisomer ((SRRR)-16, (RRRR)-16) but the 19F NMR of quasiisomer 
((SSRR)-16, (RSRR)-16). These results clearly indicated that these compounds were the 
diastereomeric impurities formed in the allylation of aldehyde M13 (3rd allylation).    
Each quasiisomer 16 showed a unique 1H NMR spectrum. Figure 9 shows an expansion 
of the carbinol region (5-3.5 ppm) of each quasiisomer 16 1H NMR resonance. Analysis of the 
carbinol region from the 1H NMR spectrum also showed a pairing pattern among the 
quasiisomers. For example: quasiisomer (SRRR)-16 stereocenters C5, C7, and C9 are of the 
opposite configuration to those of (RSSR)-16 and, by comparing the carbinol region, the peaks 
have similar chemical shifts. This relationship is seen clearly in the carbinol region from the 1H 
NMR spectrum shown in Figure 9. The same pattern is seen for pairs (SRSR)-16:(RSRR)-16, 
(SSRR)-16:(RRSR)-16, and (SSSR)-16:(RRRR)-16.  
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Figure 9. 1H NMR carbinol region for compounds 16  
 
The next step was the global deprotection of the individual quasiisomers 16. Deprotection 
conditions were tested with the impurities collected from the demixing (16a-e) and the results are 
listed in Table 8. The reaction of 16a with TBAF in THF gave a messy TLC with no trace of 
lactone by 1H NMR spectroscopy (Entry 1).46 The reaction was next tried with PPTS in MeOH at 
RT, but only starting material was recovered. However, when the reaction was heated to 80 oC, 
the crude 1H NMR spectrum showed decomposition (Entry 2). Similar results were obtained 
when 16b reacted with HF·Py in THF and HCl 0.5M in MeOH (Entries 3 and 4). However, when 
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16b was reacted with HCl 2M in THF/H2O, traces of the product were observed in the crude 1H 
NMR spectrum (Entry 5).  
 
Table 8. Optimization of global deprotection reaction 
Entry Conditions Time (h) Yield
C14H29
OOPOP
OTBDPS
O
conditions C14H29
OOHOH
OH
O
16a-e 3
a) Traces of lactone olef in resonance on 1H NMR of crude reaction mixture.
b) Isolated yield.
Entry Conditions Time (h) Yield
1
2
5
4
3
6
7
8
TBAF/THF(6equiv)
PPTS/MeOH
HCl 2M THF/H2O
HF-Py/THF
HCl/MeOH 0.5N
HCl 0.5M EtOH/THF
HCl 3M EtOH/THF
HCl 3M EtOH/THF
0.5
6
12
20
12
20
20
48 64b
20b
5b
messy
messy
tracesa
decomposition
messy
579
12
579
12
 
 
The global deprotection of 16c was attempted using HCl 0.5 M in EtOH/THF to provide 
triol 3 in 5% yield after silica gel flash chromatography (Entry 6).47 It was next decided to do the 
reaction of 16d with HCl 3N in EtOH/THF and 3 was isolated in 20% after 20 h of reaction. 
Finally, when 16e was reacted under the same conditions for 48 h, 3 was isolated in 64% yield 
(Entries 7 and 8). 
These results encouraged us to use the optimized global deprotection conditions on all 
eight quasiisomers 16. Each quasiisomer 16 reacted with HCl 3M in EtOH/THF for 48 h to 
provide the respective triols 3. The crude mixture of each global deprotection reaction for 
quasiisomers 16 was purified first by silica gel flash chromatography, then by reverse phase 
HPLC (80:20 ACN:H2O for 20 min, then 100% ACN for 40 min), and finally by chiral HPLC on 
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a Chiracel OD semi-preparative column (90:10 Hex:iPrOH isocratic for 1 h). The global 
deprotection yields and isolated amounts for each diastereomer 3 are listed in Table 9. All the 
diastereomers were carefully characterized by NMR spectroscopy, HPLC, and optical rotation.    
 
Table 9. Global deprotection of quasiisomers 
Diasteromera tagb yield (%)c amount (mg) TR (min, OD)d TR (min, C18)e optical rotationf C (mg/mL)
(RSRR)-3
(RSSR)-3
(RRRR)-3
(RRSR)-3
(SSRR)-3
(SSSR)-3
(SRRR)-3
(SRSR)-3
40 (6.4) 8
22 (4.2) 4
21 (7.8) 4
29 (4.0) 5
44 (7.8) 8
32 (6.2) 7
27 (3.7) 6
28 (3.4) 6
8.3
11.9
12.3
7.8
7.9
8.5
9.1
9.4
9.1
9.1
11.5
14.8
9.0
7.3
10.5
12.4
P1+ P0
P2+ P0
P1+ P1
P1+ P2
P1+ P0
P2+ P0
P1+ P1
P1+ P2
a) The stereochemistry of the four stereocenter reads from right to left.
b) P1 = (i-Pr)2SiC2H4C3F7, P2 = (i-Pr)2SiC2H4C4F9, P0 = (i-Pr)3Si.
c) Yield of the global deprotection after chiral HPLC purification, and the yield in () is the overall yield for that
isomer.
d) Chiralcel OD column (isocratic hexanes:isopropanol 86:14).
e) C18 column (isocratic acetonitrile:water 80:20).
f) Measured the same day, all in MeOH.
-15.8
-21.5
-26.8
+15.3
+3.4
+12.2
-34.1
+19.2
C14H29
OOPOP
OTBDPS
O
HCl 3M EtOH/THF C14H29
OOHOH
OH
O
16 3
579
12
579
12
48h
0.93
0.7
0.8
0.8
0.31
0.9
0.46
0.39
 
 
Once the 1H NMR, 13C NMR, and αD for diastereomers 3 were obtained, it was possible 
to match the natural sample and synthetic passifloricin A to diastereomer (SRRR)-3. The 
matching of passifloricin A as the enantiomer of (SRRR)-3 was a further proof of the 
consistency of the tag coding and the efficiency of the multiple-tag FMS route. It was confirmed 
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that (SRRR)-3 was the enantiomer when its αD (−26.8, c = 0.8, MeOH) was of similar number to 
passifloricin A (26.8, c = 0.8, MeOH) but opposite in sign.  
 
(SSRR)-3
(SSSR)-3
(SRRR)-3
(SRSR)-3
C14H29
OOHOH
OH
O
579
12
(RSRR)-3
(RSSR)-3
(RRRR)-3
(RRSR)-3
(5R,7S,9S,12S)-Passifloricin A- 3
A
B
C
A'
D'
B'
C'
D
PAIRING PAT TERN
A/A', B/ B' , C/ C', D/D'  
Figure 10. 1H NMR fingerprint region for final diastereomers 3 
 
The other 3 diastereomers made by Marco were also matched with the diastereomers 
obtained here. Diastereomer (RSSR)-3 spectroscopic data matched Marco’s diastereomer 3d. In 
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the same fashion, (SSSR)-3 matched 3c and (RSSR)-3 matched 3b but their αD’s were of the 
opposite sign. The other 4 diastereomers had unique 1H and 13C NMR data.   
Figure 9 shows an expansion of the carbinol region for 1H NMR resonances (5-3.5 ppm) 
for all eight diastereomers. Analysis of the carbinol region shows the same pairing pattern seen 
for the quasiisomers 16 among the final diastereomers. For example: quasiisomer (SSRR)-3 
stereocenter C5, C7, and C9 are of the opposite configuration to those of (RRSR)-16, and by 
comparing the carbinol region the peaks have similar chemical shifts. This relationship is seen 
clearly in the 1H NMR resonance carbinol region shown in Figure 10. The same pattern is seen 
for the pairs (SSSR)-3:(RRRR)-3, (SRRR)-3:(RSSR)-3, and (SRSR)-3: (RSRR)-3.  
2.3 CONCLUSIONS 
 All eight diastereomers of passifloricin A have been synthesized by FMS. Spectroscopic 
data (1H NMR, 13C NMR, 1H1H COSY) have been obtained for the eight diastereomers. The 1H 
NMR spectrum for (SRRR)-3 matched the spectrum of the reported natural and synthetic 
passifloricin A ((SRRR)-3 is the enantiomer of passifloricin A). Three other diastereomers 
((SSSR)-3, (RRRR)-3 and (RSSR)-3) matched the corresponding three made by Marco. In 
addition four new diastereomers ((SSRR)-3, (SRSR)-3, (RSRR)-3, and (RRSR)-3) of 
passifloricin A were synthesized. 
 This FMS is the first example of multiple tagging fluorous mixture synthesis for the 
successful synthesis of all diastereomers of a natural product. In addition, this powerful 
technique demonstrated the accumulative sense of the fluorous tags as expressed by the 
systematic order of elution during the demixing.    
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 Multiple-tag FMS is very economical in the number of tags. Four diastereomers only 
required three tags, as eight will need five, and sixteen will need nine tags. We also proved that 
standard non-fluorous silanes may behave as tags (P0). This is especially important when too-
fluorous compounds get stuck in the fluorous HPLC columns.    
Enantioselective allylations are difficult reactions to carry out under complete reagent 
control with chiral substrates. We proved that Duthaler-Hafner enantioselective allylation is the 
best reaction for reagent control facial selectivity in acyclic aldehydes with β and δ chiral centers 
bearing a silyloxy group.  
 We achieved the FMS of the eight diastereomers of passifloricin A in 18 mixture steps, 
whereas the synthesis of all the diastereomers in a linear fashion would have required 44 steps. 
Multiple tagging FMS represents a very useful tool for organic synthesis and combinatorial 
chemistry. The impact lies on the versatility and efficiency of the method, allowing not only the 
synthesis of all the diastereomers of a natural product, but also the synthesis of libraries of 
related compounds. 
2.4 EXPERIMENTAL  
All reactions were performed under an atmosphere of argon unless otherwise specified or 
the reaction solvent contained water. The reaction times reported are dictated by TLC analysis of 
the reaction mixture in comparison to the starting material. Reaction solvents were freshly dried 
either by distillation or passing through an activated alumina column. Methylene chloride 
(CH2Cl2) was distilled from CaH2 and toluene, benzene, diethyl ether, and tetrahydrofuran (THF) 
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were distilled from Na/benzophenone. Acryloyl chloride was freshly distilled before use. All 
other commercially available solvents and reagents were used without further purification. 
 Products were analyzed by 1H NMR, 13C NMR,   19F NMR, LC-MS, FT-IR, high and low 
resolution mass spectrometry, and HPLC. NMR spectra were recorded on a Bruker WH-300, an 
IBM AF-300, an AM-500, or a Bruker AvanceTM 600 NMR spectrometer. Spectra were recorded 
at room temperature in the indicated deuterated solvents and chemical shifts were reported in 
parts per million (ppm) from the residual solvent signal of the deuterated solvent. In the case of 
19F NMR spectroscopy, no internal standard was used or any special care was taken to measure 
it. IR spectra were recorded on an IBM IR/32 spectrometer and ran as chloroform solutions. Low 
resolution mass spectra were obtained on a Hewlett Pakard-9000 GC-MS and high resolution 
spectra were recorded on a Varian MATCH-5DF instrument. HPLC analysis was performed on a 
Waters 600E system with UV detector. LC-MS spectra were obtained on a Hewlett Packard-
1100 LC-MS using APCI positive mode. All MS peaks are reported in units of m/z. Melting 
points were measured on a MEL-TEMP II apparatus and were not corrected.  
General allylation procedures: 
 (1)-AllylMgBr allylation of aldehyde 4: A 50 mL round bottom flask was filled with dry diethyl 
ether (20 mL) followed by addition of aldehyde 4 (452 mg, 2 mmol). At room temperature 
allylMgBr 1M (2.5 ml, 2.5 mmol) was added dropwise. The reaction was stirred at RT for 2 h. 
The reaction was quenched by addition of a saturated NH4Cl aqueous solution and the aqueous 
layer was extracted with diethyl ether (2x). The combined organic fractions were dried over 
MgSO4. The solution was concentrated and the crude mixture was purified by silica gel flash 
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chromatography eluting with hexanes/ethyl acetate (95:5) to yield homoallylic alcohol rac-5 
(530 mg, 100 %) as a waxy solid. 
(2)-Brown stereoselective allylation of aldehydes 4: (−)-methoxydiisopinocampheylborane 
(3.48 g, 1.1 mmol) was dissolved in dry diethyl ether (10 mL) in a 2-neck 100 ml flask 
previously heated under vacuum and flushed with argon. The solution was cooled to 0 °C before 
AllylMgBr 1M (10 mL, 10 mmol) was added slowly via syringe. After 10 min, the cooling bath 
was removed and stirring of the mixture was continued overnight at RT. The solvent was 
removed to a cooling trap by applying vacuum. Dry petroleum ether (25 ml) was added and the 
mixture was filtered under argon through a pad of celite in a filter tube to another 100 ml 2-neck 
flask. The precipitate was washed with dry petroleum ether (5 mL x 2) and the solvent was 
removed under vacuum. Dry ethyl ether was added to obtain a 0.5 M stock solution of (−)-allyl-
diisopinocampheylborane (20 mL, 10 mmol) in dry ether. The stock solution was cooled to −100 
°C under Argon and more ethyl ether (10 mL) was added. Aldehyde 4 (1.51 g, 6.67 mmol) was 
dissolved in a 1:1 mixture of ether:THF (60 mL) and was added slowly (1 h) via syringe. The 
temperature of the cooling bath was maintained at −100 °C for 2 h and another 2 h at −78 °C, 
before the reaction was quenched by addition of methanol (1 mL). The solution was warmed to 
RT overnight before 3 N NaOH (4 mL) and 30% wt. H2O2 (8 mL) were added at 0 °C. After 10 
min at 0 °C, the mixture was refluxed for 3 h. After cooling to 0 °C, a saturated Na2SO3 aqueous 
solution was added and the aqueous layer was extracted with diethyl ether (2x). The combined 
organic fractions were dried over MgSO4. The solution was concentrated and the crude mixture 
was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 95:5 to yield 
homoallylic alcohol (R)-5  (1.60 g, 91 %) as a waxy solid. 
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(2)-Leighton stereoselective allylation of aldehyde 4: Aldehyde 4 (100 mg, 0.44 mmol) was 
dissolved in dry dichloromethane (0.5 mL) and added slowly under inert conditions to a solution 
of silacyle (R,R)-29 (444 mg, 0.80 mmol) in dry dichloromethane (3.5 mL) at −10 °C. After 4 h 
at −15 °C, ethyl acetate and 1 M aqueous solution of HCl were added. The mixture was stirred 
vigorously for 1 h. The aqueous layer was extracted with diethyl ether (2x). The combined 
organic fractions were dried over MgSO4. The solution was concentrated and the crude mixture 
was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 92:8 to yield 
homoallylic alcohol (R)-5 (54 mg, 51 %) as a waxy solid. 
(4)-Keck stereoselective allylation of aldehyde 4:  (S)-BINOL (120 mg, 0.4 mmol) was slurred 
in dry toluene (4 mL) under an argon atmosphere at RT followed by the addition of Ti(OiPr)4 
(120 μl, 0.40 mmol) over a time period of 5 min. A color change to deep red was observed and 
stirring at RT was continued for 60 min. Aldehyde 4 (184 mg, 0.81 mmol) was added, followed 
by allyltributyltin (0.3 ml, 0.9 mmol) After 20 h at RT, the reaction was quenched by the 
addition of water. The aqueous layer was extracted with diethyl ether (2x). The combined 
organic fractions were dried over MgSO4. The solution was concentrated and the crude mixture 
was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 9:1 to yield 
homoallylic alcohol (R)-5 (110 mg, 50 %) as a waxy solid. 
(5)-Duthaler-Hafner stereoselective allylation of aldehdye 4: (R,R)-Duthaler-Hafner reagent 
(676 mg, 1.1 mmol) was dissolved in dry diethyl ether (12 mL) under an argon atmosphere. The 
solution was cooled to 0 °C. AllylMgCl 2M (0.4 ml, 0.8 mmol) was added dropwise over a 
10 min time period. The reaction was stirred at 0 °C for 1.5 h. Before the solution was cooled to 
−78 °C, aldehyde 4 (360 mg, 0.4 mmol), dissolved in diethyl ether (1 mL), was added. After 3 h, 
a 45% aqueous NH4F solution was added. The mixture was stirred overnight allowing it to warm 
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up to RT. The mixture was diluted with water. The aqueous layer was extracted with diethyl 
ether (2x). The combined organic fractions were dried over MgSO4. The solution was 
concentrated and the crude mixture was purified by silica gel flash chromatography eluting with 
hexanes/ethyl acetate 9:1 to yield homoallylic alcohol (R)-5 (162 mg, 86 %) as a waxy solid. 
(6)-Maruoka stereoselective allylation of aldehyde 4: A 25 mL round bottom flask was filled 
with Ti(i-PrO)4 (88 μL, 0.3 mmol) followed by 1M TiCl4 (0.1 mL, 0.1 mmol) and dissolved in 
dichloromethane (2 mL). The solution was cooled to 0 oC then stirred for 1 h. Ag2O (46 mg, 0.2 
mmol) was added. The reaction mixture was protected from light by wrapping the reaction flask 
with aluminium foil. Stirring at RT continued for 5 h and (S)-BINOL (114 mg, 0.4 mmol), 
dissolved in dichloromethane (1 mL), was added. The resulting solution was stirred for 2 h. 
Aldehyde 4 (452 mg, 2 mmol) dissolved in dichloromethane (5 mL) was added slowly to the 
solution. The solution was stirred at RT for 5 min then allylBu3Sn (680 μL, 2.2 mmol) was 
added. The resulting mixture was stirred for 48 h. The reaction was quenched by addition of 
water. The aqueous layer was extracted with diethyl ether (2x). The combined organic fractions 
were dried over MgSO4. The solution was concentrated and the crude mixture was purified by 
silica gel flash chromatography eluting with hexanes/ethyl acetate 9:1 to yield homoallylic 
alcohol (R)-5  (172 mg, 91 %) as a waxy solid. 
(7)-Walsh stereoselective allylation of aldehyde 4: A 10 mL round bottom flask was filled with 
(S)-BINOL (36 mg, 0.12 mmol) and dichloromethane (0.5 mL), followed by the addition of Ti(i-
PrO)4 (35 mg, 0.12 mmol). The solution was stirred for several minutes, and 2-propanol (633 μL, 
8.3 mmol) followed by aldehyde 4 (100 mg, 0.4 mmol) dissolved in dichloromethane (1 mL) 
were added together with tetraallyltin (150 μL, 0.6 mmol). The color of the reaction mixture 
changed from brown to yellow after several minutes and stirring was continued for 2 h at RT. 
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The reaction was quenched with a saturated NH4Cl solution and the aqueous layer was extracted 
with diethyl ether (2x). The combined organic fractions were dried over MgSO4, and the solution 
was concentrated and the crude mixture was purified by silica gel flash chromatography eluting 
with hexanes/ethyl acetate 9:1 to yield homoallylic alcohol (R)-5 (160 mg, 85 %) as a waxy 
solid.   
                                                                     C14H29
O
    
Pentadecanal (4):  
A 100 mL round bottom flask was filled with dry dichloromethane (120 mL) followed by 
n-pentadecanol (15.03 g, 66.4 mmol), to this solution was added Et3N (52 mL, 372 mmol) 
followed by DMSO (140 mL). The solution was cooled to 0 oC and a solution of PySO3 complex 
(29.6 g, 186 mmol) in DMSO (100 mL) was added slowly. The reaction mixture was allowed to 
warm up to RT and stirred vigorously for 2 h. The reaction mixture was quenched with a 0.1 M 
aqueous solution of HCl and the organic layer was extracted with diethyl ether (2x). After drying 
over MgSO4, the solution was concentrated and the crude product was purified by silica gel flash 
chromatography eluting with hexanes/ethyl acetate 97:3 to yield n-pentadecanal 4  
(14.53 g, 96 %) as a waxy solid. 1H-NMR (300 MHz, CDCl3) δ  9.74 (t, J = 1.6 Hz, 1H), 2.40 
(td, J = 7.4, 1.8 Hz, 2H), 1.89-1.12 (m, 24H), 0.86 (t, J = 6.6 Hz, 3H). 
 
C14H29
OH
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A 25 mL round bottom flask was filled with Ti(i-PrO)4 (88 μL, 0.3 mmol) followed by 
TiCl4 (0.1 mL, 1M) and dissolved in dichloromethane (2 mL). The solution was cooled to 0 oC 
and was stirred for 1 h and AgO (46 mg, 0.2 mmol) was added and the flask was protected from 
light with aluminium foil. The reaction was stirred at RT for another 5 h and then (S)-BINOL 
(114 mg, 0.4 mmol), dissolved in dichloromethane (1 mL), was added, followed by continuous 
stirring for 2 h. Aldehyde 4 (452 mg, 2 mmol) dissolved in dichloromethane (5 mL) was added 
slowly to the solution and after 5 min, allylBu3Sn (680 μL, 2.2 mmol) was added and the 
reaction was stirred at RT for 48 h. The reaction was quenched by addition of water and the 
aqueous layer was extracted with diethyl ether (2x). The combined organic fractions were dried 
over MgSO4, the solution was concentrated and the crude mixture was purified by silica gel flash 
chromatography eluting with hexanes/ethyl acetate 9:1 to yield homoallylic alcohol (R)-5  
(172 mg, 91 %, >99.5:0.5 er) as a waxy solid: [α]D +2.9 (c 0.8, CHCl3); 1H-NMR (300 MHz, 
CDCl3) δ 5.96 (ddt, J = 19.7, 12.4, 7.8 Hz, 1H), 5.28 (dd, J = 19.7, 4.3 Hz, 1H), 5.27 (dd, J = 
12.4, 4.3 Hz, 1H), 3.60 (tt, J = 7.0, 5.7 Hz, 1H), 2.28 (dd, J = 7.8, 6.1 Hz, 1H), 2.11 (dd, J = 7.8, 
6.1 Hz, 1H), 1.44-1.46 (m, 2H), 1.36-1.22 (m, 24H), 0.86 (t, J = 6.7 Hz, 3H); 13C-NMR (75 
MHz, CDCl3) δ 134.9, 118.1, 70.7, 41.9, 36.8, 31.9, 29.7(x8), 29.5, 25.7, 22.7, 14.1 ppm.  
 
                                                        C14H29
O O
PhMeO
 
(S)-((R)-Octadec-1-en-4-yl) 2-methoxy-2-phenylacetate ((RS)-33): 
A 25 mL round bottom flask was filled with dichloromethane (1 mL), followed by 
addition of homoallylic alcohol (R)-5 (27 mg, 0.1 mmol) and (2S)-methoxy-2-phenyl acetic acid 
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(25 mg, 0.15 mmol). DMAP (18 mg, 1.5 mmol) was added and the solution was cooled to 0 °C 
and DCC (41 mg, 0.2 mmol) was then added and the reaction was warmed to RT overnight. The 
white precipitate was filtered on a plug of celite, and after evaporation of the solvent the crude 
product was quickly purified by silica gel flash chromatography eluting with hexanes/ethyl 
acetate 9:1 to yield (RS)-33 (49 mg, 95 %) as a clear oil: [α]D +14.3 (c 0.5, CHCl3); IR (thin 
film) 3054, 1741, 1265 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.59-7.56 (m, 2H), 7.50-7.47 (m, 
3H), 5.55 (ddt, J = 17.0, 10.0, 7.1 Hz, 1H), 5.04 (d, J = 17.9 Hz, 1H), 5.02 (d, J = 9.6 Hz, 1H), 
4.96 (tt, J = 6.3, 6.3 Hz, 1H), 4.73 (s, 1H), 3.42 (s, 3H), 2.31 (t, J = 6.6 Hz, 2H), 1.46-1.37 (m, 
4H), 1.30-0.98 (m, 24H), 0.86 (t, J = 6.5 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 170.4, 136.5, 
133.6, 128.6, 128.5, 127.2, 117.7, 82.7, 74.2, 57.3, 38.7, 33.5, 31.9, 29.7(x8), 29.4, 24.8, 22.7, 
14.1 ppm; HRMS exact mass calcd for C27H44O3: 516.3292, found: 516.3284. The analysis to 
determine the er was done by HPLC on a silica-pak column, with isocratic elution 99:1 
hexanes:isopropanol at 0.7 mL/min. TR = 7.5 min.  
 
                                                       C14H29
OTBDPS
 
(R)-tert-Butyl(octadec-1-en-4-yloxy)diphenylsilane ((R)-43): 
A 50 mL round bottom flask was filled with dry DMF (3 mL) followed by TBDPSCl 
(1.9 ml, 7.1 mmol) and imidazole (964 mg, 14.2 mmol). Homoallylic alcohol (R)-5 (1.46 g, 6.38 
mmol) was then added portion wise to the solution, and after 4 h of vigorous stirring, the solution 
was diluted by addition of dichloromethane and 1M aqueous solution of HCl was added for 
hydrolysis. The aqueous layer was extracted with diethyl ether (2x) and the combined organic 
fractions were dried over MgSO4, and the solution was concentrated and the crude mixture was 
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purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 99.5:0.5 to yield 
(R)-43 (2.95 g, 92 %)  as a clear oil: [α]D +12.1 (c 0.9, CHCl3); IR (thin film) 3072, 3052, 2927, 
2856, 1639, 1589, 1469, 1110, 1058, 920 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.65 (dd, J = 7.6, 
1.5 Hz, 4H), 7.40-7.30 (m, 6H), 5.78 (ddt, J = 19.7, 12.4, 7.8 Hz, 1H),  5.00 (d, J = 17.3 Hz, 1H) 
4.97 (d, J = 9.9 Hz, 1H), 3.78 (tt, J = 5.7, 5.5 Hz, 1H), 2.23 (dd, J = 7.3, 6.2 Hz, 2H), 1.42-1.34 
(t, J = 5.5 Hz, 2H), 1.30-1.05 (m, 26H), 1.03 (s, 9H), 0.86 (t, J = 6.6 Hz, 3H); 13C-NMR (75 
MHz, CDCl3) δ 135.9, 135.1, 134.6, 129.4, 127.4, 116.6, 72.8, 41.0, 36.0, 31.9, 29.7(x8), 29.4, 
27.0(x3), 24.8, 22.7, 19.4, 14.1 ppm; HRMS exact mass calcd for C34H54O1Si: 506.3949, found: 
506.3931. 
 
                                                       
C14H29
OTBDPS
OH  
(R)-4-(tert-Butyldiphenylsilyloxy)octadecan-1-ol ((R)-44): 
TBS ether (R)-43 (2.43 g, 4.8 mmol) was dissolved in dry THF (48 mL) under argon 
atmosphere and cooled to 0 °C. 0.5 M 9-BBN (29 ml, 57.6 mmol) was added to the reaction 
dropwise, and the reaction was stirred continuously for 3 h. The reaction was quenched by the 
addition of ethanol (10 mL), followed by phosphate buffer pH = 7 (10 mL) and slow addition of 
30 % wt H2O2 (15 mL). The ice-bath was removed and the solution was stirred at RT overnight. 
The solution was cooled to 0 °C before saturated Na2SO3 aqueous solution was added slowly. 
The layers were separated and the aqueous layer was extracted with dichloromethane (2x). After 
drying over MgSO4, the solution was concentrated and the crude product was purified by silica 
gel chromatography eluting with hexanes/ethyl acetate 92:8 to yield primary alcohol (R)-44 
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(2.10 g, 83 %) as a clear oil: [α]D +9.5 (c 1.1, CHCl3); IR (thin film) 3150, 3054, 2985, 1421, 
1305 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.66 (dd, J = 7.6, 1.5 Hz, 4H), 7.43-7.32 (m, 6H), 3.78 
(t, J = 5.2 Hz, 1H), 3.52 (t, J = 5.5 Hz, 2H), 2.43 (t, J = 6.4 Hz, 1H), 1.98-1.94 (m, 2H), 1.79-
1.75 (m, 2H), 1.57-1.46 (m, 8H), 1.35-1.10 (m, 24H), 1.04 (s, 9H), 0.86 (t, J = 6.6 Hz, 3H);  13C-
NMR (75 MHz, CDCl3) δ 135.9, 134.4, 129.5, 127.4, 72.9, 63.1, 41.9, 36.0, 32.3, 31.9, 29.7(x8), 
27.0(x3), 25.6, 24.7, 22.7, 19.3, 14.1 ppm; HRMS exact mass calcd for C34H56O2SiNa: 547.3947, 
found: 547.3965. 
                                                              
C14H29
OTBDPS
O  
(R)-4-(tert-butyldiphenylsilyloxy)-octadecanal ((R)-12): 
A 100 mL round bottom flask was filled with dichloromethane (20 mL) followed by 
alcohol (R)-44 (832 mg, 1.6 mmol). The solution was cooled to 0 oC and TEMPO (2.5 mg, 1 
mol%) was added.  To the mixture was added KBr (4 mL,  2.25 M)  and KHCO3 (10 mL, 1.6 M), 
followed by slow addition of NaOCl (8 mL, 6.15%). The mixture was stirred until the dark 
orange color disappeared. The reaction was quenched with saturated aqueous solution of 
Na2SO3, and the reaction was stirred at 0 oC for 1 h. The layers were separated and the aqueous 
layer was extracted with dichloromethane (2x). After drying over MgSO4, the solution was 
concentrated and the crude product was purified by silica gel chromatography eluting with 
hexanes/ethyl acetate (10:1) to yield aldehyde (R)-12 (757 mg, 91%) as a clear oil: [α]D +13.6 (c 
0.8, CHCl3); IR (thin film) 3049, 2989, 2887, 1720, 1620, 1612, 1260, 1110, 960 cm-1; 1H-NMR 
 73 
(500 MHz, CDCl3) δ 9.65 (s, 1H), 7.64 (dd, J = 8.4, 1.8 Hz, 4H), 7.43-7.35 (m, 6H), 3.79 (t, J = 
5.6 Hz, 1H), 2.45 (td, J = 6.0, 1.5 Hz, 2H), 1.81 (ddt, J = 6.0, 5.6 Hz, 1H), 1.71 (ddt, J = 7.6, 5.6 
Hz, 1H), 1.43-1.39 (m, 2H), 1.30-1.05 (m, 24H), 1.03 (s, 9H), 0.86 (t, J = 6.9 Hz, 3H); 13C-NMR 
(75 MHz, CDCl3) δ 202.6, 135.9, 134.3, 129.6, 127.5, 72.1, 39.4, 36.2, 31.9, 29.7(x8), 29.5, 
28.1, 27.0(x3), 25.0, 22.7, 19.4, 14.1 ppm; LRMS m/z 521 ((M − H), 21%), 368 (100%), 223 
(35%). 
 
                                                          
C14H29
OTBDPS
OH  
(4R,7R)-7-(tert-Butyldiphenylsilyloxy)henicos-1-en-4-ol ((RR)-34): 
Titanocene (R,R)-23 (676 mg, 1.1 mmol) was dissolved in dry diethyl ether (12 mL) under an 
argon atmosphere. The solution was cooled to 0 °C and allylMgCl 2M (0.4 ml, 0.8 mmol) was 
added dropwise over 10 min. The mixture was stirred at 0 °C for 1.5 h, before the solution was 
cooled to −78 °C. Aldehyde (R)-12 (511 mg, 0.98 mmol) was dissolved in diethyl ether (1 mL) 
and added. After 3 h, a 45% aqueous NH4F solution was added and the mixture was stirred 
overnight allowing it to warm up to RT. The mixture was diluted with water and diethyl ether. 
The layers were separated and the aqueous layer was extracted with dichloromethane (2x). After 
drying over MgSO4, the solution was concentrated and the crude product was purified by silica 
gel chromatography eluting with hexanes/ethyl acetate 9:1 to yield homoallylic alcohol (RR)-34 
(162 mg, 73 %, 1:99 dr) as a light yellow oil: [α]D +21.4 (c 0.6, CHCl3); IR (thin film) 3463, 
3085, 2983, 1741, 1556, 1465, 1373, 1299, 1099 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.66 (dd, J 
= 8.4, 1.8 Hz, 4H), 7.41-7.33 (m, 6H), 5.75 (ddt, J = 16.4, 10.8, 7.8 Hz, 1H), 5.10 (d, J = 10.9 Hz, 
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1H), 5.09 (d, J = 16.4 Hz, 1H), 3.76 (tt, J = 5.4, 5.3 Hz, 1H), 3.50 (ddt, J = 7.7, 7.4, 4.8 Hz, 1H), 
2.18 (ddd, J = 7.8, 7.0, 6.5 Hz, 1H), 2.09 (ddd, J = 7.8, 7.5, 6.5 Hz, 1H), 1.65-1.59 (m, 2H), 1.49-
1.38 (m, 6H), 1.36-1.09 (m, 24H),  1.04 (s, 9H), 0.86 (t, J = 6.6 Hz, 3H); 13C-NMR (75 MHz, 
CDCl3) δ 135.9, 134.9, 134.5, 129.5, 127.4, 117.7, 73.2, 71.0, 41.7, 36.1, 32.3, 32.0, 31.9, 
29.7(x8), 29.4, 27.0(x3), 24.9, 22.7, 19.4, 14.1 ppm; HRMS exact mass calcd for C37H60O2Si: 
564.4368, found: 564.4544. 
 
C14H29
OTBDPS
OH  
(4S,7R)-7-(tert-Butyldiphenylsilyloxy)henicos-1-en-4-ol ((SR)-34): 
The synthesis of this compound was done by same the procedure as (RR)-34, using 
allyltitanocene (S,S)-23 with (R)-12 (528 mg, 1.01 mmol). The purification was done by silica 
gel flush chromatography eluting with hexanes/ethyl acetate (95:5) to yield (SR)-34 (468 mg, 
75%, 99:1 dr) as a slightly yellow oil: [α]D -4.3 (c 0.5, CHCl3); IR (thin film) 3450, 3085, 2940, 
1741, 1448, 1370, 1160 cm-1; 1H-NMR (500 MHz, CDCl3) δ  7.66 (dd, J = 8.4, 1.8 Hz, 4H), 
7.40-7.32 (m, 6H), 5.75 (ddt, J = 17.2, 10.0, 7.6 Hz, 1H), 5.11 (d, J = 10.0 Hz, 1H), 5.10 (d, J = 
16.4 Hz, 2H), 3.78 (tt, J = 5.4, 5.2 Hz, 1H), 3.48 (ddt, J = 7.9, 7.4, 4.0 Hz, 1H), 2.19 (ddd, J = 
7.7, 7.1, 6.7 Hz, 1H), 2.07 (ddd, J = 7.9, 7.3, 6.7 Hz, 1H), 1.55-1.39 (m, 8H), 1.35-1.02 (m, 
24H), 1.01 (s, 9H), 0.87 (t, J = 6.6 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 135.9, 134.9, 134.6, 
129.5, 127.4, 117.9, 72.9, 70.7, 41.8, 36.2, 31.9, 31.8, 31.6, 29.7(x8), 29.4, 27.1(x3), 25.0, 22.7, 
19.4, 14.1 ppm; HRMS exact mass calcd for C37H60O2Si: 564.4368, found: 564.4442. 
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C14H29
OTBDPS
O O
OMePh  
(S)-((4R,7R)-7-(tert-Butyldiphenylsilyloxy)henicos-1-en-4-yl)2-methoxy-2-phenylacetate 
((SRR)-28): 
The synthesis of this compound was done by same method as (R)-26, with (RR)-27 (57 
mg, 0.1 mmol). The purification was done by silica gel chromatography eluting with 
hexanes/ethyl acetate (95:5) to yield (SRR)-28 (70 mg, 97 %) as a clear oil: [α]D +17.8 (c 0.5, 
CHCl3); IR (thin film) 3061, 2927, 1740, 1569, 1456 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.63 
(dd, J = 8.4, 1.8 Hz, 4H), 7.43-7.29 (m, 11H), 5.37 (ddt, J = 17.0, 10.4, 6.7 Hz, 1H), 4.87 (tt, J = 
6.6, 5.9 Hz, 1H), 4.79 (d, J = 8.6 Hz, 1H), 4.76 (d, J = 16.8 Hz, 1H), 3.70 (tt, J = 5.6, 5.5 Hz, 
1H), 3.39 (s, 3H), 2.06 (t, J = 6.6, 2H), 1.62-1.45 (m, 4H), 1.42-1.38 (m, 6H), 1.36-1.08 (m, 
26H), 1.07 (s, 9H), 0.86 (t, J = 6.6 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 170.3, 136.4, 135.9, 
134.6, 132.9, 129.5, 128.5, 127.4, 127.2, 117.7, 82.6, 74.3, 72.7, 57.3, 38.3, 36.3, 31.9, 31.6, 
29.7(x8), 29.4, 28.7, 27.1(x3), 24.8, 22.7, 19.4, 14.1 ppm; HRMS exact mass calcd for 
C46H68O4SiNa: 735.4785, found: 735.4801. The analysis to determine the dr was done by HPLC 
on a silica-pak column, with isocratic elution 99:1 hexanes:isopropanol at 0.7 mL/min. TR = 
10.18 min.  
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C14H29
OTBDPS
O O
OMePh  
(S)-((4S,7R)-7-(tert-Butyldiphenylsilyloxy)henicos-1-en-4-yl)2-methoxy-2-phenylacetate 
((SSR)-28): 
The synthesis of this compound was done by same method as (R)-26, with (SR)-27 (54 
mg, 0.1 mmol). The crude mixture was purified by silica gel flash chromatography eluting with 
hexanes/ethyl acetate (95:5) to yield (SSR)-28 (63 mg, 93 %) as a clear oil: [α]D -9.2 (c 0.4, 
CHCl3); IR (thin film) 3065, 2985, 1744, 1560, 1421 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.60 
(dd, J = 8.4, 1.8 Hz, 4H), 7.41-7.30 (m, 11H), 5.60 (ddt, J = 15.5, 10.7, 6.9 Hz, 1H), 5.00 (d, J = 
15.5 Hz, 1H), 4.99 (d, J = 10.7 Hz, 1H), 4.84 (tt, J = 6.7, 5.4 Hz, 1H), 4.69 (s, 1H), 3.51 (tt, J = 
5.7, 5.5 Hz, 1H), 3.40 (s, 3H), 2.22 (t, J = 6.9 Hz, 2H), 1.56-1.46 (m, 2H), 1.36-1.10 (m, 28H), 
1.09 (s, 9H), 0.86 (t, J = 6.6 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 170.3, 136.4, 135.9, 134.6, 
134.5, 129.4, 128.5, 127.4, 127.1, 117.7, 82.7, 74.7, 73.0, 57.3, 38.6, 36.4, 31.9, 31.7, 29.7(x8), 
29.5, 29.4, 27.0(x3), 24.5, 22.7, 19.4, 14.1 ppm; HRMS exact mass calcd for C46H68O4SiNa: 
735.4785, found: 735.4818. The analysis to determine the dr was done by HPLC on a silica-pak 
column, with isocratic elution 99:1 hexanes:isopropanol at 0.7 mL/min. TR = 12.61 min.  
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C14H29
OTBDPS
OP1   
P1 = (i-Pr)2SiCH2CH2C3F7 
1-(tert-Butyl((4R,7R)-4-((3,3,4,4,5,5,5-heptafluoropentyl)diisopropylsilyloxy)henicos-1-en-7-
yloxy)(phenyl)silyl)benzene ((RR)-39): 
Trifluoromethanesulfonic acid (1.3 ml, 15.1 mmol) was added to (3,3,4,4,5,5,5-
heptafluoropentyl)diisopropylsilane (5.53 g, 17.7 mmol) at 0 °C, and the solution was stirred 
overnight. The mixture was cooled to 0 °C before a solution of secondary alcohol (RR)-27 (5 g, 
8.9 mmol) and 2,6-lutidine (3.4 ml, 30.2 mmol) dissolved in dry dichloromethane (13 mL) was 
added. The resulting mixture was stirred for 30 min at 0 °C and 1 h at RT. The solution was 
diluted with dichloromethane and quenched with a saturated NH4Cl solution and water. The 
layers were separated and the aqueous layer was extracted with dichloromethane (2x). After 
drying over MgSO4, the solution was concentrated and the crude product was purified by silica 
gel chromatography eluting with pure hexanes followed by hexanes/ethyl acetate 95:5 to yield 
(RR)-39 (7.36 g, 95 %) as a slightly yellow liquid: [α]D +16.2 (c 1.3, CHCl3); IR (thin film) 
3068, 2977, 1459, 1365, 1230, 1110, 1050, 960 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.63 (dd, J 
= 8.4, 1.8 Hz, 4H), 7.39-7.30 (m, 6H), 5.68 (ddt, J = 17.7, 9.3, 7.1 Hz, 1H), 5.00 (d, J = 9.3 Hz, 
1H), 4.99 (d, J = 17.7 Hz, 1H), 3.75-3.60 (m, 2H), 2.15-1.99 (m, 4H), 1.55-1.38 (m, 8H), 1.37-
1.03 (m, 28 H), 1.02 (s, 9H), 0.98 (s, 14H), 0.89 (t, J = 6.6 Hz, 3H), 0.85-079 (m, 2H); 19F-NMR 
(282 MHz, CDCl3) δ -79.4 (3F), -116.3 (2F), -126.4 (2F); 13C-NMR (75 MHz, CDCl3); δ 135.9, 
134.8, 134.7, 129.4, 127.4, 117.1, 73.3, 72.7, 41.4, 36.3, 31.9(x3), 31.7, 29.7(x8), 29.4, 27.0(x3), 
25.4 , 24.8, 22.7, 21.3, 19.4, 17.7 (x4), 17.4 (t, JCF= 4.5 Hz), 14.1, 12.9, 12.4, 0.5 ppm; HRMS 
exact mass calcd for C48H77F7O2Si2: 874.5352, found: 874.5358.  
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C14H29
OTBDPS
OP2  
                                     P2 = (i-Pr)2SiCH2CH2C4F9 
1-(tert-Butyl((4S,7R)-4-(diisopropyl(3,3,4,4,5,5,6,6,6-nonafluorohexyl)silyloxy)henicos-1-en-
7-yloxy)(phenyl)silyl)benzene ((SR)-39): 
The synthesis of this compound was done by the same method used for (SR)-39, with 
(3,3,4,4,5,5,6,6,6-nonafluorohexyl)silane (6.42 g, 17.7 mmol) and alcohol (SR)-27 (5 g, 
8.8 mmol) The crude product was purified by silica gel flash chromatography eluting with pure 
hexanes followed by hexanes/ethyl acetate 95:5 to yield (SR)-39 (6.63 g, 81 %) as a slightly 
yellow oil: [α]D -21.2 (c 1.4, CHCl3); IR (thin film) 3050, 2975, 1459, 1365, 1288, 1180, 1070, 
912 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.63 (dd, J = 8.4, 1.8 Hz, 4H), 7.39-7.30 (m, 6H), 5.67 
(ddt, J = 16.7, 10.8, 7.1 Hz, 1H), 5.04 (d, J = 10.8 Hz, 1H), 5.03 (d, J = 16.7 Hz, 1H), 3.78-3.60 
(m, 2H), 2.16-2.05 (m, 4H), 1.48-1.40 (m, 8H), 1.32-1.00 (m, 28 H), 0.99 (s, 9H),  0.95 (s, 14H), 
0.91 (t, J = 6.3 Hz, 3H), 0.86-0.80 (m, 2H); 19F-NMR (282 MHz, CDCl3) δ -79.8 (3F), -115.6 
(2F), -123.1 (2F), -124.9(2F); 13C-NMR (75 MHz, CDCl3) δ 135.9, 134.7, 134.6, 129.4, 127.4, 
117.1, 73.3, 72.8, 41.3, 36.2, 31.9(x3), 31.7, 29.7(x8), 29.4, 27.6, 27.0(x3), 25.5 (t, JCF= 24.4 
Hz), 24.8, 22.7, 19.4, 18.6, 17.6(x4), 14.1, 12.9, 0.5 ppm; HRMS exact mass calcd for 
C49H77F9O4Si2: 924.5328, found: 924.5351. 
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C14H29
OTBDPS
OP2,1
O
  
P1 = (i-Pr)2SiCH2CH2C3F7 
P2 = (i-Pr)2SiCH2CH2C4F9 
(6R)-6-(tert-Butyldiphenylsilyloxy)-3-((perfluoroalkylethyl)diisopropylsilyloxy)icosanal 
(M13): 
Alkene mixture M47 (695 mg, 0.77 mmol) was suspended under vigorous stirring in 
acetone/water 4:1 (5 mL) and cooled to 0 °C. NMO (181 mg, 1.5 mmol) was added, followed by 
OsO4 (9 mg, 0.04 mmol). Stirring was continued for 30 min, the ice bath was removed and 
stirring was continued overnight at RT. The mixture was diluted with ether and a saturated 
Na2SO3 aqueous solution was added. The layers were separated and the aqueous layer was 
extracted with dichloromethane (3x). After drying over MgSO4, the solution was concentrated 
and the crude product (394 mg, 0.42 mmol) was suspended in acetone/water 4:1 (3 mL), to the 
resulting solution was added NaIO4 (540 mg, 2.53 mmol) portion-wise at RT. After 6 h diethyl 
ether and water were added and the layers were separated. The aqueous layer was extracted two 
times with dichloromethane and the combined organic layers were dried over MgSO4, the 
resulting solution was concentrated and the crude product was purified over silica gel flash 
chromatography eluting with hexanes/ethyl acetate 8:2 to yield M13 (506 mg, 73 %) as a clear, 
slightly yellow oil: 1H-NMR (300 MHz, CDCl3) δ 9.76-9.73 (m, 1H), 7.68 (dd, J = 7.7, 1.6 Hz, 
4H), 7.47-7.36 (m, 6H), 4.22 (tt, J = 5.6, 5.4 Hz, 1H), 4.1 (tt, J = 5.5, 5.4 Hz, 1H), 3.82-3.68 (m, 
2H), 2.44-2.39 (m, 2H), 2.20-1.97 (m, 2H), 1.57-1.39 (m, 6H), 1.34-1.09 (m, 28H), 1.07 (s, 9H), 
1.03-0.98 (m, 14H), 0.91 (t, J = 6.7 Hz, 3H), 0.86-0.80 (m, 2H); 19F-NMR (282 MHz, CDCl3): 
δ = -79.4 (3F), -79.8 (3F), -115.5 (2F), -116.2 (2F), -123.0 (2F), -124.8 (2F), -126.4 (2F) ppm; 
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LCMS (APCI, positive mode) m/z for M13: (RR)-13 = 918.5 (M + K), 799.5 (M − Ph), 662.5, 
471.5, 275.2; (SR)-13 = 966.5 (M + K), 849.5 (M − Ph), 671.3, 471.4, 293.2, 275.2. 
 
                              OH
C14H29
OTBDPS
OP2,1   
P1 = (i-Pr)2SiCH2CH2C3F7 
P2 = (i-Pr)2SiCH2CH2C4F9 
(4S,9R)-9-(tert-Butyldiphenylsilyloxy)-6-((perfluoroalkylethyl)diisopropylsilyloxy)tricos-1-
en-4-ol ((SMR)-29): 
The synthesis of this compound was done by the same method used for (RR)-34, using 
M13 (840 mg, 0.93 mmol). The crude product was purify by silica gel flash chromatography 
over silica gel eluting with hexanes/ethyl acetate (95:5) to yield (SMR)-36 (815 mg, 88%) as a 
slightly yellow oil: 1H-NMR (300 MHz, CDCl3) δ 7.64 (dd, J = 8.5, 2.1 Hz, 4H), 7.41-7.35 (m, 
6H), 5.76 (ddt, J = 15.8, 9.6, 7.1 Hz, 1H), 5.13 (d, J = 17.0, 9.6, 7.1 Hz, 1H), 5.10 (d, J = 15.8 Hz, 
1H), 4.01-3.81 (m, 2H), 3.78-3.59 (m, 1H), 2.24-1.98 (m, 4H), 1.54-1.38 (m, 8H), 1.38-0.99 (m, 
30 H), 0.93 (s, 24H), 0.88 (t, J = 6.5 Hz, 3H), 0.86-079 (m, 2H); 19F-NMR (282 MHz, CDCl3) δ -
79.4 (3F), -79.8 (3F), -115.6 (2F), -116.3 (2F), -123.0 (2F), -124.8 (2F), -126.3 (2F) ppm; LCMS 
(APCI, positive mode) m/z for (SMR)-36: (SRR)-36A = 969.5 (M + 1), 713.5, 335.4, 317.5; 
(SSR)-36B =1020.5 (M + 1), 840.5, 663.5, 513.5, 317.5.  
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                                          OH
C14H29
OTBDPS
OP2,1   
P1 = (i-Pr)2SiCH2CH2C3F7 
P2 = (i-Pr)2SiCH2CH2C4F9 
(4R,9R)-9-(tert-Butyldiphenylsilyloxy)-6-((perfluoroalkylethyl)diisopropylsilyloxy)tricos-1-
en-4-ol ((RMR)-29):  
The synthesis of this compound was done by the same method used for (RR)-34, using 
M13 (840 mg, 0.93 mmol). The crude product was purify by silica gel flash chromatography 
over silica gel eluting with hexanes/ethyl acetate (95:5) to yield (RMR)-36 (835 mg, 91%) as a 
slightly yellow oil: 1H-NMR (300 MHz, CDCl3) δ  7.63 (dd, J = 8.4, 1.8 Hz, 4H), 7.39-7.30 (m, 
6H), 5.68 (ddd, J = 17.2, 11.7, 7.5 Hz, 1H), 5.13 (d, J = 11.7 Hz, 1H), 5.11 (d, J = 17.2 Hz, 1H), 
3.95-3.60 (m, 3H), 2.20-2.01 (m, 4H), 1.53-1.36 (m, 8H), 1.34-1.01 (m, 30 H), 0.97 (s, 23H), 
0.89 (t, J = 6.3 Hz, 3H), 0.85-0.80 (m, 2H); 19F-NMR (282 MHz, CDCl3) δ -79.4 (3F), -79.8 
(3F), -115.6 (2F), -116.3 (2F), -123.0 (2F), -124.8 (2F), -126.3 (2F) ppm; LCMS (APCI, positive 
mode) m/z for(RMR)-36: (RRR)-36A = 969.5 (M + 1), 724.5, 513.5, 317.5; (RSR)-36B =1020.5 
(M + 1), 848.5, 663.5, 335.4, 317.5.  
 
OTBDPS
OH OH
C14H29
 
(4S,6R,9R)-9-(tert-butyldiphenylsilyloxy)tricos-1-ene-4,6-diol ((SRR)-37A): 
Semiprep HPLC separation was carried out on a 600E waters HPLC system. The mixture 
(SMR)-36 (40 mg, 0.04 mmol) of 2 compounds was filtered trough a Whatman filter paper (0.45 
μM pore size) before injection. The separation was done on a FluoroFlash HPLC column (20mm 
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x 250 mm), and was achieved by gradient elution with isocratic 100% acetonitrile for 40 minutes 
with a flow rate of 10 mL/min. UV detector (254 nm, 230 nm) was used to identify the peaks. 
The injection of 40 mg of (SMR)-36 provided in 78% yield (SRR)-36A (15 mg, 13.2 min) and 
(SSR)-36B (16 mg, 17.0 min), as clear oils. (SRR)-36A (15 mg, 15.0 µmol) was dissolved in 
ethanol (1.5 mL) followed by addition of 1 M HCl/Ethanol (1.5 mL). Stirring was continuous for 
2 h at RT, then NaHCO3 was added followed by removal of the solvent under vacuum. The 
crude reaction mixture was extracted with dichloromethane and filtered on a plug of celite. The 
organic layer was concentrated and the residue was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate (20:1) to yield (SRR)-37A (8 mg, 41%) as a clear oil: [α]D -3.1 
(c 0.9, CHCl3), IR (thin film) 3054, 2987, 2925, 1421, 1361, 1255, 1222.65, 896, 734 cm-1; 1H-
NMR (500 MHz, CDCl3) δ 7.68 (dd, J = 8.4, 1.8 Hz, 4H), 7.43-7.35 (m, 6H), 5.80 (ddt, J = 17.6, 
10.8, 7.2, Hz, 1H), 5.15 (d, J = 17.6 Hz, 1H), 5.14 (d, J = 10.8 Hz, 1H), 3.86-3.76 (m, 2H), 3.73-
3.69 (m, 1H), 3.00 (s, 1H), 2.89 (s, 1H), 2.24-2.21 (m, 2H), 1.51-1.45 (m, 4H), 1.43-1.39 (m, 
4H), 1.29-1.09 (m, 27H), 1.06 (s, 9H), 0.89 (t, J = 6.7 Hz, 3H); 13C-NMR (126 MHz, CDCl3); δ 
135.9, 134.5, 134.4, 129.5, 127.5, 118.2, 73.0, 72.8, 71.8, 42.5, 42.3, 36.1, 32.8, 31.9, 31.3, 
29.7(x8),  29.4, 27.1(x3), 25.0, 22.7, 19.4, 14.1 ppm. 
 
                                                   
OTBDPS
OH OH
C14H29
 
(4S,6S,9R)-9-(tert-butyldiphenylsilyloxy)tricos-1-ene-4,6-diol ((SSR)-37B): 
The synthesis of this compound was done by the same method used for (SRR)-37A, with 
alcohol (SSR)-36B (16 mg) obtained from the demixing. The residue was purified by silica gel 
flash chromatography eluting with hexanes/ethyl acetate (20:1) to yield (SSR)-37B (7 mg, 39%) 
 83 
as a clear oil: [α]D -24.5 (c 0.8, CHCl3), IR (thin film) 3060, 2971, 2893, 1452, 1360, 1158, 1220, 
1066, 960 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.69 (dd, J = 8.4, 1.8 Hz, 4H), 7.43-7.36 (m, 6H), 
5.80 (ddt, J = 13.7, 12.4, 7.2 Hz, 1H), 5.14 (dd, J = 13.7, 12.4 Hz, 2H), 3.93 (t, J = 5.8 Hz, 1H), 
3.85-3.77 (m, 2H), 2.36 (s, 2H), 2.24 (dd, J = 7.0, 6.9 Hz, 2H), 1.55 (t, J = 5.4 Hz, 2H), 1.52-
1.48 (m, 4H), 1.45-1.41 (m, 2H), 1.28-1.10 (m, 27H), 1.07 (s, 9H), 0.89 (t, J = 6.7 Hz, 3H); 13C-
NMR (126 MHz, CDCl3); δ 135.9, 134.7, 134.5, 129.5, 127.4, 118.1, 73.0, 69.2, 68.2, 42.0, 41.7, 
36.1, 32.2, 31.9, 31.8, 29.7(x8),  29.3, 27.1(x3), 25.0, 22.7, 19.4, 14.1 ppm. 
 
OTBDPS
C14H29
O O
 
((R)-1-((4R,6S)-6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)heptadecan-3-yloxy)(tert-
butyl)diphenylsilane (38): 
To a solution of diol (SRR)-37A (8 mg, 0.02 mmol) in acetone (0.3mL) was added 
sequentially 2,2-dimethoxypropane (0.3mL) and CSA (2 mg, 0.01 mmol). After 30 min at 25 oC, 
the reaction mixture was quenched with Et3N (17 µL) and then concentrated under reduced 
pressure. The crude product was purified by silica gel flash chromatography eluting with 
hexanes/ethyl acetate 20:1 to yield 38 (8 mg, 95%) as a clear oil: [α]D -12.9 (c 0.5, CHCl3), IR 
(thin film) 2999, 2927, 2854, 1643, 1469, 1378, 1224, 910 cm-1; 1H-NMR (300 MHz, CDCl3) δ 
7.65 (dd, J = 8.4, 1.8 Hz, 4H), 7.41-7.32 (m, 6H), 5.78 (ddt, J = 18.6, 9.3, 7.0 Hz, 1H), 5.10 (d, J 
= 9.3 Hz, 1H), 5.08 (d, J = 18.6 Hz, 1H), 3.76-3.72 (m, 2H), 3.53-3.46 (m, 1H), 2.32-2.19 (m 
2H), 2.14-2.05 (m, 2H), 1.97-1.83 (m, 2H), 1.77-1.72 (m, 2H), 1.33 (s, 3H), 1.31 (s, 3H), 1.21-
1.09 (m, 30H), 1.02 (s, 9H), 0.88 (t, J = 6.8 Hz, 3H); 13C-NMR (75 MHz, CDCl3); δ 135.9, 
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134.7, 134.3, 129.4, 127.4, 116.9, 98.3, 72.6, 68.6(x2), 40.8, 36.3, 36.1, 31.9, 31.1, 31.0, 30.2, 
29.7(x8), 29.4, 27.1(x3), 24.9, 22.7, 19.7, 19.4, 14.1 ppm. 
 
                                                
OTBDPS
O O
C14H29
 
((R)-1-((4S,6S)-6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)heptadecan-3-yloxy)(tert-
butyl)diphenylsilane (39): 
The synthesis of this compound was done by the same method used for 38, with (SSR)-
37A (8 mg, 0.02 mmol). The crude was purified by silica gel flash chromatography eluting with 
hexanes/ethyl acetate (20:1) to yield 39 (7 mg, 92%) as a clear oil: [α]D -25.1 (c 0.8, CHCl3), IR 
(thin film) 3003, 2927, 2824, 1640, 1378, 1230, 1108, 991, 730 cm-1; 1H-NMR (300 MHz, 
CDCl3) δ 7.66 (dd, J = 8.4, 1.8 Hz, 4H), 7.43-7.35 (m, 6H), 5.78 (ddt, J = 18.6, 9.3, 7.0 Hz, 1H), 
5.10 (d, J = 9.3 Hz, 1H), 5.08 (d, J = 18.6 Hz, 1H), 3.80-3.76 (m, 2H), 3.59-3.50 (m, 1H), 2.31-
2.14 (m 4H), 1.49-1.39 (m, 8H), 1.31 (s, 3H), 1.27-1.09 (m, 30H), 1.06 (s, 9H), 0.89 (t, J = 6.7 
Hz, 3H); 13C-NMR (75 MHz, CDCl3); δ 135.9, 134.7, 134.5, 129.4, 127.4, 116.7, 100.1, 72.7, 
66.5, 66.1, 40.1, 37.9, 36.2, 31.9, 31.7, 30.7, 29.7(x8), 29.4, 27.1(x3), 24.9, 24.8, 24.7, 22.7, 
19.4, 14.1 ppm. 
 
 
 
 
 85 
                                         C14H29
O
O
 
(R)-octadec-1-en-4-yl acrylate ((R)-40): 
Homoallylic alcohol (R)-5 (100 mg, 0.37 mmol) was dissolved in dry dichloromethane (3 
mL) under argon atmosphere. The resulting mixture was cooled to 0 °C and DIPEA (142 mg, 
1.1 mmol) was added, followed by addition of freshly distilled acryloyl chloride (67 mg, 
0.74 mmol) by syringe. After continuous stirring for 1 h at 0 °C the ice bath was removed and 
the mixture continued stirring overnight at RT. The reaction mixture was filtered over a pad of 
silica gel, and washed with dichloromethane (2x). The solution was concentrated and the crude 
product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate (10:1) 
to yield (R)-40 (74 mg, 78 %) as clear oil: [α]D +6.7 (c 0.8, CHCl3), 1H-NMR (300 MHz, CDCl3) 
δ 6.39 (dd, J = 17.3, 1.6 Hz, 1H), 6.11 (dd, J = 17.3, 10.3 Hz, 1H), 5.79 (dd, J = 10.3, 1.6 Hz, 
1H), 5.76 (ddt, J = 17.1, 8.8, 7.0 Hz, 1H) 5.08 (d, J = 8.8 Hz, 1H), 5.07 (d, J = 17.1 Hz, 1H), 
5.00 (tt, J = 6.4, 6.1 Hz, 1H), 2.34 (ddd, J = 7.1, 5.9, 1.9 Hz 2H), 1.61-1.55 (m, 2H), 1.26-1.05 
(m, 24H), 0.89 (t, J = 6.6 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 166.2, 134.0, 130.6, 129.2, 
117.9, 73.9, 38.9, 33.9, 32.2, 29.9, 29.7(x8), 25.5, 22.9, 14.4 ppm. 
 
                                                           C14H29
O
O
Ph
 
(R)-octadec-1-en-4-yl cynnamate ((R)-41): 
Homoallylic alcohol (R)-5 (495 mg, 0.4 mmol) was dissolved in dry dichloromethane (3 
mL) under argon atmosphere.  The resulting mixture was cooled to 0 °C and DMAP (173 mg, 
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1.42 mmol) was added, followed by a solution of cynnamoyl chloride (169 mg, 1 mmol) in dry 
dichloromethane (1 mL). After continuous stirring for 1 h at 0 °C the ice bath was removed and 
the mixture continued stirring overnight at RT. The mixture was filtered over a small pad of 
silica gel, and washed with dichloromethane (2x). The solution was concentrated and the crude 
product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate (98:2) 
to yield (R)-41 (426 mg, 89 %) as clear oil: [α]D +7.8 (c 1.3, CHCl3), 1H-NMR (300 MHz, 
CDCl3) δ 7.69 (d, J = 16.0 Hz, 1H), 7.54 (d, J = 3.9 Hz, 2H), 7.41-7.37 (m, 3H), 6.45 (d, J = 16.0 
Hz, 1H), 5.83 (ddt, J = 17.1, 10.0, 7.1 Hz, 1H), 5.19-4.97 (m, 3H), 2.40 (t, J = 6.5 Hz, 2H), 1.67-
1.61 (m, 2H), 1.27-1.09 (m, 27H), 0.89 (t, J = 6.7 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 166.8, 
144.7, 134.7, 134.0, 130.4, 129.0, 128.2, 118.7, 117.8, 73.7, 38.9, 33.9, 32.1, 29.7(x8), 29.6, 
25.5, 22.9, 14.3 ppm. 
 
                                                              C14H29
O
O
 
(R)-6-tetradecyl-5,6-dihydropyran-2-one ((R)-42): 
Cinnamate ester (R)-41 (390 mg, 0.3 mmol) was dissolved in dry toluene (30 mL) under 
an argon atmosphere and heated at reflux. To the refluxing solution Grubbs II catalyst (24 mg, 10 
mol%) dissolved in dry toluene (1 mL) was added. After continuous stirring at reflux for 6 h, the 
reaction mixture was allowed to warm up to RT. The resulting mixture was concentrated and 
filtered with diethyl ether trough a small pad of Celite. The solution was concentrated and the 
crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 
9:1 to yield (R)-42 (336 mg, 89%) as a yellow oil: [α]D +13.3 (c 0.6, CHCl3), IR (thin film) 3055, 
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2985, 2927, 2854, 1465, 1390, 1421, 1265 cm-1;  1H-NMR (300 MHz, CDCl3) δ 6.86 (ddd, J = 
9.6, 5.9, 3.2 Hz, 1H), 6.11 (d, J = 9.6 Hz, 1H), 4.39 (tt, J = 5.4, 5.3 Hz, 1H), 2.29 (ddd, J = 6.9, 
5.4, 3.1 Hz, 2H), 1.79-1.75 (m, 1H), 1.66-1.60 (m, 1H), 1.26-1.09 (m, 4H), 0.85 (t, J = 6.5 Hz, 
3H); 13C-NMR (75 MHz, CDCl3) δ 164.5, 145.0, 121.3, 77.9, 34.8, 31.8, 29.6(x8), 29.3, 29.2, 
24.7, 22.6, 14.0 ppm. 
 
OP1
C14H29
OTBDPS
OP2,1  
 P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
1-(tert-Butyl((4S,9R)-6-((perfluoroalkylethyl)diisopropylsilyloxy)-4-((3,3,4,4,5,5,5-
heptafluoropentyl)diisopropylsilyloxy)tricos-1-en-9-yloxy)(phenyl)silyl)benzene((SMR)-49): 
The synthesis of this compound was done by the same method used for (SR)-39, with 
(SMR)-36 (2.6 g, 2.6 mmol). The crude mixture was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate (95:5) to yield (SMR)-49 (3.1 g, 94 %) as a clear, slightly 
yellow liquid: 1H-NMR (300 MHz, CDCl3) δ 7.66 (dd, J = 8.4, 1.8 Hz, 4H), 7.42-7.28 (m, 6H), 
5.74 (ddt, J = 18.9, 10.4, 6.9 Hz, 1H), 5.08 (d, J = 10.4 Hz, 1H), 5.06 (d, J = 18.9 Hz, 2H), 3.94-
3.61 (m, 3H), 2.12-2.03 (m, 6H), 1.66-1.55 (m, 6H), 1.38-0.99 (m, 30H), 0.93 (s, 37H), 0.88 (t, J 
= 6.7 Hz, 3H), 0.86-0.79 (m, 4H); 19F-NMR (282 MHz, CDCl3) δ -79.5 (3F), -79.9 (6F), -115.6 
(2F), -116.3 (4F), -123.0 (2F), -124.8 (2F), -126.4 (4F) ppm; LCMS (APCI, positive mode) m/z 
for (SMR)-49: (SRR)-49A = 1228.7 (M+), 1192.7, 949.6; (SSR)-49B =1278.7 (M+), 1262.3, 
1099.9, 944.3. 
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OP0
C14H29
OTBDPS
OP2,1   
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
 
1-(tert-Butyl((4R,9R)-6-((perfluoroalkylethyl)diisopropylsilyloxy)-4-
(triisopropylsilyloxy)tricos-1-en-9-yloxy)(phenyl)silyl)benzene ((RMR)-51):  
A 25 mL round bottom flask was filled with dichloromethane (5 mL), followed by 
(RMR)-36 (2 g, 1 mmol). The solution was cooled to 0 oC, and 2,6-lutidine (2 equiv) was added. 
To the solution TIPSOTf (2 equiv.) was added, and stirring was continued for 3 hours. The 
reaction was quenched with saturated NH4Cl solution. The layers were separated and the 
aqueous layer was extracted with dichloromethane (2x). The combined organic layers were dried 
over MgSO4, the resulting solution was concentrated and the crude product was purified by silica 
gel flash chromatography eluting with hexanes/ethyl acetate 95:5 to yield (RMR)-51 (2.28 g,  
90 %) as a clear, slightly yellow oil: 1H-NMR (300 MHz, CDCl3) δ 7.64 (dd, J = 8.4, 1.8 Hz, 
4H), 7.44-7.28 (m, 6H), 5.74 (ddt, J = 17.0, 9.9, 7.1 Hz, 1H), 5.07-5.01 (m, 2H), 3.91-3.61 (m, 
3H), 2.15-2.07 (m, 4H), 1.63-1.57 (m, 6H), 1.38-0.99 (m, 30 H), 0.93 (s, 44H), 0.88 (t, J = 6.7 
Hz, 3H), 0.85-0.79 (m, 4H); 19F-NMR (282 MHz, CDCl3) δ -79.5 (3F), -79.9 (3F), -115.6 (2F), -
116.3 (2F), -123.0 (2F), -124.8 (2F), -126.4 (2F) ppm; LCMS (APCI, positive mode) m/z for 
(RMR)-51: (RRR)-51  = 1074.7 (M+), 1039.7, 837.7; (RSR)-51  =1124.7 (M+), 1082.9, 1030.6, 
970.8. 
 
 89 
O
OP0,1
C14H29
OTBDPS
OP2,1  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
 
(8R)-8-(tert-Butyldiphenylsilyloxy)-5-((perfluoroalkylethyl)diisopropylsilyloxy)-3-(( 
perfluoroalkylethyl)diisopropylsilyloxy)docosanal (M14): 
The synthesis of this compound was done by the same method used for M13. Using 
M50B (2.5 g, 2.02 mmol). The crude was purified by silica gel flash chromatography eluting 
with hexanes/ethyl acetate (8:2) to yield M14 (1.83 g, 73 %) as a clear, slightly yellow oil: 1H-
NMR (300 MHz, CDCl3) δ 9.8-9.77 (m, 1H), 7.63 (dd, J = 8.4, 1.8 Hz, 4H), 7.46-7.36 (m, 6H), 
4.41-4.34 (m, 1H), 3.81-3.62 (m, 2H), 2.68-2.39 (m, 2H) 2.16-1.94 (m, 4H), 1.63-1.52 (m, 6H), 
1.38-0.99 (m, 30 H), 0.95 (s, 41H), 0.86 (t, J = 6.7 Hz, 3H), 0.84-0.77 (m, 4H); 19F NMR (282.4 
MHz, CDCl3) δ -79.4(12F), -79.8(6F), -115.6(4F), -116.2(4F), -123.0(4F), -124.9(4F), -
126.4(8F) ppm; LCMS (APCI, positive mode) m/z for M14: (SRR)-14 = 1145.8 (M + H), 1067.8 
(M − Ph), 896.6; (SSR)-14 =1212.8 (M + H2O), 1195.8 (M + H), 1117.8 (M − Ph), 939.7; 
(RRR)-14 = 1299.7 (M + 1), 1221.7 (M − Ph), 1043.7; (RSR)-14 = 1349.7 (M + H), 1271.7 (M − 
Ph), 1093.6. 
 
 
 
 90 
C14H29
OTBDPS
OP2,1OP0,1OH  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(4S,11R)-11-(tert-Butyldiphenylsilyloxy)-8-((perfluoroalkylethyl)diisopropylsilyloxy)-6-(( 
perfluoroalkylethyl)diisopropylsilyloxy)pentacos-1-en-4-ol ((S)-M52): 
The synthesis of this compound was done by the same method used for (RR)-34, with 
M14 (733 mg, 0.6 mmol). The crude was purified by silica gel flash chromatography eluting 
with hexanes/ethyl acetate (10:1) to yield (S)-M52 (498 mg, 80 %) as a colourless oil: 1H-NMR 
(300 MHz, CDCl3) δ 7.63 (dd, J = 8.4, 1.8 Hz, 4H), 7.43-7.36 (m, 6H), 5.76 (ddt, J = 16.7, 9.3, 
6.5, Hz, 1H), 5.16-5.08 (m, 2H), 4.01-3.91 (m, 2H), 3.83-3.69 (m, 2H), 2.33-1.99 (m, 4H) 1.59-
1.46 (m, 6H), 1.38-0.96 (m, 30H), 0.93 (s, 41H), 0.86 (t, J = 6.7 Hz, 3H), 0.90-0.73 (m, 4H); 19F 
NMR (282.4 MHz, CDCl3) δ -79.4(12F), -79.8(6F), -115.6(4F), -116.2(4F), -123.0(4F), -
124.9(4F), -126.4(8F) ppm; LCMS (APCI, positive mode) m/z for (S)-M52: (SRRR)-52 = 
1117.7 (M − H), 1059.7, 896.6, 749.6, 697.4; (SRSR)-52 = 1167.7 (M − H), 1109.7, 935.6, 
871.5, 749.6; (SSRR)-52 = 1271.7 (M − H), 1213.7, 975.5, 647.4, 629.3; (SSSR)-52 = 1321.7 
(M − H), 1264.7, 1191.6, 1025.5, 697.4,  629.3. 
 
 
 91 
                                                    
C14H29
OTBDPS
OP2,1OP0,1OH  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(4R,11R)-11-(tert-Butyldiphenylsilyloxy)-8-((perfluoroalkylethyl)diisopropylsilyloxy)-6-(( 
perfluoroalkylethyl)diisopropylsilyloxy)pentacos-1-en-4-ol ((R)-M52): 
The synthesis of this compound was done by the same method used for (RR)-34, with 
M14 (603 mg, 0.493 mmol). The crude mixture was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate (10:1) to yield (R)-M52 580 mg (0.459 mmol, 93 %) as a 
colourless oil: 1H-NMR (300 MHz, CDCl3) δ 7.65 (dd, J = 8.4, 1.8 Hz, 4H), 7.40-7.36 (m, 6H), 
5.78 (ddt, J = 16.7, 9.3, 6.5, Hz, 1H), 5.13-5.05 (m, 2H), 4.39-3.65 (m, 4H), 2.38-1.98 (m, 6H), 
1.59-1.46 (m, 6H), 1.38-0.96 (m, 30H), 0.93 (s, 41H), 0.86 (t, J = 6.7 Hz, 3H), 0.90-0.73 (m, 
4H); 19F NMR (282.4 MHz, CDCl3) δ -79.4(12F), -79.8(6F), -115.6(4F), -116.2(4F), -123.0(4F), 
-124.9(4F), -126.4(8F) ppm; LCMS (APCI, positive mode) m/z for (R)-M52: (RRRR)-52 = 
1117.7 (M - H), 1059.7, 821.5, 769.6, 647.4; (RRSR)-52 = 1167.7 (M - H), 1109.7, 935.6, 899.5, 
679.5; (RSRR)-52 = 1271.7 (M - H), 1213.7, 885.5, 647.4, 629.3; (RSSR)-52 = 1321.7 (M - H), 
1264.7, 1191.6, 1055.5, 647.4,  629.4. 
 
 
 
 92 
     
C14H29
OTBDPS
OP2,1OP0,1O
O
Ar
 
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(4S,11R)-11-(tert-Butyldiphenylsilyloxy)-8-((perfluoroalkylethyl)diisopropylsilyloxy)-6-(( 
perfluoroalkylethyl)diisopropylsilyloxy)pentacos-1-en-4-yl cynnamate ((S)-M15): 
The synthesis of this compound was done by the same method used for (R)-41, with (S)-
M52 (479 mg, 0.39 mmol). The crude was purified by silica gel flash chromatography eluting 
with hexanes/ethyl acetate (98:2) to yield (S)-M15 (426 mg, 78 %) as a clear oil: 1H-NMR (300 
MHz, CDCl3) δ 7.66-7.56 (m, 5H), 7.50-7.25 (m, 10H), 6.34 (dd, J = 15.9, 4.3 Hz, 1H ), 5.75 
(ddt, J = 15.7, 10.2, 6.5, Hz, 1H), 5.23-5.15 (m, 1H), 5.09 (d, J = 15.7 Hz, 1H), 5.08 (d, J = 10.2 
Hz, 1H), 4.12-3.57 (m, 3H), 2.39 (m, 4H), 2.06 (m, 6H), 1.27 (m, 29H), 1.19-0.97 (m, 41H), 0.89 
(t, J = 6.7 Hz, 3H), 0.86-0.78 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ -79.4(12F), -79.8(6F), -
115.6(4F), -116.2(4F), -123.0(4F), -124.9(4F), -126.4(8F) ppm; LCMS (APCI, positive mode) 
m/z for (S)-M15: (SRRR)-15 = 1266.8 (M + H2O), 1076.8, 993.8, 819.8, 665.5; (SRSR)-15 = 
1316.8 (M + H2O), 1126.8, 921.7, 870.5, 665.5; (SSRR)-15 = 1420.8 (M + H2O), 1325.8 (M − 
Ph), 1147.6, 1076.6, 689.4; (SSSR)-15 = 1453.8 (M + H), 1376.8 (M − Ph), 1197.6, 819.5,  
689.4. 
 
 
 93 
C14H29
OTBDPS
OP2,1OP0,1O
O
Ar
 
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(4R,11R)-11-(tert-Butyldiphenylsilyloxy)-8-((perfluoroalkylethyl)diisopropylsilyloxy)-6-(( 
perfluoroalkylethyl)diisopropylsilyloxy)pentacos-1-en-4-yl cynnamate ((R)-M15): 
The synthesis of this compound was done by the same method used for (R)-41, with (R)-
M52 (517 mg, 0.42 mmol). The crude mixture was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate (98:2) to yield  (R)-M15 (490 mg, 83 %) as a clear oil: 1H-
NMR (300 MHz, CDCl3) δ  7.67-7.62 (m, 5H), 7.53-7.27 (m, 10H), 6.36 (dd, J = 15.7, 4.4 Hz, 
1H ), 5.77 (ddt, J = 15.9, 10.5, 6.5, Hz, 1H), 5.28-5.13 (m, 1H), 5.09 (d, J = 15.9 Hz, 1H), 5.08 
(d, J = 10.5 Hz, 1H), 4.25-3.95 (m, 3H), 2.41-2.37 (m, 2H), 2.09-2.05 (m, 5H), 1.27-1.05 (m, 
30H), 0.99 (s, 43H), 0.89 (t, J = 6.7 Hz, 3H), 0.87-0.79 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ 
-79.4(12F), -79.9(6F), -115.6(4F), -116.2(4F), -123.0(4F), -124.9(4F), -126.4(8F) ppm; LCMS 
(APCI, positive mode) m/z for (R)-M15: (RRRR)-15 = 1266.8 (M + H2O), 1076.8, 993.8, 854.8; 
(RRSR)-15 = 1316.8 (M + H2O), 1126.8, 1043.7, 918.3, 879.5; (RSRR)-15 = 1420.8 (M +H2O), 
1325.8 (M − Ph), 1140.6, 1096.6, 779.4; (RSSR)-15 = 1453.8 (M + H), 1376.8 (M − Ph), 1197.6, 
829.5, 750.5. 
 
 
 94 
C14H29
OTBDPS
OP2,1OP0,1O
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(S)-6-((7R)-7-(tert-Butyldiphenylsilyloxy)-4-((perfluoroalkylethyl)diisopropylsilyloxy)-2-(( 
perfluoroalkylethyl)diisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one ((S)-M16): 
The synthesis of this compound was done by the same method used for (R)-42, with (S)-
M15 (381 mg, 0.28 mmol). The crude mixture was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate (9:1) to yield (S)-M16 (336 mg, 92%) as a yellow oil: 1H 
NMR (300 MHz, CDCl3) δ 7.67 (dd, J = 8.4, 1.8 Hz, 4H), 7.43-7.33 (m, 6H), 6.85 (ddd, J = 9.7, 
5.9, 2.9 Hz, 1H), 6.02 (d, J = 9.8 Hz, 1H), 4.69-4.65 (m, 0.5H), 4.59-4.55 (m, 0.5H), 4.32-4.28 
(m, 0.5H), 4.17-4.13 (m, 0.5H), 4.04-3.98 (m, 0.5H), 3.79-3.65 (m, 1.5H),  2.35-3.27 (m, 2H), 
2.18-1.95 (m, 4H), 1.27-1.09 (s, 25H), 1.03 (s, 43H), 0.89 (t, J = 6.7 Hz, 3H); 19F NMR (282.4 
MHz, CDCl3) δ -79.4(12F), -79.8(6F), -115.5(4F), -116.2(4F), -123.0(4F), -124.8(4F), -
126.3(8F) ppm; LCMS (APCI, positive mode) m/z for (S)-M16: (SRRR)-16 = 1145.8 (M + H), 
1067.8 (M − Ph), 896.6; (SRSR)-16 =1212.8 (M + H2O), 1195.8 (M + H), 1117.8 (M − Ph), 
939.7; (SSRR)-16 = 1299.7 (M + H), 1221.7 (M − Ph), 1043.7; (SSSR)-16 = 1349.7 (M + H), 
1271.7 (M − Ph), 1093.6. 
 
 
 95 
C14H29
OTBDPS
OP2,1OP0,1O
O  
 P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(R)-6-((7R)-7-(tert-Butyldiphenylsilyloxy)-4-((perfluoroalkylethyl)diisopropylsilyloxy)-2-(( 
perfluoroalkylethyl)diisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one ((R)-M16): 
The synthesis of this compound was done by the same method used for (R)-42, with (R)-
M15 (465 mg, 0.346 mmol). The crude mixture was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate (9:1) to yield (R)-M16 (379 mg, 85%) as a yellow oil: 1H 
NMR (300 MHz, CDCl3) δ 7.67 (dd, J = 8.4, 1.8 Hz, 4H), 7.42-7.27 (m, 6H), 6.86 (ddd, J = 9.8, 
5.9, 2.8 Hz, 1H), 6.03 (d, J = 9.8 Hz, 1H), 4.66-4.40 (m, 1H), 4.23-4.19 (m, 0.5H), 4.14-4.10 (m, 
0.5H), 3.91-3.87 (m, 0.5H), 3.79-3.65 (m, 1.5H),  2.40-2.31 (m, 2H), 2.18-2.05 (m, 4H), 1.29-
1.09 (m, 25H), 1.06 (s, 46H), 0.87 (t, J = 6.7 Hz, 3H); 19F NMR (282.4 MHz, CDCl3) δ -
79.4(12F), -79.8(6F), -115.5(4F), -116.2(4F), -123.0(4F), -124.8(4F), -126.3(8F) ppm; LCMS 
(APCI, positive mode) m/z for (R)-M16: (RRRR)-16 = 1145.8 (M + H), 1067.8 (M − Ph); 
(RRSR)-16 = 1212.8 (M + H2O), 1195.8 (M + H), 1117.8 (M − Ph); (RSRR)-16  = 1299.7 (M + 
H), 1221.7 (M − Ph); (RSSR)-16  = 1349.7 (M + H), 1271.7 (M − Ph). 
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C14H29
OOP0OP1
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(S)-6-((2R,4R,7R)-7-(tert-Butyldiphenylsilyloxy)-4-((3,3,4,4,5,5,5-                    
heptafluoropentyl)diisopropylsilyloxy)-2-(triisopropylsilyloxy)henicosyl)-5,6-dihydropyran-
2-one ((SRRR)-16): 
Semiprep HPLC separation was carried out on a 600E waters HPLC system. The mixture 
(S)-M16 (336 mg, 0.26 mmol) of 4 compounds was filtered trough a Whatman filter paper (0.45 
μM pore size) before injection. The separation was done on a FluoroFlash HPLC column (20mm 
x 250 mm). The separation was achieved by gradient elution with 95:5 acetonitrile/water to 
100% acetonitrile in 30 minutes then isocratic acetonitrile for 60 min with a flow rate of 10 
mL/min. UV detector (254 nm, 230nm) was used to manually identify the peaks. Aliquots (33 
mg/mL) of (S)-M16 were injected per run. The yield of the demixing was 85%, collecting the 
first peak (SRRR)-16 (61 mg) at 30.9 min as a clear oil: [α]D -17.3 (c 0.6, CHCl3); 1H NMR (300 
MHz, CDCl3) δ 7.67 (dd, J = 9.8, 1.9 Hz, 4H), 7.42-7.31 (m, 6H), 6.87 (ddd, J = 9.8, 5.9, 3.1 Hz, 
1H), 6.02 (d, J = 9.8 Hz, 1H), 4.68-4.64 (m, 1H), 4.15-4.11 (m, 1H), 3.74-4.70 (m, 2H),  2.34-
2.29 (m, 2H), 2.19-2.01 (m, 4H), 1.85-1.76 (m, 4H), 1.63-1.51 (m, 8H), 1.27-1.09 (m, 27H), 
1.08-1.01 (m, 35H), 1.00 (s, 9H), 0.88 (t, J = 6.7 Hz, 3H), 0.85-0.79 (m, 2H); 19F NMR (282.4 
MHz) δ -79.4 (3F), -116.2 (3F), -126.3 (3F); 13C-NMR (75 MHz, CDCl3) δ 163.9, 144.9, 135.9, 
134.7, 134.4, 129.4, 127.4, 121.6, 74.5, 73.2, 71.0, 66.6, 46.6, 43.1, 36.5, 31.9, 31.8, 30.0, 
29.7(x8), 29.5, 29.4, 27.0(x3), 25.3 (t, JCF= 24.4 Hz), 24.8, 22.7, 19.3, 18.6, 18.2(x5), 18.1(x5), 
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17.7(x3), 14.1, 13.1, 13.0, 12.8(x3), 0.8 ppm; LCMS (APCI, positive mode) m/z = 1145.8 (M + 
H), 1067.8 (M − Ph). 
 
                                              
C14H29
OOP0OP2
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(S)-6-((2R,4S,7R)-7-(tert-Butyldiphenylsilyloxy)-4-(diisopropyl(3,3,4,4,5,5,6,6,6-           
nonafluorohexyl)silyloxy)-2-(triisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one 
((SRSR)-16): 
From the demixing of (S)-M16, the second peak (SRSR)-16 (72 mg) at 45.1 min was 
isolated as a clear oil: [α]D -5.0 (c 1.2, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.66 (dd, J = 9.8, 
1.9 Hz, 4H), 7.42-7.23 (m, 6H), 6.85 (ddd, J = 9.7, 6.1, 3.0 Hz, 1H), 6.02 (d, J = 9.7 Hz, 1H), 
4.67-4.63 (m, 1H), 4.31-4.27 (m, 1H), 3.80-3.78 (m, 1H), 3.74-3.71 (m, 1H), 2.31-2.27 (m, 2H), 
2.25-1.98 (m, 4H), 1.77-1.68 (m, 2H), 1.61-1.53 (m, 8H), 1.27-1.11 (m, 27H), 1.10-1.03 (m, 
35H), 1.01 (s, 9H), 0.89 (t, J = 6.7 Hz, 3H), 0.84-0.80 (m, 2H); 19F NMR (282.4 MHz) δ -79.8 
(3F), -115.4 (2F), 123.0 (2F), 124.8 (2F); 13C-NMR (75 MHz, CDCl3) δ 163.8, 144.6, 135.8, 
134.7, 134.4, 129.5, 127.4, 121.7, 74.6, 73.0, 70.4, 66.1, 45.3, 42.7, 35.9, 33.0, 31.9, 31.5, 30.0, 
29.7(x8), 29.5, 29.4, 27.0(x3), 25.5 (t, JCF= 24.4 Hz), 24.9, 22.7, 19.3, 18.1(x10), 17.7(x3), 14.1, 
13.0, 12.8(x3), 0.8 ppm; LCMS (APCI, positive mode) m/z = 1212.8 (M + H2O), 1195.8 (M + 
H), 1117.8 (M − Ph). 
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C14H29
OOP1OP1
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(S)-6-((2S,4R,7R)-7-(tert-Butyldiphenylsilyloxy)-2,4-bis((3,3,4,4,5,5,5-
heptafluoropentyl)diisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one ((SSSR)-16): 
From the demixing of (S)-M16, the third peak (SSRR)-16 (73 mg) at 53.3 min was 
isolated as a clear oil: [α]D +9.7 (c 0.4, CHCl3); 1H NMR (300 MHz) δ 7.67 (dd, J = 9.8, 1.9 Hz, 
4H), 7.41-7.29 (m, 6H), 6.86 (ddd, J = 9.8, 6.5, 3.4 Hz, 1H), 6.49 (d, J= 9.8 Hz, 1H), 4.57-4.53 
(m, 1H), 4.17-4.13 (m, 1H), 3.85-3.81 (m, 1H), 3.73-3.69 (m, 1H), 2.37-2.31 (m, 2H), 2.25-1.96 
(m, 5H), 1.83-1.79 (m, 2H), 1.65-1.59 (m, 6H), 1.47-1.39 (m, 8H), 1.26-1.16 (m, 27H), 1.12-1.05 
(m, 28H), 1.03 (s, 9H), 0.86 (t, J = 6.7 Hz, 3H), 0.84-0.79 (m, 4H); 19F NMR (282.4 MHz) δ -
79.4 (6F), -116.2 (4F), -126.3 (4F); 13C-NMR (75 MHz, CDCl3) δ 163.6, 144.4, 135.9, 134.7, 
134.5, 129.4, 127.4, 121.7, 74.5, 73.3, 70.3, 67.1, 43.7, 41.6, 36.3, 33.2, 31.9(x3), 31.3, 31.2, 
30.0, 29.7(x8), 29.5, 29.4, 27.0(x3), 25.0 (t, JCF= 24.4 Hz), 24.9, 22.7, 19.4, 17.7(x5), 17.6(x5), 
14.1, 13.0, 12.8(x3), 12.7(x3), 1.2, 0.9 ppm; LCMS (APCI, positive mode) m/z = 1299.7 (M + 
H), 1221.7 (M − Ph). 
 
 
 
 99 
                                              
C14H29
OOP1OP2
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(S)-6-((2S,4S,7R)-7-(tert-Butyldiphenylsilyloxy)-4-(diisopropyl(3,3,4,4,5,5,6,6,6-
nonafluorohexyl)silyloxy)-2-((3,3,4,4,5,5,5-
heptafluoropentyl)diisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one ((SSSR)-16):  
From the demixing of (S)-M16, the fourth peak (SSSR)-16 (80 mg) at 69.7 min was 
isolated as a clear oil: [α]D +13.5 (c 0.6, CHCl3); 1H NMR (300 MHz) δ 7.67 (dd, J = 9.8, 1.9 Hz, 
4H), 7.44-7.34 (m, 6H), 6.83 (ddd, J = 9.7, 6.3, 3.5 Hz, 1H), 6.03 (dd, J = 9.7, 1.9 Hz, 1H), 4.58-
4.54 (m, 1H), 4.02-3.98 (m, 1H), 3.79-3.75 (m, 1H), 3.73-3.69 (m, 1H), 2.38-2.28 (m, 2H), 2.21-
1.97 (m, 6H), 1.74-1.65 (m, 4H), 1.63-1.56 (m, 6H), 1.41-1.35 (m, 5H), 1.26-1.13 (s, 27H), 1.10-
1.05 (m, 28H), 1.02 (s, 9H), 0.87 (t, J = 6.7 Hz, 3H), 0.83-0.78 (m, 4H); 19F NMR (282.4 MHz) 
δ -79.4 (3F), -79.9 (3F), -115.5 (2F), -116.3 (2F), -123.0 (F), -124.9 (2F), -126.4 (2F);  13C-NMR 
(75 MHz, CDCl3) δ 163.6, 144.3, 135.9, 134.7, 134.4, 129.4, 127.4, 121.7, 74.5, 73.4, 70.6, 67.4, 
45.1, 42.0, 36.4, 32.8, 31.9, 31.6, 30.0, 29.7(x8), 29.5, 29.4, 26.8(x5), 25.6 (t, JCF= 24.4 Hz), 
24.8, 22.7, 19.4, 17.7(x5), 17.6 (x5), 14.1, 13.1, 13.0, 12.8(x5), 1.1, 0.9 ppm; LCMS (APCI, 
positive mode) m/z = 1349.7 (M + H), 1271.7 (M − Ph). 
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C14H29
OOP0OP1
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
 
(R)-6-((2R,4R,7R)-7-(tert-Butyldiphenylsilyloxy)-4-((3,3,4,4,5,5,5-                    
heptafluoropentyl)diisopropylsilyloxy)-2-(triisopropylsilyloxy)henicosyl)-5,6-dihydropyran-
2-one ((RRRR)-16): 
Semiprep HPLC separation was carried out on a 600E waters HPLC system. The mixture 
(R)-M16 (336 mg, 0.26 mmol) of 4 compounds was filtered trough a Whatman filter paper (0.45 
μM pore size) before injection. The separation was done on a FluoroFlash HPLC column (20mm 
x 250 mm). The separation was achieved by gradient elution with 95:5 acetonitrile/water to 
100% acetonitrile in 30 minutes then isocratic acetonitrile for 60 min with a flow rate of 10 
mL/min. UV detector (254 nm, 230nm) was used to manually identify the peaks. Aliquots (33 
mg/mL) of (R)-M16 were injected per run. The yield of the demixing was 85%, collecting the 
first peak (RRRR)-16 (56 mg) at 33.5 min as a clear oil [α]D -11.3 (c 0.8, CHCl3); 1H NMR (300 
MHz, CDCl3) δ 7.65 (dd, J = 9.8, 1.9 Hz, 4H), 7.42-7.30 (m, 6H), 6.85-6.81 (ddd, J = 9.8, 5.6, 
2.5 Hz, 1H), 6.01 (dd, J = 9.8, 2.5 Hz, 1H), 4.67-4.63 (m, 1H), 4.05-4.01 (m, 1H), 3.77-3.73 (m, 
2H),  2.38-2.26 (m, 2H), 2.11-1.96 (m, 4H), 1.85-1.72 (m, 5H), 1.46-1.37 (m, 8H), 1.26-1.15 (m, 
27H), 1.06-1.04 (m, 35H), 1.00 (s, 9H), 0.88 (t, J = 6.7 Hz, 3H), 0.85-0.79 (m, 2H); 19F NMR 
(282.4 MHz) δ -79.4 (3F), -116.2 (2F), -126.3 (2F); 13C-NMR (75 MHz, CDCl3) δ 164.0, 144.7, 
135.8, 134.7, 134.4, 129.5, 127.4, 121.6, 74.8, 73.3, 70.4, 67.0, 44.8, 41.5, 36.6, 32.0, 31.9, 31.4, 
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31.2, 30.0, 29.7(x8), 29.5, 29.4, 27.0(x3), 25.3 (t, JCF= 24.4 Hz), 24.9, 22.7, 19.4, 18.2(x10), 
17.7(x3), 14.1, 12.9(x3), 12.7(x3), 0.8 ppm; LCMS (APCI, positive mode) m/z = 1145.8 (M + 
H), 1067.8 (M − Ph). 
  
                                               
C14H29
OOP0OP2
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(R)-6-((2R,4S,7R)-7-(tert-Butyldiphenylsilyloxy)-4-(diisopropyl(3,3,4,4,5,5,6,6,6-           
nonafluorohexyl)silyloxy)-2-(triisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one 
((RRSR)-16): 
From the demixing of (R)-M16, the second peak (RRSR)-16 (70 mg) at 47.0 min was 
isolated as a clear oil: [α]D +23 (c 1.1, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.66 (dd, J = 9.8, 
1.9 Hz, 4H), 7.43-7.230 (m, 6H), 6.86 (ddd, J = 9.8, 6.6, 2.5 Hz, 1H), 6.03 (d, J = 9.8 Hz, 1H), 
4.67-4.63 (m, 1H), 4.23-4.19 (m, 1H), 3.91-3.87 (m, 1H), 3.76-3.72 (m, 1H), 2.41-2.32 (m, 2H), 
2.10-2.01 (m, 4H), 1.89-1.84 (m, 2H), 1.69-1.64 (m, 3H), 1.52-1.48 (m, 5H), 1.26-1.13 (m, 27H), 
1.10-1.05 (m, 35H), 1.01 (s, 9H), 0.88 (t, J = 6.7 Hz, 3H), 0.82-0.79 (m, 2H); 19F NMR (282.4 
MHz) δ -79.8 (3F), -115.5 (2F), -123.0 (2F), -124.9 (2F); 13C-NMR (75 MHz, CDCl3) δ 163.9, 
144.6, 135.9, 134.8, 134.5, 129.5, 127.4, 121.6, 74.7, 73.2, 70.6, 66.7, 43.7, 41.3, 36.1, 33.2, 
31.9, 31.4, 30.1, 29.7(x8), 29.4, 27.0(x3), 25.6 (t, JCF= 24.4 Hz), 24.9, 22.7, 19.3, 18.1(x10), 
17.7(x3), 14.1(x3), 13.1, 13.0, 12.8(x3), 0.8 ppm; LCMS (APCI, positive mode) m/z = 1212.8 
(M + H2O), 1195.8 (M + H), 1117.8 (M − Ph). 
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C14H29
OOP1OP1
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(R)-6-((2S,4R,7R)-7-(tert-Butyldiphenylsilyloxy)-2,4-bis((3,3,4,4,5,5,5-
heptafluoropentyl)diisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one ((RSRR)-16): 
From the demixing of (R)-M16, the third peak (RSRR)-16 (69 mg) at 54.3 min was 
isolated as a clear oil: [α]D +16.2 (c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.67 (dd, J = 9.8, 
1.9 Hz, 4H), 7.43-7.30 (m, 6H), 6.86 (ddd, J = 9.6, 6.9, 2.4 1H), 6.49 (d, J = 9.6 Hz, 1H), 4.60-
4.57 (m, 1H), 4.30-4.26 (m, 1H), 3.72-3.67 (m, 2H), 2.31-2.26 (m, 2H), 2.18-1.96 (m, 6H), 1.71-
1.67 (m, 3H), 1.52-1.49 (m, 5H), 1.44-1.37 (m, 5H), 1.27-1.17 (m, 27H), 1.10-1.03 (m, 28H), 
1.01 (s, 9H), 0.88 (t, J = 6.7 Hz, 3H), 0.83-0.77 (m, 4H); 19F NMR (282.4 MHz) δ -79.4 (6F), -
116.2 (4F), -126.3 (4F); 13C-NMR (75 MHz, CDCl3) δ 163.6, 144.6, 135.9, 134.7, 134.6, 129.6, 
127.5, 121.7, 74.2, 73.2, 70.2, 66.2, 45.2, 42.5, 36.3, 33.5, 31.9, 31.6, 30.0, 29.7(x8), 29.6, 29.4, 
27.0(x3), 25.3 (t, JCF= 24.4 Hz), 24.8, 22.7, 19.4, 17.6(x13), 14.1, 12.9(x5), 12.7, 0.8 ppm; 
LCMS (APCI, positive mode) m/z = 1299.7 (M + H), 1221.7 (M − Ph). 
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C14H29
OOP1OP2
OTBDPS
O  
P1 = (i-Pr)2SiCH2CH2C3F7 
                                                     P2 = (i-Pr)2SiCH2CH2C4F9 
                                                                       P0 = (i-Pr)3Si 
(R)-6-((2S,4S,7R)-7-(tert-Butyldiphenylsilyloxy)-4-(diisopropyl(3,3,4,4,5,5,6,6,6-
nonafluorohexyl)silyloxy)-2-((3,3,4,4,5,5,5-
heptafluoropentyl)diisopropylsilyloxy)henicosyl)-5,6-dihydropyran-2-one ((RSSR)-16):  
From the demixing of (R)-M16, the fourth peak (RSSR)-16 (75 mg) at 68.6 min was 
isolated as a clear oil: [α]D -3.8 (c 1.2, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.66 (dd, J = 9.8, 
1.9 Hz, 4H), 7.43-7.30 (m, 6H), 6.89-6.84 (ddd, J = 9.9, 6.0, 3.0 Hz, 1H), 6.02 (d, J = 9.9 Hz, 
1H), 4.59-4.55 (m, 1H), 4.10-4.06 (m, 1H), 3.72-4.68 (m, 2H), 2.33-2.28 (m, 2H), 2.19-1.96 (m, 
6H), 1.83-1.71 (m, 2H), 1.57-1.51 (m, 5H), 1.43-1.35 (m, 5H), 1.26-1.16 (m, 27H), 1.15-1.03 (m, 
28H), 1.01 (s, 9H), 0.86 (t, J = 6.7 Hz, 3H), 0.85-0.80 (m, 4H); 19F NMR (282.4 MHz) δ -79.4 
(3F), -79.8 (3F), -115.5 (2F), -116.3 (2F), -123.0 (2F), -124.9 (2F), -126.4 (2F); 13C-NMR (75 
MHz, CDCl3) δ 163.6, 144.6, 135.9, 134.7, 134.4, 129.4, 127.4, 121.6, 74.1, 73.2, 71.7, 66.8, 
46.4, 42.8, 36.3, 32.6, 31.9, 31.6, 30.0, 29.7(x8), 29.5, 29.4, 27.0(x3), 25.3 (t, JCF= 24.4 Hz), 
24.8, 22.7, 19.3, 17.6(x19), 14.1, 13.0, 12.8, 0.9 ppm; LCMS (APCI, positive mode) m/z = 
1349.7 (M + H), 1271.7 (M − Ph). 
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C14H29
OOHOH
OH
O  
(S)-6-((2S,4R,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((SSRR)-3): 
Quasiisomer (SRRR)-16 (60 mg, 0.04 mmol) was dissolved in ethanol (1 mL), and 3N 
HCl/ethanol (1.5 mL, 12 equiv.) was added. Stirring was continued for 40 hours or until TLC 
indicated completion of the reaction by consumption of starting material. The reaction was 
quenched with solid NaHCO3 and the organic product was dried over with MgSO4. The solution 
was concentrated and dissolved in 1:1 ACN/THF (0.5 mL), and then injected in C18 semi-prep 
HPLC column for purification. The purification was done by isocratic elution with 80:20 
ACN/H2O for 30 min with a flow rate of 10 mL/min. UV detector (210 nm, 254 nm) was used to 
identify the peaks. The reaction after purification by C18 HPLC column yielded in 48% (12 mg, 
9 min) (SSRR)-3 as a white solid. (SSRR)-3 was dissolved in a 1:1 mixture of THF:ethanol (0.2 
mL), and then injected in a Chiracel OD semi-prep HPLC column for purification. The 
purification was done by isocratic elution with 86:14 hexanes/isopropanol for 30 min with a flow 
rate of 10 mL/min. UV detector (210 nm, 254 nm) was used to identify the peaks.  The yield of 
the purification was 72% (8 mg, 7.9 min), obtaining (SSRR)-3 as a white solid: [α]D -15.8 (c 
0.93, MeOH);  1H NMR (600 MHz) δ 6.90 (ddd, J = 9.6, 6.5, 3.4 Hz, 1H), 6.03 (d, J = 9.6 Hz, 
1H), 4.79-4.75 (m, 1H), 4.35-4.31 (m, 1H), 4.01-3.97 (m, 1H), 3.65-3.63 (m, 1H), 2.41-2.39 (m, 
2H), 1.91-1.87 (m, 1H), 1.81-1.77 (m, 1H), 1.69-1.65 (m, 4H), 1.47 (t, J = 7.1 Hz, 2H), 1.29-1.21 
(m, 27H), 0.89 (t, J = 6.9 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 164.7, 145.5, 121.3, 75.1, 73.6, 
71.9, 68.1, 42.5, 42.3, 38.2, 34.1, 31.9, 30.1, 29.7(x8), 29.5, 29.4, 25.3, 22.7, 14.1 ppm; LCMS 
(APCI, positive mode) m/z = 509 (M + 3Na), 486 (M + 2Na), 463 (M + Na), 440 (M+), 422 (M – 
H2O), 404 (M – 2XH2O), 386 (M − 3XH2O). 
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C14H29
OOHOH
OH
O  
(S)-6-((2S,4S,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((SSSR)-3): 
The synthesis of this compound was done by the same method used for (SSRR)-3, with 
(SRSR)-16 (69 mg, 0.04 mmol). The crude after Chiracel OD purification provided (SSSR)-3 (7 
mg, 32%) as a white solid: [α]D -21.5 (c 0.7, MeOH); 1H NMR (600 MHz) δ 6.90 (ddd, J = 9.8, 
6.5, 3.4 Hz, 1H), 6.03 (d, J = 9.8 Hz, 1H), 4.78-4.74 (m, 1H), 4.27-4.23 (m, 1H), 3.95-3.91 (m, 
1H), 3.66-3.63 (m, 1H), 2.39-2.35 (m, 2H), 1.87 (t, J = 12.1 Hz, 1H), 1.75-1.68 (m, 4H), 1.58-
1.56 (m, 2H), 1.49-1.46 (m, 2H), 1.41-1.38 (m, 1H), 1.27 (m, 24H), 0.88 (t, J= 6.9 Hz, 3H); 13C-
NMR (75 MHz, CDCl3) δ 164.6, 145.5, 121.4, 74.8, 73.1, 72.5, 68.0, 43.7, 43.2, 37.9, 35.3, 33.9, 
31.9, 30.0, 29.7(x8), 29.4, 25.8, 22.7, 14.1 ppm; LCMS (APCI, positive mode) m/z = 509 (M + 
3Na), 486 (M + 2Na), 463 (M + Na), 440 (M+), 422 (M – H2O), 404 (M – 2XH2O), 386 (M − 
3XH2O). 
 
                                    
C14H29
OOHOH
OH
O  
(S)-6-((2R,4R,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((SRRR)-3): 
The synthesis of this compound was done by the same method used for (SSRR)-3, with 
(SSRR)-16 (70 mg, 0.04 mmol). The crude after Chiracel OD purification provided (SRRR)-3 (6 
mg, 327%) as a white solid: [α]D -26.8 (c 0.8, MeOH); 1H NMR (600 MHz) δ 6.90 (ddd, J = 9.0, 
6.5, 3.4 Hz, 1H), 6.03 (d, J = 8.8 Hz, 1H), 4.72-4.66 (m, 1H), 4.22-4.19 (m, 1H), 4.02-3.95 (m, 
1H), 3.73-3.66 (m, 1H), 2.51-2.38 (m, 2H), 2.09-2.01 (m, 1H), 1.82-1.75 (m, 1H), 1.75-1.55 (m, 
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4H), 1.53-1.45 (m, 2H), 1.43-1.36 (m, 1H), 1.32-1.20 (m, 25H), 0.89 (t, J=6.9 Hz, 3H); 13C-
NMR (75 MHz, CDCl3) δ 164.3, 145.1, 121.4, 76.3, 72.5, 71.9, 69.3, 42.6, 42.2, 37.5, 34.1, 32.7, 
32.0, 29.7(x8), 29.5, 29.4, 25.9, 22.7, 14.1 ppm; LCMS (APCI, positive mode) m/z = 509 (M + 
3Na), 486 (M + 2Na), 463 (M + Na), 440 (M+), 422 (M – H2O), 404 (M – 2XH2O), 386 (M − 
3XH2O). 
 
                                    
C14H29
OOHOH
OH
O  
(S)-6-((2R,4S,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((SRSR)-3): 
The synthesis of this compound was done by the same method used for (SSRR)-3, with 
(SSSR)-16 (78 mg, 0.04 mmol). The crude after Chiracel OD purification provided (SRSR)-3 (6 
mg, 28%) as a white solid: [α]D +15.3 (c 0.8, MeOH);  1H NMR (600 MHz) δ 6.90 (ddd, J = 8.5, 
6.5, 3.4 Hz, 1H), 6.03 (d, J = 8.1 Hz, 1H), 4.79-4.74 (m, 1H), 4.38-4.34 (m, 1H), 4.06-4.02 (m, 
1H), 3.73-3.69 (m, 1H), 2.47-2.31 (m, 2H), 2.08-1.86 (m, 2H), 1.77-1.63 (m, 2H), 1.62-1.53 (m, 
1H), 1.52-1.44 (m, 2H), 1.42-1.37 (m, 1H), 1.34-1.27 (m, 25H), 0.88 (t, J=6.9 Hz, 3H); 13C-
NMR (75 MHz, CDCl3) δ 164.6, 145.5, 121.6, 75.1, 73.5, 72.8, 68.4, 43.8, 43.3, 38.1, 34.0, 32.1, 
30.2, 29.8(x8), 29.5, 29.4, 25.9, 22.9, 14.3 ppm; LCMS (APCI, positive mode) m/z = 509 (M + 
3Na), 486 (M + 2Na), 463 (M + Na), 440 (M+), 422 (M – H2O), 404 (M – 2XH2O), 386 (M − 
3XH2O). 
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C14H29
OOHOH
OH
O  
(R)-6-((2S,4R,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((RSRR)-3): 
The synthesis of this compound was done by the same method used for (SSRR)-3, with 
(RRRR)-16 (53 mg, 0.04 mmol). The crude after Chiracel OD purification provided (RSRR)-3 (8 
mg, 40%) as a white solid: [α]D +3.4 (c 0.31, MeOH);  1H NMR (600 MHz) δ 6.91 (ddd, J = 
10.3, 6.6, 3.1 Hz, 1H), 6.03 (d, J = 10.7 Hz, 1H), 4.85-4.67 (m, 1H), 4.40-4.28 (m, 1H), 4.26-
4.16 (m, 1H), 3.94-3.82 (m, 1H), 2.57-2.26 (m, 2H), 1.91-1.82 (m, 1H), 1.83-1.75 (m, 1H), 1.73-
1.53 (m, 4H), 1.52-1.42 (m, 2H), 1.42-0.96 (m, 27H), 0.89 (t, J=6.9 Hz, 3H); 13C-NMR (75 
MHz, CDCl3) δ 164.3, 145.1, 121.4, 76.3, 72.5, 71.9, 69.3, 42.6, 42.2, 37.5, 34.1, 32.7, 32.0, 
29.7(x8), 29.5, 29.4, 25.9, 22.7, 14.1 ppm; LCMS (APCI, positive mode) m/z = 509 (M + 3Na), 
486 (M + 2Na), 463 (M + Na), 440 (M+), 422 (M – H2O), 404 (M – 2XH2O), 386 (M − 3XH2O). 
  
                                   
C14H29
OOHOH
OH
O  
(R)-6-((2S,4S,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((RSSR)-3): 
The synthesis of this compound was done by the same method used for (SSRR)-3, with 
(RRSR)-16 (68 mg, 0.04 mmol). The crude after Chiracel OD purification provided (RSSR)-3 (4 
mg, 22%) as a white solid: [α]D +12.2 (c 0.9, MeOH); 1H NMR (600 MHz) δ 6.92 (ddd, J = 10.3, 
6.5, 3.1 Hz, 1H), 6.04 (d, J = 10.5 Hz, 1H), 4.79-4.75 (m, 1H), 4.29-4.25 (m, 1H), 4.02-3.98 (m, 
1H), 3.72-3.68 (m, 1H), 2.54-2.36 (m, 2H), 1.93-1.85 (m, 1H), 1.78-1.74 (m, 1H), 1.63-1.56 (m, 
4H), 1.53-1.46 (m, 2H), 1.29-1.24 (m, 27H), 0.89 (t, J=6.9 Hz, 3H);  13C-NMR (75 MHz, 
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CDCl3) δ 164.1, 145.1, 121.6, 76.1, 73.2, 72.3, 69.4, 43.0, 42.3, 37.9, 35.2, 33.8, 31.9, 29.7(x8), 
29.5, 29.4, 25.8, 22.7, 14.1 ppm; LCMS (APCI, positive mode) m/z = 509 (M + 3Na), 486 (M + 
2Na), 463 (M + Na), 440 (M+), 422 (M – H2O), 404 (M – 2XH2O), 386 (M − 3XH2O). 
 
                                   
C14H29
OOHOH
OH
O  
(R)-6-((2R,4R,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((RRRR)-3): 
The synthesis of this compound was done by the same method used for (SSRR)-3, with 
(RSRR)-16 (66 mg, 0.04 mmol). The crude after Chiracel OD purification provided (RRRR)-3 (4 
mg, 21%) as a white solid: [α]D -34.1 (c 0.46, MeOH); 1H NMR (600 MHz) δ 6.90 (ddd, J = 9.8, 
6.5, 3.4 Hz, 1H), 6.03 (d, J = 9.7 Hz, 1H), 4.76 (t, J = 10.8 Hz, 1H), 4.25 (t, J = 9.4 Hz, 1H), 
4.00-3.96 (m, 1H), 3.69-3.65 (m, 1H), 2.43-2.32 (m, 2H), 1.87 (t, 1H), 1.73 (t, 1H), 1.63 (t, J = 
13.2 Hz, 2H), 1.57 (t, J = 14.1 Hz, 2H), 1.49-1.45 (m, 2H), 1.43-1.38 (m, 1H), 1.27 (m, 25H), 
0.89 (t, J=6.9 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 164.6, 145.5, 121.6, 75.0, 72.9, 72.3, 68.5, 
43.5, 43.3, 37.4, 34.3, 32.4, 32.1, 30.2, 29.7(x8), 29.5, 25.9, 22.9, 14.1 ppm; LCMS (APCI, 
positive mode) m/z = 509 (M + 3Na), 486 (M + 2Na), 463 (M + Na), 440 (M+), 422 (M – H2O), 
404 (M – 2XH2O), 386 (M − 3XH2O). 
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C14H29
OOHOH
OH
O  
(R)-6-((2R,4S,7R)-2,4,7-Trihydroxyhenicosyl)-5,6-dihydropyran-2-one ((RRSR)-3): 
The synthesis of this compound was done by the same method used for (SSRR)-3, with 
(RSSR)-16 (71 mg, 0.04 mmol). The crude after Chiracel OD purification provided (RRSR)-3 (5 
mg, 29%) as a white solid: [α]D +19.2 (c 0.39, MeOH); 1H NMR (600 MHz) δ 6.90 (ddd, J = 9.8, 
6.5, 3.4 Hz, 1H), 6.03 (d, J = 9.8 Hz, 1H), 4.78-4.74 (m, 1H), 4.27-4.23 (m, 1H), 3.95-3.91 (m, 
1H), 3.67-3.63 (m, 1H), 2.39-2.35 (m, 2H), 1.93-1.83 (m, 1H), 1.78-1.65 (m, 2H), 1.63-1.53 (m, 
2H), 1.52-1.44 (m, 2H), 1.43-1.37 (m, 1H), 1.36-1.13 (m, 26H), 0.89 (t, J = 6.9 Hz, 3H); 13C-
NMR (75 MHz, CDCl3) δ 164.4, 145.3, 121.3, 74.9, 73.3, 72.6, 68.1, 43.6, 43.1, 37.8, 35.3, 33.8, 
31.9, 29.7(x8), 25.7, 22.7, 14.1 ppm; LCMS (APCI, positive mode) m/z = 509 (M + 3Na), 486 
(M + 2Na), 463 (M + Na), 440 (M+), 422 (M – H2O), 404 (M – 2XH2O), 386 (M − 3XH2O). 
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2.6 APPENDIX A 
HPLC traces for allylation derivatives for the first, second and third allylation. HPLC 
traces for relevant fluorous mixtures.  
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Mandelate
(SR)-33 from 
(R)-5
Mandelates
33 from 
rac-5
HPLC traces from mandelates 33 to measure
the enantioselectivities for the allylation of aldehyde 4
These samples were eluted with Hex:EtOAc 99:1 in 
a Silica-pakHPLC column. 0.7 ml/min
7.5 min, (SR)-33
7.5 min, (SR)-33
8.5 min, (SS)-33
12.6 min, (SRR)-35
Mandelate (SSR)-35
from (SR)-34
10.2 min, (SSR)-35
HPLC traces from mandelates 35 to measure
the diastereoselectivities for the allylation of aldehyde 12
These samples were eluted with Hex:EtOAc 99:1 in 
a Silica-pakHPLC column. 0.7 ml/min
dr for (SR)-34 = 99:1, dr for (RR)-34 = 1:99
12.6 min, 
(SRR)-35
12.6 min, 
(SRR)-35
10.2 min, 
(SSR)-35
10.2 min, 
(SSR)-35
Mandelate (SRR)-35
from (RR)-34
Mandelates 35
from 34
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SSR24
14.82 11.7
HPLC traces for diol 37 fto measure the diastereoselectivities for the allylation of aldehydes M13. The 
samples were eluted with Hex:EtOAc 9:1 in a Silica-pak HPLC column. 0.7 ml/min
dr for mixtures RmR25M = 97:3 RSR25:SSR25 and 5:95 SRR25:RRR25
6
8
Diols 37 after 
deprotection of 
(SRR)-36A
Diols 37 after 
deprotection of 
36B
SRR24
11.7 min, (SRR)-37A
11.8 min,
(RSR)-37B
14.9 min,
(SSR)-37B
14.9 min, (SSR)-37B
Diols 37 after 
deprotection of 
(SSR)-36B
Diols 37 after 
deprotection of 
36A
11.7 min,
(SRR)-37A 14.8 min,(RRR)-37A
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20 30
(RRR)-51
(RSR)-51
(SRR)-49
(SSR)-49
HPLC trace of mixture of two
quasiisomers (RMR)-51
HPLC trace of mixture of two
quasiisomers (SMR)-49
(RRR)-14
(RSR)-14
(SRR)-14
(SSR)-14
HPLC trace of mixture of four aldehyde
quasiisomers M14
These are analytical HPLC traces (gradient elution  95:5 ACN:H2O to 100% ACN in 30 min + 100% ACN for 30 min)
from injections in a fluoroflash column.  
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HPLC trace of (R)-M52 from
(RRRR)-52
(RSRR)-52
(RRSR)-52
(RSSR)-52 (SRRR)-52
(SSRR)-52
(SRSR)-52
(SSSR)-52
the allylation of M14 with (S,S)-23
HPLC trace of (S)-M52 from
the allylation of M14 with (R,R)-23
(RRRR)-15 (RSRR)-15 (RRSR)-15
(RSSR)-15
HPLC trace of (R)-M15 from
the acylation of  (R)-M52
These are analytical HPLC traces (gradient elution  95:5 ACN:H2O to 100% ACN in 30 min
 + 100% ACN for 30 min)from injections in a fluoroflash column.
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HPLC trace of (S)-M15 from
the acylation of  (S)-M52
This is a analytical HPLC trace (gradient elution  95:5 ACN:H2O to 100% ACN in 30 min
 + 100% ACN for 30 min) from an injection in a fluoroflash column.
(SRRR)-15 (SSRR)-15
(SRSR)-15
(SSSR)-15
(SRRR)-16
(SSRR)-16 (SRSR)-16
(SSSR)-16
(RRRR)-16
(RSRR)-16 (RRSR)-16
(RSSR)-16
HPLC trace of (S)-M16 from
the RCM reaction of  (S)-M16
HPLC trace of (R)-M16 from
the RCM reaction of  (R)-M16
These are analytical HPLC traces (gradient elution  95:5 ACN:H2O to 100% ACN in 30 min
 + 100% ACN for 30 min) from injections in a fluoroflash column.  
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3.0  SELECTIVE SYNTHESIS OF (2Z,4E)-DIENYL ESTERS BY ENE-DIENE 
CROSS METATHESIS 
3.1 INTRODUCTION 
Dienyl esters and conjugated esters are recurrent functionalities in chemotherapeutic 
agents.1 For example, the (2Z, 4E)-dienyl ester moiety (in lactone form) is one of the key 
structural features that differentiates the potent dictyostatin family of anti-cancer agents from its 
relatives in the discodermolide family.2 SAR studies on dictyostatin and analogs has proven that 
the (2Z,4E)-dienyl ester moiety plays an important role in activity.3  
The construction of the (2Z,4E)-dienyl ester functionality in all the reported syntheses of 
dictyostatin and analogs has relied on a late-stage coupling reaction to complete that part of the 
molecule.3 Recently, our group developed a multi-step approach to incorporate the (2Z,4E)-diene 
before fragment coupling through a sequence of cross metathesis, olefination and reduction 
reactions for the synthesis of 16-epi-15,16-dehydrodictyostatin (Figure 11).3,7  
The Curran group has spent the last 8 years focusing on the synthesis of discodermolide 
and dictyostatin analogues with great success.4 Because of the need for developing a short and 
efficient synthetic approach for dictyostatin, we engaged in experiments directed towards 
obtaining a rapid and general approach to substituted (2Z,4E)-dienyl esters (cis,trans) by ene-
diene cross metathesis. 
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Cross metathesis reactions of two alkenes have seen increasing use in synthesis in the last 
years,5 and ene-diene cross metathesis reactions have recently gained attention.5c Our starting 
point was a recent report by Grubbs and coworkers on cross metathesis of alkenes with (2E,4E)-
dienyl esters (trans,trans).6 Grubbs proposed that it should be feasible to obtain cross-metathesis 
products from the reaction of only one of the olefins in a diene. His strategy was based on 
shielding one of the olefins in the conjugated diene by attaching either electron-withdrawing 
substituents or steric bulk (Scheme 16). The reaction of allylanisole and diene 1 promoted by 
Grubbs second generation catalyst provided diene product 2 in 50% yield and 10:1 E/Z ratio for 
the C4-C5 olefin. The reaction using bulkier and more electron poor diene 3 provided diene 4 in 
65% yield and 8.5:1 E/Z ratio. Moreover, the cross metathesis reaction with dibromo diene 5 
provided diene product 6 in 60% yield and much better >20:1 E/Z ratio. This report showed that 
the formation of the new double bond at C4-C5 occurred with modest to good E-selectivity, for a 
broad range of substrates.   
 
+
Y
X Grubbs 2nd
CH2Cl2, 40 oC
3 equiv 1 (X = COOEt, Y = H) 1 equiv 2, 50% E/ Z 10:1a
3 (X = COOEt, Y = Br) 1 equiv 4, 65% E/Z 8.5:1
5 (X = COOEt, Y = Br) 1 equiv 6, 60% E/ Z >20:1
23
4
5
Y
X
23
4
5
Ph
allylanisole diene product
a) C4-C5 olefin ratio  
Scheme 16. Grubbs’ studies on ene-diene metathesis 
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Inspired by these results, we proposed that methyl-(2Z,4E)-dienyl ester are perfect 
substrates to obtain functionalized dienyl esters like bottom fragment 8 for a more convergent 
coupling strategy in the synthesis of (−)-dictyostatin 7. The key open question for the intended 
use in dictyostatin and analogues syntheses was the fate of the “spectator” double bond at C2-C3 
of the dienyl ester during the cross metathesis reaction. We also envisioned applying this 
methodology for the multi-gram scale synthesis of bottom fragment 8.   
 
O
HO
OH
OH
OH
O Dictyostatin 7
Bottom Fragment 8
R
R
CO2Me
ENE
CO2Me
ENE-DIENE CROSS MET AT HESIS
2
4
2
4
5
PRODUCT
MeO
OHO
O
+ O41)
2) CO2Me
2(RO)2(O)P
CROSS MET AT HESIS/ STILL-GENARI
5
2
4
6
 
Figure 11. Ene-diene metathesis reaction for the synthesis of bottom fragment 8 
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3.1.1 Cross-metathesis catalysts 
The commercial availability of well-defined catalysts; such as the molybdenum 
alkoxyimido alkylidene 9a developed by Schrock,8 and the ruthenium benzylidene catalysts 9b 
and 9c developed by Grubbs,9 have made the olefin metathesis reaction practical for small 
molecule synthesis (Figure 12). The availability of more air-stable and compatible catalysts like 
the phophine-free Hoveyda-Grubbs catalyst (10a)10 and the Grela catalyst (10b)11 for the cross-
metathesis of more electron deficient olefins has contributed to increase the generality of the 
cross metathesis reaction. However, the high cost of these catalysts is a limitation, even for small 
scale reactions. Therefore, the introduction of reusable cross metathesis catalysts has become an 
important alternative for more traditional catalysts.13  
 
Ru
PhPCy3
Cl
Cl
MesN NMes
9c, Mes = mesityl
Ru
MesN NMes
Cl
Cl
O
10a
Ru
MesN NMes
Cl
Cl
O (CH2)3C8F17
12
Ru
Ph
PCy3
Cl
Cl
PCy3
9b
Mo
N
Me(F3C)2CO
Me(F3C)2CO
iPriPr
Me
Me
Ph
9a
Ru
MesN NMes
Cl
Cl
O
10b
NO2
Ru
PCy3
Cl
Cl
O (CH2)nC8F17
11a, n = 3
11b, n = 2  
Figure 12. Metathesis catalysts 
 
Light fluorous catalysts are especially convenient since they typically promote the 
reaction of organic substrates like their nonfluorous relatives, but are reliably removed from the 
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crude reaction products by fluorous solid-phase extraction (FSPE).12 Our group recently 
developed a family of fluorous olefin metathesis catalysts (11a and 11b) that are highly active 
towards cross metathesis and show high levels of recovery and recycling.13 Due to our interest in 
the ene-diene metathesis at a multi-gram scale, we decided to prepare the fluorous Hoveyda-
Grubbs (FHG) 2nd-generation catalyst 12, to evaluate the ene-diene cross metathesis reaction. 
3.2 RESULTS AND DISCUSSION 
The synthesis of FHG catalyst 12 was based on previous chemistry developed in the 
Curran group.13 We started by reacting fluorous iodide (C8F17I) and 1-allyl-3-methoxybenzene 
mediated by Pd(PPh3)4 to provide a secondary iodide intermediate in 64% yield.14 The resulting 
iodide was then reduced with Zn dust to provide 13 in 95% yield,15 followed by demethylation 
reaction to provide phenol intermediate16 and protection with an isopropyl group to provide 14 in 
91% yield over 2 steps. Intermediate 14 was brominated17 and the resulting bromide was coupled 
with vinyl tributyltin18 to provide ligand 16 in 79% overall yield. Trans-metathesis with catalyst 
9c provided catalyst 12 in 92% yield as green crystals (mp 141-142 oC) after recrystalization. 
Catalyst 12 was characterized by 1H, 13C, and 19F NMR spectroscopy. However, crystals suitable 
for X-ray analysis were not obtained. 
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Ru C8F17
O
Cl
Cl
NNMes Mes
12
g
C8F17
O
14
C8F17
O
15
O
C8F17
O
13
a,b c,d
e,f
Reagents and conditions: a) 2.2 equiv of C8F17I, 1 equiv of Me3Al, 5 mol% of Pd(PPh3)4, CH2Cl2, rt 64%; b)
NiCl2, Zn, THF, 95%; c) 4 equiv of BBr3S(CH3)2, dichloroethane, ref lux, 88%, d) 1.5 equiv of NaH,
2 equiv of iPrI. THF/DMF, rt, 94%;e) 1.1 equiv of Br2, 0.04 equiv of AcOH, CH2Cl2, rt, 94%; f) 50 mol% of
Pd(PPh3)4, 3 equiv of tributylvinylstannane,toluene, reflux, 64%; g) 1.1 equiv of catalyst 9c, 1.25 equiv CuCl,
CH2Cl2, rt, 71%.
allylanisole
8
 
Scheme 17. Synthesis of third generation FHG catalyst 12 
 
Next, we tested the ene-diene cross metathesis reaction for terminal olefins. We initially 
surveyed catalysts and solvents for the cross metathesis reaction of readily available alkene 
(R,S)-16 (C5-C9 of dictyostatin) and methyl (2Z,4E)-hexadienoate 17 (C1-C4), as summarized in 
Table 10. In a typical reaction, a mixture of 1 equiv of 16, 1 equiv of 17 and 5 mol% of Grubbs 
second generation catalyst 9c dissolved in CH2Cl2 (0.2 M) was refluxed for 8 h. The solvent was 
then removed and the crude mixture was purified twice by silica gel flash chromatography to 
provide 18a in a promising 47% yield (Entry 1). Moreover, diene 18a was a single compound 
resulting from metathesis at C4-C5 olefin, and there was no evidence of metathesis products at 
the C2-C3 olefin in 17.19 We also isolated a fraction containing starting material alkene 16 and 
its homodimerized byproduct 18b. Careful chromatography provided pure homodimer 18b as the 
less polar fraction from the mixture of compounds.  
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Table 10. Initial solvent and catalyst survey 
a Isolated yields as single isomers.
Conditions: a) 1 equiv 16, 1 equiv 17, 5 mol% of catalyst, 8h.
OTBSTBSO
OTBSTBSO
CO2Me
entry catalyst solvent concentration yielda
9c
9c
9c
9c
Toluene
Toluene
0.1 M
0.2 M
43%
47%
0.1 M
0.2 M
23%
25%
10a
12
0.15 M
0.15 M
62%
64%
9c 0.15 M 58%
CO2Me
catalyst
solvent, ref lux
17
16
18a
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
OTBSTBSO
TBSO OTBS
18b
+
1
2
3
4
5
6
7
 
 
Further optimization of the reaction conditions showed that diluting the mixture to 0.15M 
provided 18a in a better 58% yield; however, when the reaction mixture was further diluted to 
0.1M, 18a was isolated in a lower 43% yield (Entries 2 and 3). The reaction using refluxing 
toluene at 110 oC provided 18a in only 23% yield when the concentration was 0.1M, and 25% 
yield when it was 0.2M (Entries 4 and 5). We tried the reaction using 5 mol% of catalyst 10a and 
refluxing CH2Cl2 at 0.15M concentration, to obtain 18a in 62% yield (Entry 6). Finally, the 
reaction with 5 mol% of FHG catalyst 12 under the same conditions provided 18a in 64% yield 
(Entry 7).  
Next, we investigated the stoichiometry of the ene-diene metathesis in an attempt to 
further optimize the yield of the product. We conducted a series of model reactions using p-
allylanisole 19 (1.2, 1.5, 2 equiv) and methyl (2Z,4E)-hexadienoate 17 (1.2, 1.5 and 2 equiv) at 
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different molar ratios, as summarized in Table 11. The reaction of 2 equiv of methyl (2Z,4E)-
hexadienoate 17 and 1 equiv of 19 promoted by 5 mol% of 9c provided 20 in 64% yield as a 
single olefin isomer (Entry 1). The reaction with 1.5 equiv of 17 provided 20 in 65% yield, and 
with 1.2 equiv of 17 provided 20 in a slightly better 68% yield (Entries 2 and 3). The reaction of 
1.2 equiv of 19 and 1 equiv of 17 provided 20 in 71% yield also as a single olefin isomer (Entry 
4).  
 
Table 11. Ene/diene stoichiometry survey 
64%
65%
68%
76%
1
1
1
1.2
1.5
2
71%
79%
CO2Me
MeO MeO
CO2Me
entry 19 equiv 17 equiv Yield 20a,b
2
1.5
1.2
1
1
1
catalyst 9c
19 17
20
1
2
3
4
5
6
a) Reactions run at 0.15 M in refluxing CH2Cl2 with 5 mol% of catalyst 9c.
b) Isolated yields as a single olefin isomer.  
 
Similarly, the reaction with 1.5 equiv of 19 provided 20 in 76% yield, and with 2 equiv of 
19 provided 20 in a comparable 79% yield. In addition to the target product 20, these reaction 
mixtures exhibited a second, less polar spot on TLC. This spot was deduced to contain a mixture 
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of products resulting from self-metathesis of alkene 19 (no methyl esters or conjugated alkene 
protons in the 1H NMR spectrum). A similar mixture of products was obtained when the 
metathesis of 19 was attempted in the absence of 17. These results implied that the competing 
reactions cannot be completely suppressed by using a modest excess of one of the components, 
and therefore a 1:1 stoichiometry is satisfactory for most applications. 
3.2.1 Scope of the ene-diene cross metathesis 
Because of the success found in the ene-diene metathesis reaction of olefin 16 and 19, we 
decided to investigate the scope of ene-diene cross metathesis reaction for diene 17 with different 
alkenes, as summarized in Table 12.  
The reaction of 1 equiv of alkene 16 and 1 equiv of diene 17 promoted by 5 mol% of 
catalyst 9c in refluxing CH2Cl2 provided 18a in 58% yield as a single olefin isomer (Entry 1). 
Under the same conditions, the reaction of diene 17 with MOM-protected alkene provided the 
desired product in 65% yield, and the reaction with PMB-protected alkene provided the product 
in 62% yield (Entries 2 and 3). Similarly, the reaction of unprotected alkene with 17 provided the 
respective product in 61% yield (Entry 4). The reaction of simple p-allylanisole with 17 provided 
the desired diene in 69% yield (Entry 5). Allylbenzene reacted with 17 under the same conditions 
to give the desired product in a very good 76% yield as a 10:1 ratio of E/Z olefin isomers (Entry 
6).  
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Table 12. Scope of the ene-diene cross metathesis for the ene component 
Conditions: 1 equiv ene, 1 equiv 17, 5 mol% 9c, 0.15M, CH2Cl2, 40 oC, 8h.
a) Isolated yield as single isomer. b) E/Z ratio = 10:1.
c) E/Z ratio = 8:1 .
R2
catalyst 9c
R2
CO2Me
Entry R1 R2 yielda
1 4
5
6
58% 61%
69%
68%
R1
7
8
H H
H
H
CH2OAc
CH2Cl
CH2OAc
CH2Cl
CH2Ph
CH2PhOMe
OTBSOHOTBSTBSO
76%b
63%
OMOMTBSO
OPMBTBSO
2
3
H
H
65%
62%
9 H
N
O
OMeO
76%c
4
2
Entry R1 R2 yield
CO2Me
17
 
 
The ene-diene metathesis reaction with symmetrical 1,2-disubstituted alkenes (entries 7 
and 8) provided dienes in good yields (68% and 63%, respectively). Moreover, the reaction with 
complex triene20 (Entry 9) provided tetraene in 76% yield as an 8:1 ratio of E/Z isomers at the C4 
alkene. All products isolated from these ene-diene metathesis reactions were exclusively Z-
isomers at the spectator C2 alkene.  
The success of the ene-diene metathesis for simple olefins encouraged us to investigate 
the reaction with dienes with different substitution patterns, as summarized in Table 13. The 
reaction of 1 equiv of allylbenzene and 1 equiv of methyl (2Z,4E)-4-methyl-hexadienoate 21 
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(trisubstituted C4-C5 alkene) promoted by 5 mol% of catalyst 9c in refluxing CH2Cl2 and at 
0.25M concentration provided diene 23a in 68% yield as a single olefin isomer (Entry 1). The 
reaction with p-allylanisole provided diene 23b in 63% yield (Entry 2). 
 
Table 13. Scope of the ene-diene cross metathesis for the diene component 
Conditions: a) 1 equiv ene, 1 equiv diene, 5 mol% 9c, 0.25M, CH2Cl2, 40 oC, 8h.
a) Isolated yield as single isomer.
catalyst 9c
CO2Me
entry R diene product yielda
R
CH2Ph
CH2PhOMe1
2
68%
63%
CH2Ph
CH2PhOMe3
4
71%
73%
5 73%Ph
CO2Et
22
R
CO2Me
R
CO2Et
or
23a, 23b
24a, 24b, 24c
21
21
22
22
22
21
diene
23a
23b
24a
24b
24c
4
5
2
3
 
 
The ene-diene metathesis reaction with modified ethyl (2Z, 4E)-3-methyl-hexadienoate 
22 (trisubstituted C2-C3 alkene) and allylbenzene provided dienoate 24a in 71% yield (Entry 3).  
The reaction with p-allylanisole and 22 provided dienoate 24b in 73% yield, and the reaction 
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with styrene provided dienoate 24c in 73% yield. All these products were single stereoisomers at 
both the reacting (4E) and spectator (2Z) alkenes. 
3.2.2 Multi-gram scale synthesis of bottom fragment for 6-epi-dictyostatin 
The final goal was to implement a multi-gram scale ene-diene metathesis process with 
catalyst removal and recycle for potential use in the synthesis of dictyostatin or analogs. Based 
on structure activity relationships (SAR) studies, recently synthesized 6-epimer analog (6-epi-
dictyostatin) proved to be four times more active than dictyostatin.4c  
Based on these results, we focused on the scale-up synthesis of the bottom fragment for 6-
epi-dictyostatin. We made the olefin starting material with the desired stereochemistry at C6 by 
reacting aldehyde 25 with (+)-cis-crotyl-diisopinocampheylborane in diethyl ether at −78 oC to 
provide alcohol 26 in 63% yield as a single diastereomer, followed by protection of the resulting 
alcohol 26 with TBSCl and imidazole to provide starting material 27 in 95% yield.  
The big-scale ene-diene metathesis reaction for olefin 27 was performed in three different 
batches.  We used the FHG catalyst 12 in 3 mol% instead of the usual 5 mol% to increase 
catalyst turnover, as summarized in Table 14. In the first cycle, we reacted alkene 27 (15 g, 42 
mmol) and diene 17 (42 mmol) with 3 mol% of catalyst 12 in refluxing CH2Cl2 at 0.15 M 
concentration for 8 h. After cooling we removed the solvent and the crude product was loaded 
onto a 50 g fluorous spe cartridge that was eluted in a first pass with 9/1 MeOH/H2O followed by 
second pass with THF. The MeOH/H2O fraction yielded 10.9 g (59%) of diene 28 after silica gel 
flash chromatography, and the THF fraction yielded 74% of catalyst 12 after recrystallization. 
The crude catalyst recovery was nearly quantitative; however, 1H NMR analysis showed small 
but significant impurities.  During the purification of 28, the less polar fraction accounted for 
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37% of the mass balance and contained a substantial amount of 27 (~50%) along with other 
unidentified products derived from 27.  
 
Table 14. Preparative cross metathesis for the multi-gram synthesis of bottom fragment 30 
ORTBSO
Ru C8F17
O
Cl
Cl
NNMes Mes
CO2Me
OTBSTBSO
CO2Me
cycle yield 28 weight 12 scale recovered 12
1
2
3
59%
60%
56%
42 mmol 74 %
31 mmol 70%
21 mmol 70%i
26, R = H 28
OTBSTBSO
CO2Me
28
d
OTBSX
CO2Me
17
12
c
29, X = OH, H
e
30, X = O
1.0g
0.7g
0.4g
10.9 g
8.1 g
5.2 g
1.3g
1.0g
0.7g
i) The recovered catalyst was recrystalized twice in hexanes to obtain it pure.
Conditions: a) (+)-cis-crotyl-diisopinocampheylborane, diethyl ether, −78 oC, 63%;
b) TBSCl, imidazole, CH2Cl2, 95%. c) 1 equiv 27, 1 equiv 17, 3 mol% 12, 0.15M, CH2Cl2, 40 oC, 8h,
followed by fspe. d) HFPy/Py/THF, THF, RT (88%).
e) PySO3, DMSO, Et3N, CH2Cl2, 0 oC (89%).
O
TBSO
a
25
27, R = TBS
b
 
 
As a separate exercise, the entire less polar fraction isolated from the first cycle was directly 
reused in a cross metathesis with 17 to provide an additional 20% of pure 28 after FSPE and 
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flash chromatography. Including the recycling of the less polar fraction, the overall yield of 28 
based on 27 for the first cycle was 79%. 
 The recrystallized catalyst 12 from cycle 1 was reused for cycle 2 ene-diene metathesis 
reaction. The reaction of 27 (11.1 g, 31 mmol), 17 (3.9 g, 31 mmol) and 12 (1 g, 0.93 mmol) for 
cycle 2 provided 28 (8.1 g, 18.6 mmol) in 60% yield and the recovered catalyst 12 (0.7 g, 0.65 
mmol) in 70% yield. Similarly, cycle 3 provided 28 (5.2 g, 10.4 mmol) in 56% yield and the 
recovered catalyst 12 (0.4 g, 0.37mmol) in 70% yield. Overall, the initial lot of 1.3 g (1.3 mmol) 
of 12 was used to metathesize 33.5 g (94 mmol) of 27 into 24.2 g of pure 28 as a single 
diastereomer in 59% yield. This yield does not include the recycling of the less polar fraction out 
of the cross metathesis in the first cycle.  
Finally, diene 28 (24.2 g, 55 mmol) reacted with HF·Py/Py/THF for the selective 
deprotection of the primary TBS ether to provide primary alcohol 29 (12 g, 35 mmol) in 88% 
yield. The last step was the Parikh-Doering oxidation of 29 (12 g, 35 mmol) to provide aldehyde 
30 (10 g, 30 mmol) in 89% yield. 
3.3 CONCLUSIONS 
The ene-diene cross metathesis reaction for monosubstituted or symmetrical 1,2-
disubstituted alkenes with methyl (2Z, 4E)-hexadienoate and related dienyl esters provided 
substituted (2Z,4E)-dienyl esters in good yields and stereoselectivities. 
The Z-geometry of the spectator alkene of the dienyl ester (C2-C3) is strictly retained in 
the product, while the newly formed alkene (C4-C5) is mainly or exclusively the E-isomer. 
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The synthesis and characterization of third generation FHG catalyst 12 was achieved 
efficiently. Catalyst 12 proved to promote the cross metathesis of enes with dienes in good yields 
with almost complete stereoselectivity. 
Large scale reactions are conveniently conducted with 3 mol% of the third generation 
FHG catalyst 12, which can be recovered and recycled as illustrated by the rapid preparation of 
10 g of bottom fragment 30 for the synthesis of 6-epi-dictyostatin.   
3.4 EXPERIMENTAL 
All reactions were performed under an atmosphere of argon unless otherwise specified or 
the reaction solvent contained water. The reaction times reported are dictated by TLC analysis of 
the reaction mixture in comparison to the starting material. Reaction solvents were freshly dried 
either by distillation or passing through an activated alumina column. CH2Cl2 was distilled from 
CaH. Commercially available reagents were used a received from supplier. Reactions were 
monitored using thin layer chromatography (TLC) using Kieselgel 60 F254 silica gel plates. Flash 
chromatography was performed over silica gel 60, 230-400 mesh, with the designated solvents. 
1H NMR and 13C NMR spectra were recorded on a Bruker DPX-300 or a Bruker DPX-500 
spectrometer using residual solvent peaks as internal standard: CDCl3 7.23 ppm (1H NMR) and 
77.00 ppm (13C NMR). Chemical shifts are reported in ppm (δ) downfield from tetramethylsilane 
and proton-proton coupling constants (J) in Hz. Infrared spectra (IR) were recorded on a ATI 
Mattson genesis series FTIR spectrometer and are reported in reciprocal centimetres (cm-1). 
Optical rotations were measured with a Perkin-Elmer 241 digital polarimeter with a sodium lamp 
at ambient temperature. HPLC analysis was performed on a Waters 600E system with UV 
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detector. Low and high resolution mass spectra were obtained on a VG 70-G or Micromass 
Autospec double focusing instrument using EI, ESI, or CI. 
Typical procedure for the ene-diene metathesis: To a solution of (3R,4S)-4,6-bis(tert-
butyldimethylsilyloxy)-3-methylhex-1-ene 16 (100 mg, 0.279 mmol) in CH2Cl2 (1.5 mL) was 
added (2Z,4E)-methyl hexa-2,4-dienoate 17 (35.2 mg, 0.279 mmol), and the solution was heated 
to reflux. At that temperature was added catalyst 9c (12.1 mg, 0.014 mmol) dissolved in CH2Cl2 
(0.4 mL). The reaction was stirred at reflux for 10 h and then the solvent was removed by rotary 
evaporation. The crude mixture was purified twice by silica gel flash chromatography eluting 
with hexanes:EtOAc 10:1 to provide 18a (71.6 mg, 58%) as a colorless oil. 
Typical procedure for the big scale ene-diene metathesis: To a solution of (3S,4S)-4,6-
bis(tert-butyldimethylsilyloxy)-3-methylhex-1-ene 27 (15 g, 42 mmol) in CH2Cl2 (260 mL) was 
added (2Z,4E)-methyl hexa-2,4-dienoate 11 (5.3 g, 42 mmol), and the solution was heated to 
reflux. At that temperature was added catalyst 12 (1.37 g, 1.26 mmol) dissolved in CH2Cl2 (29 
mL). The reaction was stirred at reflux for 10 h and the solvent was removed by rotary 
evaporation. The crude mixture was purified by fluorous solid phase extraction in a 50 g 
cartridge with 100 mL of 9:1 MeOH, followed by 100 mL of pure MeOH to give the organic 
fraction. Silica gel flash chromatography with 20:1 Hexanes/EtOAc furnished 28 (10.9 g, 59%) 
as a colorless oil. FHG catalyst 12 was recovered by flushing the cartridge with 200 mL of THF. 
The fraction was concentrated and the dark green residue was recrystalized from a 
hexanes/CH2Cl2 mixture to furnish 12 (1005 mg, 74%) as light green crystals. 
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                                                      OTBSTBSO
CO2Me
 
(2Z,4E,6R,7S)-Methyl 7,9-bis(tert-butyldimethylsilyloxy)-6-methylnona-2,4-dienoate (18a): 
          [α]D -6.1 (c 0.4, CHCl3); IR (thin film) 2954, 2857, 1721, 1424, 1165, 1101, 830, 751 cm-1; 
1H-NMR (300 MHz, CDCl3) δ 7.35 (dd, J = 15.4, 11.3 Hz, 1H), 6.58 (t, J = 11.3 Hz, 1H), 6.04 
(dd, J = 15.4, 8 Hz, 3H), 5.59 (d, J = 11.3 Hz, 1H), 3.82-3.77 (m, 1H), 3.73 (s, 3H), 3.64 (t, J = 
6.6 Hz, 1H), 2.51-2.46 (m, 1H), 1.66-1.54 (m, 2H), 1.07 (d,  J = 6.9 Hz, 3H), 0.89 (s, 18H), 0.06 
(s, 6H), 0.04 (s, 6H); 13C-NMR (75 MHz, CDCl3) δ 167.1, 147.6, 145.8, 127.1, 115.6, 72.6, 60.0, 
51.2, 42.9, 37.4, 26.1, 18.5, 8.3, 15.7, -4.1, -5.0 ppm; HRMS (ESI) calcd for C23H46O4Si2 = 
442.2899, found = 442.2897. 
 
                                                       OTBSOH
CO2Me
 
(2Z,4E,6R,7S)-Methyl 7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-methylnona-2,4-dienoate 
(Table 11, Entry 4): 
[α]D -14.9 (c 0.25, CHCl3); IR (thin film) 3421, 2953, 2857, 1719, 1412, 1190, 1167, 837 
cm-1;  1H-NMR (300 MHz, CDCl3) δ 7.37 (dd, J = 15.4, 11.3 Hz, 1H), 6.56 (t, J = 11.3 Hz, 1H), 
6.01 (dd, J = 15.4, 8 Hz, 3H), 5.61 (d, J = 11.3 Hz, 1H), 3.87-3.83 (m, 1H), 3.75-3.71 (m, 5H), 
2.59-2.52 (m, 1H), 1.85 (bs, 1H), 1.70-1.66 (m, 2H), 1.08 (d,  J = 6.8 Hz, 3H), 0.90 (s, 9H), 0.09 
(s, 6H); 13C-NMR (75 MHz, CDCl3) δ 166.8, 147.2, 145.5, 126.8, 115.5, 73.2, 59.4, 51.0, 42.7, 
36.0, 25.8, 18.0, 15.0, -4.4 ppm; HRMS (ESI) calcd for C17H32O4Si = 328.2097, found = 
328.2092. 
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                                                    OMOMTBSO
CO2Me
 
(2Z,4E,6R,7S)-Methyl 9-(tert-butyldimethylsilyloxy)-7-(methoxymethoxy)-6-methylnona-
2,4-dienoate (Table 11, Entry 2): 
[α]D -7.8 (c 0.5, CHCl3); IR (thin film) 3053, 2955, 2930, 2857, 2254, 1713, 1637, 1463, 
1439, 1265, 1198, 1096, 909, 736 cm-1;1H-NMR (600 MHz, CDCl3) δ 7.36 (dd, J = 15.4, 11.3 
Hz, 1H), 6.54 (t, J = 11.3 Hz, 1H),  6.02 (dd, J = 15.4, 7.7 Hz, 1H), 5.58 (d, J = 11.3 Hz, 1H), 
4.64 (dd, J = 21.3, 6.8 Hz, 2H), 3.71 (s, 3H), 3.68-3.64 (m, 4H), 3.36 (s, 3H), 2.63-2.60 (m, 1H), 
1.67-1.58 (m, 2H), 1.10 (d, J = 6.8 Hz, 3H), 0.86 (s, 9H), 0.02 (s, 6H); 13C-NMR (125.8 MHz, 
CDCl3) δ 166.8, 146.9, 145.4, 127.0, 115.6, 96.5, 78.6, 78.4, 59.6, 55.7, 51.1, 40.9, 34.9, 25.9, 
18.2, 15.3, 5.4 ppm; HRMS (ESI) calcd for C18H33O5Si = 357.2097, found = 357.2098. 
 
                                                 OPMBTBSO
CO2Me
 
(2Z,4E,6R,7S)-Methyl 7-(4-methoxybenzyloxy)-9-(tert-butyldimethylsilyloxy)-6-
methylnona-2,4-dienoate (Table 11, Entry 3):  
[α]D -13.3 (c 0.41, CHCl3), IR (thin film) 3055, 2985, 2927, 2854, 1465, 1390, 1421, 
1265 cm-1;  1H-NMR (300 MHz, CDCl3) δ 7.44 (dd, J = 15.1, 11.4 Hz, 1H), 7.07 (d, J = 6.7 Hz, 
2H), 6.80 (d, J = 6.7 Hz, 2H), 6.53 (t, J = 11.4 Hz, 1H), 6.11 (dt, J = 15.2, 7.2 Hz, 1H), 5.59 (d, J 
= 11.4 Hz, 1H), 4.72 (d, J = 6.7 Hz, 2H), 3.77-3.75 (m, 1H), 3.72 (s, 3H), 3.65-3.58 (m, 2H), 
3.41 (s, 3H), 2.53-2.49 (m, 1H), 1.60-1.50 (m, 2H), 1.03 (d,  J = 6.9 Hz, 3H), 0.83 (s, 9H), 0.02 
(s, 6H); 13C-NMR (75 MHz, CDCl3) δ 166.7, 158.0, 144.9, 143.7, 130.9, 129.5, 127.1, 115.8, 
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113.8, 73.2, 59.5, 55.0, 51.0, 42.7, 36.1, 25.9, 18.0, 15.0, -4.5 ppm. HRMS (ESI) calcd for 
C25H40O5Si = 448.2613, found = 448.2628. 
 
                                                 
CO2Me
MeO  
(2Z,4E)-Methyl 6-(4-methoxyphenyl)hexa-2,4-dienoate (Table 11, Entry 5): 
IR (thin film) 3052, 2986, 2959, 2872, 2253, 1720, 1610, 1511, 1439, 1265, 1175, 909, 
734 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.44 (dd, J = 15.1, 11.4 Hz, 1H), 7.07 (d, J = 6.7 Hz, 
2H), 6.80 (d, J = 6.7 Hz, 2H), 6.53 (t, J = 11.4 Hz, 1H), 6.11 (dt, J = 15.2, 7.2 Hz, 1H), 5.59 (d, J 
= 11.4 Hz, 2H), 3.74 (s, 3H), 3.69 (s, 3H), 3.43 (d,  J = 6.7 Hz, 2H); 13C-NMR (75 MHz, CDCl3) 
δ 166.7, 158.0, 144.9, 143.7, 130.9, 129.4, 127.2, 115.8, 113.8, 55.0, 50.9, 38.4 ppm; HRMS 
(ESI) calcd for C14H16O3 = 232.1099, found = 232.1094. 
 
                                                        
CO2Me
 
(2Z,4E)-Methyl 6-phenylhexa-2,4-dienoate (Table 11, Entry 6): 
IR (thin film) 3053, 2985, 2959, 2928, 2253, 1717, 1456, 1265, 909, 735 cm-1;  1H-NMR 
(300 MHz, CDCl3) δ 7.40 (dd, J = 15.2, 11.4 Hz, 1H), 7.23-7.10 (m, 5H), 6.49 (t, J = 11.4 Hz, 
1H), 6.09 (dt, J = 15.2, 7.2 Hz, 2H), 5.54 (d, J = 11.4, 1H), 3.64 (s, 3H), 3.45(d, J = 7.2 Hz, 2H); 
13C-NMR (75 MHz, CDCl3) δ 166.8, 144.9, 143.2, 139.0, 128.5, 127.5, 126.3, 116.0, 51.0, 39.3 
ppm; HRMS (ESI) calcd for C13H14O2 = 202.0993, found = 202.0984. 
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CO2Me
Cl  
(2Z,4E)-Methyl 6-chlorohexa-2,4-dienoate (Table 11, Entry 7): 
IR (thin film) 3053, 2986, 2953, 2249, 1712, 1638, 1602, 1439, 1265, 1177, 908 cm-1; 
1H-NMR (300 MHz, CDCl3) δ 7.58 (ddt, J = 15.2, 11.3, 1.2 Hz, 1H), 6.57 (t, J = 11.3 Hz, 2H), 
6.09 (ddt, J = 15.2, 7.2, 0.7 Hz, 1H), 4.10 (d, J = 7.2 Hz, 2H), 3.73 (s, 3H); 13C-NMR (75 MHz, 
CDCl3) δ 166.3, 142.8, 137.2, 129.5, 119.0, 51.3, 44.1 ppm; HRMS (ESI) calcd for C7H9O2Cl = 
160.0291, found = 232.0286. 
 
                                                 
CO2Me
AcO  
(2Z,4E)-Methyl 6-acetoxyhexa-2,4-dienoate (Table 11, Entry 9):  
IR (thin film) 3053, 2986, 2955, 2872, 2254, 1739, 1648, 1607, 1438, 1377, 1265, 1232, 
909, 735 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.54 (dd, J = 15.5, 11.3 Hz, 1H), 6.54 (t, J = 11.3 
Hz, 1H), 6.04 (dt, J = 15.5, 5.9 Hz, 1H), 5.68 (d, J = 11.3 Hz, 1H), 4.67 (d,  J = 5.8 Hz, 2H), 3.69 
(s, 3H), 2.05 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 170.5, 166.3, 143.2, 136.1, 128.7, 127.2, 
118.2, 63.8, 51.1, 20.7 ppm; HRMS (ESI) calcd for C9H12O4 = 184.0735, found = 184.0741. 
 
                                                      
CO2Me
MeO  
(2Z,4E)-Methyl 6-(4-methoxyphenyl)-4-methylhexa-2,4-dienoate (Table 12, Entry 1): 
IR (thin film) 3052, 2986, 2959, 2872, 2254, 1720, 1610, 1511, 1439, 1265, 1175, 909, 
734 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 1H), 7.01 (d, J = 8.6 Hz, 1H), 6.60 
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(d, J = 12.5 Hz, 1H), 6.02 (t, J = 7.4 Hz, 1H), 5.82 (d, J = 12.5 Hz, 1H), 4.67 (d,  J = 5.8 Hz, 
2H), 3.95 (s, 3H), 3.87 (s, 3H), 3.60 (d,  J = 7.4 Hz, 2H), 2.12 (s, 3H); 13C-NMR (75 MHz, 
CDCl3) δ 166.9, 157.8, 145.4, 136.4, 132.8, 131.8, 129.1, 116.6, 113.7, 54.9, 51.0, 33.5, 14.9 
ppm; HRMS (ESI) calcd for C15H18O3 = 246.1255, found = 246.1259. 
 
                                                       
CO2Me
 
(2Z,4E)-Methyl 4-methyl-6-phenylhexa-2,4-dienoate (Table 12, Entry 2): 
IR (thin film) 3053, 2986, 2959, 2929, 2872, 2253, 1710, 1626, 1453, 1265, 903, 735 cm-
1; 1H-NMR (300 MHz, CDCl3) δ 7.38-7.21 (m, 5H), 6.47 (d, J = 12.5 Hz, 1H), 5.90 (t, J = 7.4 
Hz, 2H), 5.70 (d, J = 12.5 Hz, 1H), 3.72 (s, 3H), 3.52 (d, J = 7.4 Hz, 2H); 13C-NMR (75 MHz, 
CDCl3) δ 167.1, 145.5, 140.0, 135.9, 133.3, 128.5, 126.1, 116.9, 51.3, 34.6, 15.1 ppm; HRMS 
(ESI) calcd for C14H16O2 = 216.1150, found = 216.1145. 
 
 
                                             
CO2Et
MeO  
(2Z,4E)-Ethyl 6-(4-methoxyphenyl)-3-methylhexa-2,4-dienoate (Table 12, Entry 3): 
IR (thin film) 3051, 2991, 2879, 2872, 2249, 1720, 1610, 1512, 1439, 1265, 1175, 912, 
734 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.06 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H),  6.22 
(dt, J = 15.6, 6.5 Hz, 1H), 6.08 (d, J = 15.4 Hz, 1H), 5.69 (s, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.78 
(s, 3H),  3.40 (d, J = 6.5 Hz, 2H), 2.2 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H); 13C-NMR (75 MHz, 
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CDCl3) δ 167.2, 158.2, 152.2, 135.8, 134.4, 131.3, 129.6, 118.4, 114.0, 59.6, 55.2, 38.4, 29.7 
ppm; HRMS (ESI) calcd for C16H20O3 = 260.1255, found = 260.1257. 
 
                                                 
CO2Et
 
(2Z,4E)-Ethyl 3-methyl-6-phenylhexa-2,4-dienoate (Table 12, Entry 4):  
IR (thin film) 3055, 2986, 2959, 2929, 2872, 2253, 1710, 1626, 1453, 1265, 903, 735 cm-
1; 1H-NMR (300 MHz, CDCl3) δ 7.38-7.21 (m, 5H), 6.24 (dt, J = 15.6, 6.5 Hz, 1H), 6.12 (d, J = 
15.4 Hz, 1H), 5.69 (s, 1H), 4.27 (q, J = 7.1 Hz, 2H),  3.54 (d, J = 6.5 Hz, 2H), 2.02 (s, 3H), 1.25 
(t, J = 7.1 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 167.1, 152.2, 135.8, 135.8, 134.3, 129.6, 
121.7, 114.4, 55.3, 38.4, 29.7, 14.3 ppm; HRMS (ESI) calcd for C15H18O2 = 230.1150, found = 
230.1143. 
                                                    CO2Me
N
O
O
OMe
 
(E)-Methyl 1-benzoyl-5-ethylidene-4-((1E,3Z)-5-methoxy-5-oxopenta-1,3-dienyl)-2-methyl-
1,2,5,6-tetrahydropyridine-2-carboxylate (Table 12, Entry 9): 
IR (thin film) 3606, 2971, 2306, 1741, 1712, 1422, 1265, 1160, 1128, 948, 738 cm-1;  1H-
NMR (600 MHz, CDCl3) δ 7.67 (dd, J = 15.5, 11.4 Hz, 1H), 7.43-7.41 (m, 5H), 6.60 (t, J = 11.4 
Hz, 1H), 6.46 (d, J = 15.5 Hz, 1H), 5.83 (q, J = 7.0 Hz, 1H), 5.74 (s, 1H), 5.69 (d, J = 11.4 Hz, 
1H), 3.70 (s, 3H), 3.74 (s, 3H), 3.66 (d, J = 14.6 Hz, 1H), 3.14 (d, J = 14.6 Hz, 1H), 1.72 (s, 3H), 
1.61 (d, J = 7.0 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 171.8, 171.0, 166.6, 144.4, 138.0, 135.8, 
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135.7, 130.3, 129.4, 128.5, 127.9, 127.6, 127.4, 123.6, 117.9, 63.0, 52.9, 51.3, 43.6, 20.7, 13.5 
ppm; HRMS (ESI) calcd for C23H25NO5 = 395.1732, found = 395.1717. 
 
                                 
Ru C8F17
O
Cl
Cl
NNMes Mes
 
Fluorous Hoveyda Grubbs 2nd-generation catalyst (12):   
Green solid;  mp: 140-141 °C; IR (thin film) 1625, 1490, 1315, 1242, 1215, 1115, 752, 
720, 561 cm-1;  1H-NMR (300 MHz, CDCl3) δ 17.01 (s, 1H), 7.27 (dd, J = 8.4, 2 Hz, 1H), 7.04 
(s, 4H), 6.70-6.67 (m, 2H), 4.83 (q, J = 6.1 Hz, 1H), 4.15 (s, 4H), 2.66 (t, J = 7.4 Hz, 1H), 2.49-
2.34 (m, 18H), 2.15-1.95 (m, 2H), 1.87-1.79 (m, 1H), 1.22 (d, J = 6.1 Hz, 1H); 13C-NMR (75 
MHz, CDCl3) δ 211.4, 150.9, 145.3, 138.8, 134.1, 129.4, 129.2, 122.2, 112.9, 75.0, 33.6, 21.0; 
19F-NMR (282 MHz, CDCl3) δ -81.1 (3F), -114.4 (2F), -122.3 (6F), -123.9 (2F), -123.7 (2F), -
126.5 (3F) ppm.  
 
                                                      OTBSTBSO
CO2Me
 
(2Z,4E,6R,7S)-Methyl 7,9-bis(tert-butyldimethylsilyloxy)-6-methylnona-2,4-dienoate (28): 
[α]D +10.1 (c 0.87, CHCl3); IR (thin film) 2954, 2857, 1721, 1424, 1165, 1101, 830, 751 
cm-1; 1H-NMR (600 MHz, CDCl3) δ 7.31 (dd, J = 15.4, 11.3 Hz, 1H), 6.54 (t, J = 11.3 Hz, 1H), 
6.13 (dd, J = 15.4, 8 Hz, 3H), 5.55 (d, J = 11.3 Hz, 1H), 3.76-3.72 (m, 1H), 3.69 (s, 3H), 3.64-
3.58 (m, 2H), 2.49-2.44 (m, 1H), 1.62-1.50 (m, 2H), 1.02 (d, J = 6.9 Hz, 3H), 0.84 (s, 18H), 0.02 
 143 
(s, 4H), 0.01 (s, 8H); 13C-NMR (125.8 MHz, CDCl3) δ 166.9, 148.3, 145.3, 126.3, 115.3, 72.7, 
59.8, 50.9, 42.5, 36.8, 25.9, 18.2, 14.5, -4.4, -5.3 ppm; HRMS (ESI) calcd for C23H46O4Si2 = 
442.2897, found = 442.2895. 
 
                                                       OTBSOH
CO2Me
 
(2Z,4E,6S,7S)-Methyl 7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-methylnona-2,4-dienoate 
(29): 
To a solution of diene 28 (5 g, 11 mmol) in THF (20 mL) was added HF·Py/Py/THF (90 
mL, 13.2 mmol). The resulting mixture was stirred at 0 oC for 20 min and then at RT for 3 h. The 
reaction was quenched with saturated aqueous NaHCO3 and the aqueous phase was extracted 
with CH2Cl2 The combined organic phase was washed with brine and dried over MgSO4, the 
solution was concentrated and the crude product was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate 4:1 to yield alcohol 29 (12 g, 88%) as a colorless oil: [α]D 
+18.4 (c 0.35, CHCl3); IR (thin film) 3421, 2953, 2857, 1719, 1412, 1190, 1167, 837 cm-1;  1H-
NMR (300 MHz, CDCl3) δ 7.33 (dd, J = 15.4, 11.3 Hz, 1H), 6.52 (t, J = 11.3 Hz, 1H), 6.09 (dd, 
J = 15.4, 8 Hz, 1H), 5.53 (d, J = 11.3 Hz, 1H), 3.77-3.65 (m, 6H), 2.80-2.2.76 (m, 1H), 2.52 (bs, 
1H), 1.69-1.64 (m, 2H), 1.02 (d,  J = 6.8 Hz, 3H), 0.85 (s, 9H), 0.06 (s, 6H); 13C-NMR (75 MHz, 
CDCl3) δ 166.6, 147.0, 145.3, 126.4, 115.2, 73.6, 59,4, 50.8, 42.2, 35.5, 25.6, 17.8, 14.8, -4.8 
ppm; HRMS (ESI) calcd for C17H32O4Si = 328.2097, found = 328.2092. 
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                                                       OTBSO
CO2Me
 
(2Z,4E,6S,7S)-Methyl 7-(tert-butyldimethylsilyloxy)-6-methyl-9-oxonona-2,4-dienoate (30): 
To a solution of alcohol 29 (5 g, 15.2 mmol) and Et3N (3.07 g, 30.4 mmol) in CH2Cl2 (20 
mL) and DMSO (20 mL) was added a solution of Py·SO3 (3.60 g, 22.8 mmol) in DMSO (20 mL) 
at 0 oC under Ar atmosphere. The resulting mixture was stirred at 0 oC for 20 min and then 
quenched with aqueous HCl (0.1 M). The aqueous phase was extracted with CH2Cl2, and the 
combined organic phase was washed with brine and dried over MgSO4. The solution was 
concentrated and the crude product was purified by silica gel flash chromatography eluting with 
hexanes/ethyl acetate 10:1 to yield aldehyde 30 (4.35 g, 89%) as a colorless oil: IR (thin film) 
3031, 2953, 2857, 1760, 1719, 1412, 1190, 1167, 837 cm-1;  1H-NMR (300 MHz, CDCl3) δ 9.76 
(t, J = 2.1 Hz, 1H), 7.37 (dd, J = 15.6, 11.4 Hz, 1H), 6.54 (t, J = 11.2 Hz, 1H), 6.06 (dd, J = 15.6, 
7.2 Hz, 1H), 5.60 (d, J = 11.4 Hz, 1H), 4.15 (dt, J = 6.6, 5.1 Hz, 1H), 3.77 (s, 3H), 2.50 (m, 1H), 
2.47 (d, J = 5.1 Hz, 2H), 1.05 (d,  J = 6.6 Hz, 3H), 0.96 (s, 9H), 0.04 (s, 6H); 13C-NMR (75 
MHz, CDCl3) δ 201.2, 166.4, 145.4, 144.6, 126.8, 115.8, 71.0, 50.7, 47.8, 42.2, 42.8, 25.3, 17.6, 
14.6, -4.8, -5.1 ppm. 
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4.0  STUDIES ON A VERY POTENT MICROTUBULE-STABILIZING AGENT: A 
CONVERGENT SYNTHESIS OF 6-EPI-DICTYOSTATIN  
4.1 INTRODUCTION 
Microtubules are tube-shape protein polymers that are the key components in all 
eukaryotic cells. These polymers are involved in many cellular processes including transport of 
vesicles, mitochondria, cell signaling, and more important mitosis. Microtubules are composed 
of α-tubulin and β-tubulin heterodimers. The crucial role that microtubules have in cell division 
makes them and important target for anticancer drugs.1 Microtubules are the targets of a 
chemically diverse group of antimitotic drugs that have been used with great success in the 
treatment of cancer. These protein polymers represent the best cancer target to be identified so 
far. It is also likely that these drugs will continue to be chemotherapeutic agents for the treatment 
of cancer.2  
The polymerization of microtubules takes place by a nucleation-elongation mechanism. 
The mechanism is described as the slow formation of a short microtubule followed by a fast 
elongation of the microtubule at its ends by the reversible and non-covalent addition of tubulin 
dimers. The microtubule shows a dynamic behavior (dynamic instability), where the individual 
microtubule ends switch between phases of polymerization and depolymerization (Figure 13).3a  
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The second group of microtubule-targeted antimitotic drugs is known as the microtubule-
stabilizing agents. These compounds stimulate microtubule polymerization and include 
paclitaxel (the first agent in this class), docetaxel, the epothilones, the eleutherobins, 
sarcodyctins, laulimolide, rhazinalam, discodermolide, and dictyostatin (Figure 14).2 Some of 
these microtubule-stabilizing agents bind to and act directly on the microtubule or on soluble 
tubulin. As a consequence, the specific binding of these compounds onto tubulin and the 
microtubule greatly affects the response of the microtubule system to the drug.5 
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Figure 14. Selective microtubule-stabilizing agents from natural sources 
 
The main family of the microtubule-stabilizing group of compounds is the taxanes. These 
agents bind poorly to soluble tubulin itself, but instead bind directly, with high affinity, to the 
assembled tubulin along the length of the microtubule. The taxane binding site is in the β-subunit 
on the inside surface of the microtubule. When the compound is bound, microtubule 
 151 
depolymerization decreases and polymerization increases. There is one taxane-binding site per 
molecule of tubulin. The binding of a very small number of paclitaxel molecules per tubulin 
subunit strongly decreases microtubule depolymerization without enhancing microtubule 
polymerization.6 The clinical success of taxanes has led to the discovery of other families of 
drugs that enhance microtubule polymerization such as epothilones, discodermolides, 
laulimolides, and dictyostatins.7 
Discodermolide and Dictyostatin     
(+)-Discodermolide (1) is a marine sponge-derived polyketide δ-lactone. It is known to 
have activity as a microtubule-stabilizing agent.8a The discovery of discodermolide taxane-like 
mechanism of action and its limited natural supply prompted the scientific community to 
synthesize 1 and its analogs via a number of routes.8 Discodermolide activity is in the low 
nanomolar range (Figure 15). It has proven to induce tumor regression and suppression of 
angiogenesis in animal models as good as paclitaxel.9 
(−)-Dictyostatin 2 is a marine sponge-derived macrolactone, isolated from Spongia sp. by 
Pettit in 199410 and later by Wright from Corallistidia sponges.11 Structurally 2 resembles 1. 2 
has 11 stereocenters, one external (Z,E)-diene (C23-C26), and one internal (E,Z)-dienyl lactone 
moiety (C2-C5). Dictyostatin also contains a synthetically challenging internal Z-allylic alcohol 
(C10-C11), as well as, an isolated methyl group attached to a chiral sp3 carbon (C16). 
 
 
 152 
O
HO
OH
OH
OH
O
NH2
O
HO
O
OH
OH
O
O
OH
DISCODERMOLIDE 1 DICTYOSTATIN 2
6
7910
11
16
24
25
DISCODERMOLIDE
PACLITAXEL
DICTYOSTATIN
EPOTHILONE B
COMPOUND T47D MDA-MB231
cell line (GI50)
3.6
1.5
0.5
<0.2
9.8
5.5
5.3
1.2
26
23
 
Figure 15. Antiproliferative activity in breast carcinoma cells 
 
Biological testing showed that 2 displays high levels of toxicity for a wide range of 
human cancer cell lines.12 As a consequence, 2 has emerged as a new microtubule-stabilizing 
agent with promising anticancer properties (Figure 15). The strong structural similarity with 1 
helped to discover that 2 also interacts with the paclitaxel binding site on β-tubulin.12 The 
cytotoxicity of 2 is more pronounced than that for paclitaxel, and it is also retained against 
paclitaxel-resistant cell lines. Moreover, 2 displays selectivity for the taxane binding site over 
paclitaxel and even discodermolide.13 Dictyostatin’s potency and selectivity over the taxane 
binding domain has prompted many scientists to synthesize 2 in an efficient and 
enantiomerically pure fashion.14 Paterson’s and Curran’s group published back to back their 
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independent syntheses of 2.14a,b Later, Phillips14c and Ramachandran14d published their syntheses 
of 2, and many others have published syntheses of different fragments.15 
4.1.1 Dictyostatin syntheses 
The evolution of synthetic knowledge towards dictyostatin/discodermolide type of 
molecules has moved from simple linear syntheses to highly convergent routes. The synthetic 
plan that our group designed for 2 was based on the efficient coupling of fragments 3 and 4 
through an alkyne addition/cis-selective reduction reaction sequence to establish the C10-C11 Z-
alkene in advanced intermediate 6 (Figure 16).14b  
The coupling reaction started with the lithiation of fragment 3, followed by the addition 
to bottom fragment 4 to provide a ketone, followed by stereoselective reduction with (S,S)-
Noyori catalyst to provide propargyl alcohol 7 in 73% yield for the 2 steps as a single 
diastereomer. Selective cis-reduction of 7 with Lindlar catalyst provided key C10-C11 Z-alkene, 
followed by TBS protection of allylic alcohol, selective deprotection of primary TBS, and Dess-
Martin oxidation to provide aldehyde 8 in 78% yield for 4 steps.  
Final coupling of top fragment 5 with 8 provided an enone, followed by selective 
reduction of conjugated alkene with NiB2. The resulting ketone was then reduced with sodium 
borohydride to give a readily separable epimeric mixture of alcohols 9β and 9α in a 2.4:1 ratio. 
The major β-epimer was protected with a TBS group to obtain advanced intermediate 6 in 42% 
yield from 8. The longest linear sequence of 34 steps in this total synthesis ran through fragment 
3 and provided 2 in 1% overall yield from (2S)-3-hydroxy-2-methylpropionic acid methyl ester.  
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Figure 16. First generation coupling of fragments: Synthesis of (−)-dictyostatin 2 
 
Similarly, Paterson’s synthesis of dictyostatin relied on the synthesis of advanced 
intermediate 10 through the coupling of highly functionalized fragments by a Still-Genari 
olefination reaction to establish the key C10-C11 Z-alkene (Figure 17).14a The olefination 
reaction of 11 and 12 in the presence of K2CO3 and 18-crown-6 provided key enone 14 in 77% 
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yield and 5:1 Z:E ratio. Then the enone was coupled with stannane 13 followed by removal of 
TIPS group with KF to obtain seco-acid 10 in 83% overall yield from enone 14. The longest 
linear sequence of 24 steps in Paterson’s synthesis ran through fragment 11 and provided 2 in 
3.8% overall yield from (S)-1-(4-methoxybenzyloxy)-2-methylpentan-3-one.  
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Figure 17. Synthesis of (−)-dictyostatin 2 by Paterson 
 
Phillips’s synthesis relied on the coupling of fragments 15 and 16 through a RCM 
reaction to establish the C10-C11 Z-alkene in advanced intermediate 17 (Figure 18).14c The 
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acylation reaction of fragment 15 with fragment 16 under Yamaguchi conditions provided ester 
18 in 90% yield. Ester 18 reacted with 15 mol% of Grubbs second generation catalyst to provide 
lactone 19 in 75% yield as a single Z-alkene isomer. Lactone 19 was reduced to the lactol with 
DIBAL-H and then reacted with Ph3PCHCO2Et. The resulting ester was reduced again with 
DIBAL-H and then the alcohol was protected as a TBS ether to obtain advanced intermediate 17 
in 70% yield from 19. The longest linear sequence of 26 steps in Phillips synthesis ran through 
fragment 15 and provided 2 in 2.8% overall yield from 2-(S)-3-hydroxy-2-methylpropionic acid 
methyl ester.  
Ramachandran’s approach for the construction of C10-C11 Z-alkene was based on the 
addition reaction of Z-vinylzincates to aldehydes like fragment 21 to provide advanced 
intermediate 22 (Figure 18).14d The coupling reaction began with lithiation of fragment 20. Then 
undergoing transmetallation with Me2Zn to yield Z-vinylzincate, which was added to fragment 
21 to provide advanced intermediate 22 in 80% as a single diastereomer. The longest linear 
sequence of 28 steps in Ramachandran synthesis ran through fragment 20 and provided 2 in 
3.6% overall yield from 2-(S)-3-hydroxy-2-methylpropionic acid methyl ester. 
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Figure 18. Syntheses of dictyostatin 2 done by Phillips and Ramachandran 
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4.1.2 Second generation coupling of fragments: Synthesis of 16-normethyl-15,16-
dehydrodictyostatin  
The synthesis of analogs along the different fragments has been an important goal in our 
synthetic studies towards microtubule-stabilizing agents. Structure-activity relationships (SAR) 
studies, obtained from discodermolide models, suggested that loss of C16 methyl group and gain 
of C15-C16 alkene may retain cytotoxicity.16 Therefore, our group proposed the synthesis of a 
simpler analog C16-normethyl-15,16-dehydro-dictyostatin 23.  
For the synthesis of analog 23 our group envisioned the construction of the C10-C11 Z-
alkene by the coupling of top-middle fragment 30, as a Z-vinyl zincate, with bottom fragment 33 
to obtain advance intermediate 24.17 This approach introduced some new key reactions for the 
synthesis of the fragments, as described in Scheme 17. The synthesis of middle fragment 28 
began with the oxidation of alcohol 25 (derived from commercially available (S)-Roche ester) 
followed by Roush anti-crotylation reaction to obtain allylic alcohol.18 This product was 
protected as a TBS ether and the alkene underwent oxidative cleavage followed by Corey-Fuchs 
reaction to furnish alkyne 26 in 39% overall yield. Formation of Z-vinyl iodide was done by 
iodolysis of alkyne 26 with n-BuLi and I2, followed by cis-selective reduction with NBSH and 
triethylamine to provide enantiomerically pure 27 in 94% yield. Final removal of PMB and 
Dess-Martin oxidation provided 28 in 36% yield over 10 steps. The coupling reaction to obtain 
C15-C16 alkene was done by the Wittig reaction of middle fragment 28 and top fragment 29 in 
the presence of NaHMDS to provide 30 in 70% yield.  
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Scheme 18.  Synthesis of 16-normethyl-15,16-dehydrodictyostatin 23 
 
Synthesis of bottom fragment 33 started with the cross-metathesis reaction of a known 
intermediate 31 with crotonaldehyde and Grubbs second generation catalyst to provide 
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conjugated aldehyde.19 This step was followed by Still-Genari olefination to set the Z-alkene 
then selective deprotection of primary TBS ether and finally Parikh-Doering oxidation of the 
resulting alcohol to provide intermediate 32 in 75% overall yield. Aldehyde 32 was oxidized 
with NaClO2 to the acid and then transformed to the Weinreb amide. The amide was reduced 
with DIBALH and the resulting alcohol was protected as a TBS ether to obtain 33 in 50% overall 
yield and 8 steps. Advanced intermediate 24 was prepared by reacting middle fragment 30 and t-
BuLi 1.7M in THF to obtain Z-vinyl lithium, followed by transmetallation with Me2Zn and 
addition of bottom fragment 33 to provide a 1:1.6 mixture of 24α:24β epimers at C9 in 70% 
yield. Advanced intermediate 24α was isolated by silica gel flash chromatography and used to 
complete the synthesis of 23. 
4.1.3 Third generation coupling of fragments: Synthesis of 6-epi-dictyostatin 
The continuous production of discodermolide/dictyostatin analogs has led us to search 
based on structure-activity relationships (SAR) for the minimum structural elements that 
contribute to cytotoxicity and retain affinity for the taxane binding site.20 Subsequently, our 
group next hypothesized that changes to the C6 and C7 stereocenters of 2 may lead to no loss of 
activity. We proposed a fluorous mixture synthesis (FMS) approach to obtain all possible 
diastereomers for C6 and C7 stereocenters (Scheme 18).21 The synthetic strategy was similar to 
our group’s original synthesis of 2. However, new top fragment 34, including the C23-C26 
diene, and bottom fragment M35 (fluorous mixture of four quasiisomers using fluorous silanes 
as fluorous tags) were prepared. The coupling strategy relied on a previously developed alkyne 
addition/cis-selective reduction reaction sequence to provide the C10-C11 Z-alkene. This FMS 
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provided 2-4 mg of each desired analog (6-epi-dictyostatin 36, 7-epi-dictyostatin 37, 6,7-bisepi-
dictyostatin 38 and dictyostatin 2).   
The antiproliferative effects of these compounds against human ovarian carcinoma cells 
were tested and the results showed that 6,7-epi-dictyostatin 38 was considerably less active than 
2. However, 7-epi-dyctiostatin 37 showed to have comparable activity to 2 and 6-epi-dyctiostatin 
36 showed to be four times more potent than 2 (Scheme 19).21   
Recent biological studies revealed that 36 and 37 have high levels of affinity to isolated 
tubulin and proved to be effective competitors of [14C]-epothilone B for the binding site. 6-Epi-
dictyostatin 36 has also shown to be active against paclitaxel-resistant cell lines compared to 16-
normethyl analogs that were inactive.20 These experiments clearly showed that 36 not only 
improves in vitro potency, but may maintain potency in vivo. 
 
O
HO
OH
OH
OH
O TBSO
OFTIPSO
OTBS
(OMe)2OP
O
4 ANALOGS AT C6,C7
TOP FRAGMENT 34
BOT TOM FRAGMENT M35
OPMB
Me(MeO)N OTr
MIDDLE FRAGMENT 3
6
7
O
HO
OH
OH
OH
O
36 = (6S,7S)
37 = (6R,7R)
38 = (6S,7R)
2 = (6R,7S)
analog A549 1A9 1A9/PtX10 1A9/PtX22
Antiproliferative potencies - GI50 (nM)
36
37
38
2
0.36
0.31
123
<0.48
<0.12
0.09
17
0.16
4.5
7.6
201
3.8
0.81
4.7
123
3.4
910
11
23
24
26
25
6
7910
11
23
24
26
25
 
Scheme 19. Fluorous Mixture Synthesis of 6-epi-dictyostatin 
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After these promising results, we decided to focus on making 6-epi-dictyostatin 36 in 
large scale for further in vivo testing. It was envisioned an even more convergent approach so the 
scale-up could be achieved in a reasonable time frame.   
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Scheme 20. Synthetic plan for scale-up of 6-epi-dictyostatin 36 
 
As depicted in Scheme 18, we envisioned obtaining large amounts of 36 by designing an 
efficient coupling strategy to obtain advance intermediate 39. This compound will come from the 
coupling of top-middle fragment 40 and bottom fragment 41 via the in-situ formation of Z-vinyl 
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metal intermediate. The top-middle fragment will be obtained from the Still-Genari olefination 
of middle fragment 42 and top fragment 34. The synthetic route for bottom fragment 41 has been 
recently improved by the ene-diene metathesis reaction of functionalized olefins and substituted 
(E,Z)-dienyl ester recently developed in our laboratory (Chapter 3).22  
4.2 RESULTS AND DISCUSSION 
4.2.1 Fourth generation synthesis and coupling of fragments  
The application of the ene-diene metathesis reaction for the quick synthesis of bottom 
fragments 41/32 (see Chapter 3, Table 14) encouraged us to investigate different coupling 
strategies for the synthesis of 6-epi-dictyostatin. Because of our previous success with the 
coupling of Weinreb amide 4 with alkyne 3, we next investigated the coupling of alkynes with 
aldehyde 32. Due to the unknown reactivity towards nucleophiles of the dienyl ester moiety in 
aldehyde 32, we did the model addition reaction of 4-phenyl-1-propyne with aldehyde 32. The 
results are summarized in Table 15A. The lithium alkynoate, obtained from the addition of n-
BuLi to 4-phenyl-1-propyne reacted with aldehyde 32 at −78 oC in a 1:1 ratio, yielded a 
promising 51% of propargyl alcohol 43 after silica gel flash chromatography (Entry 1). 
Increasing the equivalents of lithium alkynoate to 1.5 equiv provided 43 in 78% yield; and, when 
we use 2 equiv we obtained 43 in 80% yield (Entry 2 and 3).  
Because of the promising results, we investigated the selective reduction of propargyl 
alcohol 43 to cis-allylic alcohols, as summarized in Table 15B. The selective reduction of 
alkynes has been successfully applied previously in our group (Figure 16).23 However, activated 
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dienes, like 43, are not inert to selective hydrogenation catalysts like Lindlar, Rh complexes, or 
Raney nickel.24 Moreover, the reduction of conjugated propargyl alcohols in the presence of 
Rieke zinc and at elevated temperatures is known to provide cis-dienols in high yields.26       
 
Table 15. Alkyne addition (15A) and selective reduction (15B) reactions 
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7910
11
6
7910
1179
entry alkyne (equiv) producta yieldb
1
2
3
51%
78%
80%
1
1.5
2
43
43
43
TABLE 15A TABLE 15B
6
 
 
We next decided to try the selective reduction of 43 using Lindlar catalyst in toluene for 3 
h. We obtained 44 in <10 % isolated yield after silica gel flash chromatography (Entry 1). 
Reduced product 44 was a separable mixture of diastereomers at C9 by TLC. 1H NMR analysis 
of 44 showed that it was a mixture of epimers at C9 in a 1:1 ratio. We then tried running the 
same reaction for only 1 h and we only obtained 44 in 15% isolated yield (Entry 2). We also 
attempted the selective reduction of 43 with Rieke zinc in THF at 65 oC for 24 h. We recovered 
the starting material out of the reaction mixture (Entry 3).  
Because of the low yields in the selective reduction of propargyl alcohol 43, we tried the 
addition reaction of Z-vinyl metal species to aldehyde 33 to obtain vinyl alcohol 44 directly. The 
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addition of these species to α- or β-alkoxy aldehydes sometimes gave good levels of 
stereoselectivity for the allylic alcohols due to substrate induction.27 Evans has shown that the 
stereoselectivity increases when a Z-vinyl lithium is transmetallated to a Z-vinyl magnesium 
halide along with a chelating group in the α or β position.28 In planning this reaction, we 
considered important to test the addition reaction of aldehydes with chelating protected ethers 
(45 = MOM ether, 46 = PMB ether)  and with a non-chelating protected ether (33 = TBS ether) 
in the β-position and model substrate (Z)-(3-iodoallyl)-benzene, as summarized in Table 16.   
 
Table 16. Addition reaction of Z-vinyl metal compound to aldehydes 
OR
MeO2C
OR
CO2Me
OH
O
H
Ph
PhI
t-BuLi, solvent
entry equiv vinyl iodide/tBuLi CHO solvent yielda product α:β
4 1.5/3 32 Et2O 79% 44 1:1
5 1.5/3 32 CH2Cl2 67% 44 1:1
6 1.5/3 45 CH2Cl2 66% 47 1.5:1
7 1.5/3 46 CH2Cl2 63% 48 1.7:1
32, R = TBS
45, R = MOM
46, R = PMB
44α, R = TBS
47α, R = MOM
48α, R = PMB
a) The combined isolated yield of α,β after silica gel f lash chromatography
1
2
3
55%
59%
79%
6 h
OR
CO2Me
OH
Ph
+
44β, R = TBS
47β, R = MOM
48β, R = PMB
2/2
1.5/1.5
1.5/3
32
32
32
Et2O
Et2O
Et2O
44
44
44
1:1
1:1
1:1
910
11
910
11
 
 
In a typical experiment, we reacted 2 equiv of (Z)-(3-iodoallyl)-benzene and 2 equiv of t-
BuLi at −78 oC, followed by addition of 1 equiv of aldehyde 32. The crude mixture was purified 
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by silica gel flash chromatography to provide 44 in 51% yield (Entry 1). The reaction provided 
44 as a separable 1:1 mixture of diastereomers at C9 (44α/44β). However, we reported the yield 
as the combined yields of 44α and 44β and the diastereoselectivity as the ratio of isolated 44α 
(more polar) and 44β (less polar). We then tried the reaction with 1.5 equiv of (Z)-(3-iodoallyl)-
benzene and 1.5 equiv of t-BuLi to obtain 44 in 59% yield and 1:1 dr; and, then with 1.5 equiv of 
(Z)-(3-iodoallyl)-benzene and 3 equiv of t-BuLi to obtain 44 in 79% yield and 1:1 dr (Entry 2 
and 3).  
The reaction using conditions for entry 3 and 2 equiv of MgBr2 in diethyl ether provided 
44 in 79% yield and 1:1 dr (Entry 4). Similarly, the reaction using CH2Cl2, as a transmetallating 
solvent, provided 44 in 79% yield and 1:1 dr (Entry 5). In turn, the reaction (Entry 5) with 
MOM-protected aldehyde 45 provided 47 in 66% yield and 1.5:1 dr (Entry 6). When we used 
PMB-protected aldehyde 46 as the substrate for the reaction, we obtained 48 in 66% yield and 
1.7:1 dr (Entry 7). Alcohols 47 and 48 were also obtained as a separable mixtures of epimers at 
C9 (47α:47β and 48α:48β) and the combined isolated yields are given. The addition reaction 
using Z-vinyl lithium and aldehyde 32 provided alcohol 44 in very good yields; however, the 
reactions were not very diastereoselective with aldehydes bearing β-chelating or non-chelating 
ethers.  
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OTBS
CO2Me
OH
Ph
1) TBAF,THF
2) DMP, TEA, 78% 2 steps
O
CO2Me
O
Ph
1) TBAF, THF
2) DMP, TEA, 75% 2 steps
O
CO2Me
O
Ph
44α 49
50OTBS
CO2Me
OH
Ph
44β
24.9 25.2 ppm
20.1 31.5 ppm
9 7 9 7
9 7
9 7
 
Scheme 21. Stereochemical assignment of the C9 stereocenter       
 
The next step was to assign the stereochemistry for epimers 44α/44β, 47α/47β and 
48α/48β. To achieve this task, we prepared acetonides from isolated 44α and 44β.29 First, we 
removed the TBS group of alcohol 44α with TBAF in THF to obtain the crude diol. This was 
reacted with 2,2-dimethoxypropane and Et3N to provide acetonide 49 in 78% overall yield after 
isolation by silica gel flash chromatography. The same reaction sequence was done for 44β, to 
provide acetonide 50 in 75% overall yield. Analysis of 13C NMR spectrum of 49 showed acetal 
methyl carbons resonances at 24.9 and 25.2 ppm and acetal quaternary carbon resonance at 101.1 
ppm. The same analysis for the spectrum of 50 showed acetal methyl carbons resonances at 20.1 
and 31.5 ppm and acetal quaternary carbon resonance at 97.9 ppm. These results indicated that 
acetonide 49 (from 44α) had a syn relationship between C9 and C7 and that acetonide 50 (from 
44β) had an anti relationship between C9 and C7.29 Moreover, analysis of the 1H NMR spectrum 
of alcohol 44α revealed that the C9 proton resonance was more down field (4.81 ppm) than the 
one for alcohol 44β (4.67 ppm). The same trend in the C9 proton resonances was found for 
epimers 47α/47β and 48α/48β.        
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The results from the addition of Z-vinyl lithium to aldehyde 32 encouraged us to try the 
reaction with middle fragment 27 (Scheme 22). The synthesis of fragment 27 was developed 
earlier in our group in 9 steps from (S)-Roche Ester.17 However, we found that the reaction of 
aldehyde 51 with ICH2PPh3 and NaHMDS provided fragment 27 in 76% yield as a single Z-
alkene isomer.30 The development of this step reduced the synthesis of fragment 27 to 7 steps 
from (S)-Roche Ester in 44% overall yield.  
The addition reaction of vinyl iodide 27 to aldehyde 32, in the presence of t-BuLi and 
THF, furnished allylic alcohol 52 as a mixture of anti/syn diastereomers in 1:1.3 ratio. Alcohols 
52 were isolated by silica gel flash chromatography yielding 52α (anti, more polar) and 52β (syn, 
less polar) in a 68% combined yield, along with reduced product 53 in 39% yield (relative to 27). 
Stereochemical assignment of 52α, as the anti epimer, and 52β, as the syn epimer, was 
performed by comparing C9 proton resonance patterns found in alcohols 44α and 44β with the 
ones found for alcohols 52. 
 
9 7
PMBO OH PMBO
OTBS
I
27
PMBO
OTBS
I
3 equiv. t-BuLi, Et2O, -78oC
OTBS
CO2Me
OH
TBSO
OPMB
a-d
25
32 (1 equiv), Et2O, -78 oC
27, 1.5 equiv
52α (ant i), 30%
52β (syn), 38%
PMBO
OTBS
+
53, 39%
(relative to 27)
a) SO3Py, Et3N, DMSO, CH2Cl2; b) (R,R)-Roush's reagent, THF, 73% 2 steps;
c) TBSOTf, 2,6-Lutidine, CH2Cl2, 83%; d) OsO4(10 mol%), NaIO4, THF;
e) PPh3CH2I, NaHMDS, THF, 73% yield.
PMBO
OTBS
O
51
e
 
Scheme 22. Synthesis and coupling of bottom fragment 32 and middle fragment 27 
 169 
The successful coupling of middle fragment 27 and bottom fragment 32 on small scale 
encouraged us to scale-up the coupling of fragments towards the synthesis of 6-epi-dictyostatin 
36. Mr. Won-Huyk Jung prepared 6 g of top-middle fragment 40 and I prepared 10 g of bottom 
fragment 41 (Chapter 3, Table 14, Synthesis of fragment 2). Mr. Jung did the coupling of 40 and 
41 in the presence of t-BuLi in two batches (batch 1 = 1 g of 40, batch 2 = 5 g of 40). He 
obtained 39 (39α) in 20% for batch 1 and 8% for batch 2 (Scheme 23). The reaction produced a 
mixture of 39α and 39β that was separated by silica gel flush chromatography. The yields 
reported above are of isolated 39α. The low yields of the scale-up coupling were disappointing. 
It was decided to focus on investigating better ways to couple the bottom and middle fragment.   
 
PMBO
TBSO
O
TBS
OH OTBS
CO2MeOPMB
TBSO
I
O
TBS
T OP-MIDDLE F RAGMENT 40 39α 39β
t-BuLi
41, Diethyl ether
scale-up batch 1 1g 165 mg, 20% 248 mg, 30%
scale-up batch 2 5g 331 mg, 8% 498 mg, 12%
9
PMBO
TBSO
O
TBS
OH OTBS
CO2Me
9
+
40 39α 39β
25
24
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Scheme 23. Scale-up coupling reaction for 6-epi-dictyostatin 23 
 
Before the scale-up addition reaction of top-middle fragment 40 and aldehyde 41 by Mr. 
Jung, we investigated a more direct route for the synthesis of top fragment 34 (Scheme 24). 
Because the previous synthetic approach towards 34 had some low yielding steps (PMB transfer 
from a secondary to a primary alcohol, stoichiometric CrCl3-mediated coupling, and Peterson-
type olefination to build (C23-C26)-Z,E-diene), we envisioned the construction of (C23-C26)-
Z,E-diene via a simple one step Z-selective Wittig reaction with allyltriphenylphosphine.32  
 170 
N O
OPMB
OH
MeO
a) TEMPO (5 mol%), Bleach, KBr, K2CO3, CH2Cl2/H2O; b) oxazolidinone, Bu2BOTf,
DIPEA, CH2Cl2; 67% in 2 steps; c) MeN(H)OMeHCl, AlMe3, THF, 75%; d) PMBOC(NH)CCl3,
BF3OEt2, CH2Cl2, 83%; e) TBAF•3H2O, DMF, 51%; f ) PySO3, DMSO, Et3N, CH2Cl2, 86%; g) AllylPPh3,
Ti(i-PrO)4, t-BuLi, MeI, 62%; h) phenyl triazole dione, 86%; i) (MeO)2POCH3, n-BuLi, THF, 90%.
TBSO OH
N O
OPMB
OTBS
MeO
O
OPMB
N
MeO (MeO)2OP
O
OPMB
N O
OPMB
OTBS
O O
Bn
54 56
57 58 34
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Scheme 24. Synthesis of top fragment 34 
 
We started the synthesis by oxidation of alcohol 54 with catalytic TEMPO and bleach. 
The crude aldehyde then was reacted with (S)-4-benzyl-3-propionyloxazolidin-2-one to provide 
syn aldol adduct 55 in 67% overall yield. Adduct 55 underwent reductive cleavage of chiral 
auxiliary and PMB protection in the presence of BF3·Et2O31 to obtain Weinreb amide 56 as a 
single isomer in 62% yield for the 2 steps. The removal of the sterically hindered primary TBS 
was done by the reaction of 56 with anhydrous TBAF in DMF to provide after 6 h 57 in 51% 
yield. Primary alcohol 57 underwent Parikh-Doering oxidation followed by a highly selective 
Wittig-type olefination32 with allyltriphenylphosphine, Ti(iPrO)4, and t-BuLi to furnish 58 as a 
10:1 mixture of Z/E-olefin isomers at C23-C24. The major Z-olefin isomer was purified by 
reacting the mixture with phenyl triazole dione to remove the minor but more reactive E,E-diene 
isomer.33 The resulting Diels-Alder adduct was removed from the desired Z,E-diene isomer by 
silica gel flash chromatography to provide 58 in 46% yield in 2 steps as a single Z-olefin isomer. 
Finally, reaction of 58 with dimethyl methylphosphonate and n-BuLi in THF provided top 
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fragment 34 in 90% yield. Top fragment 34 was obtained in 9% overall yield and 9 linear steps 
from TBS ether 54. This approach was 5 steps shorter than the previous synthesis of 34.   
Because of the disappointing yields in the scale-up addition reaction of top-middle 
fragment 40 to bottom fragment 41, we investigated the addition reaction of Z-vinyl chromium to 
aldehydes also known as the Nozaki-Hiyama-Kishi (NHK) reaction.34  
I + H
O NiCl2/CrCl2
solvent
OH
Stoichometric: 4 equiv of CrCl2, 0.2 equiv of NiCl2, DMF.
Asymmetric: 3 equiv of CrCl2, 3 equiv of 60, 3 equiv Base, 1 equiv NiCl2, DMF, 76% yield and 40% ee
2 equiv 1 equiv
Catalytic 1: 10 mol% CrCl2, 10 mol% 60, 10 mol% DIPEA,10mol% NiCl2, 2 equiv Mn,
2 equiv TMSCl, 20 mol% (Bn)(Bu)3NCl, 2 equiv LiCl, THF, 87% yield and 80% ee.
Catalytic 2: 5 mol% CrCl2, 5 mol% 60, 5 mol% DIPEA, 1 mol% NiCl2(dppp), 2 equiv Mn,
1 equiv Zr(Cp)2Cl2, 2 equiv LiCl, THF, 90% yield and 92% ee.
C4H9 C4H9
NH2
Me
H
N
HO
O
HN
Me
O
N
SO2
R
61
RSO2Cl, DMAP
Pyridine
60, R = Me, 58%
62, R = Naphthyl, 42%
63, R = tolyl, 40%
Ph Ph
hydrocinnamaldehyde(Z)-1-iodohex -1-ene 59
 
Figure 19. Stoichiometric and catalytic NHK reaction 
 
Kishi has found that the reaction of (Z)-1-iodohex-1-ene in the presence of NiCl2, CrCl2, 
and stoichiometric amounts of chiral sulfonamide 60 with hydrocinnamaldehyde provided allylic 
alcohol 59 in 76% yield and 40% ee (Figure 19).34 Kishi found that when the reaction of (Z)-1-
iodohex-1-ene and hydrocinnamaldehyde was set up with 1 equiv of Mn, 10 mol% of NiCl2, 10 
mol% of CrCl2, 10 mol% of 60, and 2 equiv of TMSCl. 59 was obtained in 87 yield and 80% 
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ee.35 Moreover, by replacing TMSCl with Zr(Cp)2Cl2 in the reaction, they obtained 59 in 90% 
yield and 92% ee.36      
 
Table 17.  NHK reaction for the coupling of 41 and 42 
OTBS
OTBS
I
OTBS
CO2Me
O
H Conditions+
entry ligand conditionsc base yielda ratio (64α:64β)b
61% 1:1
60 Et3N 50%asymmetric
63 Et3N 45%
62 Et3N 54%
1:1
1.2:1
1.5:1
- stoichiometric
42 41
OTBS
OTBS
OTBS
CO2Me
OH
64α = syn
64β = ant i
asymmetric
asymmetric
62 DIPEA 35%
62 DIPEA 34%
1.7:1
2:1
catalytic 1d
catalytic 2d
a) Isolated yields. b) isomer distribution determined after isolating each diastereomer. d) ~40% of
unreacted 41 was recovered.
c) Conditions: Stoichometric: 4 equiv of CrCl2, 0.2 equiv of NiCl2, DMF.
Asymmetric: 3 equiv of CrCl2, 3 equiv of ligand, 3 equiv Base, 1 equiv NiCl2, DMF.
Catalytic 1: 10 mol% CrCl2, 10 mol% ligand, 10 mol% DIPEA,10mol% NiCl2, 2 equiv Mn,
2 equiv TMSCl, 20 mol% (Bn)(Bu)3NCl, 2 equiv LiCl, THF.
Catalytic 2: 5 mol% CrCl2, 5 mol% ligand, 5 mol% DIPEA, 1 mol% NiCl2(dppp), 2 equiv Mn,
1 equiv Zr(Cp)2Cl2, 2 equiv LiCl, THF.
1
2
4
3
5
6
910
11
 
 
Chiral sulfonamides are not commercially available. However, due to the ease of their 
synthesis and the need to search for a chiral ligand that would give high levels of 
diastereoselectivity, we made three different chiral sulfonamides: a known sulfonamide 60 and 
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two new sulfonamides 62 and 63 (Figure 19). The reaction of aniline 61 with MeSO2Cl and 
DMAP in pyridine provided chiral sulfonamide 60 in 58% yield.37 Under the same conditions we 
then reacted aniline 61 with tolylsulfonyl chloride and naphthylsulfonyl chloride to obtain 
bulkier chiral sulfonamides 62 and 63 in 42 and 40% yield, respectively. The next step was to 
test the coupling reaction of bottom fragment 41 with middle fragment 42 under NHK 
conditions, as summarized in Table 17. 
In a typical reaction, we weighted NiCl2 and CrCl2 in a reaction flask in a glove box. The 
middle fragment 42 was added in DMF, followed by the addition of aldehyde 41 after 1 h. After 
6 h the crude mixture was filtered through celite to provide crude alcohol 64 as a separable 1:1 
mixture of diastereomers at C9. Alcohols 64 were purified by silica gel flash chromatography to 
provide 64α (more polar) in 31% yield and 64β (less polar) in 30% yield (Entry 1). 
Stereochemical assignment of 64α and 64β was performed by comparison of C9 proton 
resonance patterns found in alcohols 44α and 44β with the ones found for alcohols 64. The 
reaction, under the same conditions, using ligand 60 provided 64 in 50% yield and 1:1 ratio of 
64α:64β (Entry 2). Moreover, the reaction with ligand 62 provided 64 in 45% yield and 1.5:1 
ratio of 64α:64β. The reaction with ligand 63 provided 64 in 54% yield and 1.2:1 ratio of 
64α:64β (Entries 3 and 4). We next tried the reaction, under catalytic conditions, with ligand 62 
and TMSCl to obtain 64 in 35% yield and 1.7:1 ratio of 64α:64β. The same reaction but using 
Zr(Cp)2Cl2 provided 64 in 34% yield and 2:1 ratio of 64α:64β. Because of the moderate yield 
and selectivities, no further optimization of this reaction was tried.  
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4.2.2 Fifth generation synthesis and coupling of fragments 
The application of convergent strategies for the coupling of bottom and middle fragment 
in which the C9 stereocenter was formed together with the C10-C11 Z-alkene gave 
unsatisfactory results. We hypothesized that incorporation of C9 stereocenter before coupling 
could make coupling of fragments more efficient and convergent.  
Our group has recently reported the ring-closing metathesis (RCM) reaction of ester 65 
(already has C9 stereocenter) with Grubbs first generation catalyst to provide lactone 66 in 76% 
yield as a single olefin isomer (Figure 20).38 Phillips’s synthesis of dictyostatin also utilized a 
ring-closing metathesis (RCM) reaction strategy to incorporate the C10-C11 Z-alkene (Figure 
18). Intermediate ester 18 (already has C9 stereocenter)39 reacted with Grubbs second generation 
catalyst to provide lactone 19 in 76% yield as a single olefin isomer.14c These results suggested 
that the RCM reaction might be a good approach to make the C10-C11 Z-alkene in a fragment 
coupling. 
 
OTBSOTBS
OTBSO O
TBSO
OTBS
Grubbs I (50mol%)
CH2Cl2, reflux, 78%
65
OTBSOTBS
OTBSO O
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OTBS
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11
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Figure 20. RCM strategy for the synthesis of C10-C11 Z-alkene 
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RCM reactions of silaketals of different sizes is also a recurrent strategy for the synthesis 
of encumbered Z-alkenes (Figure 20).40 In order to provide medium-size rings (7, 8 or 9 
membered rings), RCM reactions of silicon-tethered substrates need preorganization of the 
substrate into a cyclic-like conformation to overcome the substantial enthalpic barrier.41 The 
RCM reactions of diisopropyl and diphenyl silaketals to give seven-membered rings have been 
applied successfully for the total synthesis of (−)-muccocin42 and (+)-gigantecin.43  
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Figure 21. RCM of dimethylsilaketals for the synthesis of eight-member rings 
 
Furthermore, the RCM reaction of dimethylsilaketal 67 promoted by Grubbs second 
generation catalyst provided eight-membered ring product 68 in 89% as a single Z-olefin 
isomer.44 Likewise, the RCM reaction of similar dimethylsilaketal 69 with Grubbs first 
generation catalyst provided eight-membered ring product 70 in 68% yield. In contrast, when 69 
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was reacted with Grubbs second generation catalyst (5 to 10 mol%), large amounts of cross-
metathesized dimeric byproduct 71 were isolated.45 Comparatively, when dimethylsilaketal 72 
(bearing methyl group in allylic position) reacted with Grubbs second generation catalyst 
followed by addition of CF3COOH in MeOH/THF to remove dimethylsilyl group, diol 73 was 
isolated in 65% overall yield (Figure 21).46 
Based on those results, we envisioned the application of the RCM reaction of silaketals 
for the construction of C10-C11 Z-alkene for the synthesis of 6-epi-dyctiostatin 36. We proposed 
the RCM reaction of dimethylsilaketal 74 for the synthesis of key middle-bottom fragment 75. In 
turn, dimethylsilaketal 74 was synthesized by the coupling of middle fragment 76 and bottom 
fragment 77 (Figure 22).   
 
O
HO
OH
OH
OH
O
COOMe
Me
O
OTBSO
TBSO
6-epi-dictyostatin-23
Me2
Si
COOMe
Me
OH
OTBSOHTBSO
MIDDLE F RAGMENT 76 BOTT OM F RAGMENT 77
MIDDLE-BOTT OM FRAGMENT 75
11
10 9
COOMe
Me
O
OTBSO
TBSO Me2
Si
DIMET HY LSILAKETAL 74
9
9
9
10
10
10
1111
11
+
 
Figure 22. Fifth generation synthetic plan and coupling of fragments 
 
The first task to implement this plan was the synthesis of fragments 76 and 77 (Scheme 
23). The synthesis of middle fragment 76 started with the desilylation of primary alcohol 78 with 
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HCl 3N in THF to provide crude diol. The diol was selectively protected with TBSCl in CH2Cl2 
to provide alcohol 76 in 75% yield over 2 steps. Bottom fragment 77 was synthesized by the 
addition of vinyl magnesium bromide to aldehyde 41 followed by Parikh-Doering oxidation and 
(S)-CBS reduction of the resulting ketone to provide a 5:1 mixture of C9 epimers 77α/β in 74% 
overall yield over the 3 steps. The diastereoselectivity for the CBS reduction was measured by 
integrating the C9 proton resonances in the 1H NMR spectra (anti 77α 4.23 ppm, syn 77β 4.08 
ppm). The same chemical shift pattern was seen for the anti and syn compounds synthesized 
from the previous generations coupling experiments. Since the diastereomers coeluted during 
flash chromatography and the desired 77α-isomer was the major product, this mixture was used 
directly. From here on, all the compounds made with this mixture (77α/β) will be labeled as α/β; 
although, we will only show the α-epimer. 
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Scheme 25. Sixth generation synthesis of fragments 
 
In planning the RCM reaction sequence, we considered that having groups of different 
size (Me, iPr, Ph) on the silaketal might affect the outcome of the RCM. The results for the 
synthesis of silaketals bearing different groups are summarized in Table 18. We tested several 
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reagent and base combinations for the synthesis of silaketals 74α/β, 79α/β and 80α/β. In a typical 
coupling reaction, 12 equiv of diisopropyldichlorosilane were added to a mixture of 1.2 equiv of 
76 and 1.5 equiv of imidazole in CH2Cl2. The excess silane and solvent were removed under 
vacuum and a mixture of 1 equiv of 77α/β and 1.5 equiv of imidazole in CH2Cl2 were added. 
After 24 h, the crude mixture was purified by silica gel flash chromatography to provide silaketal 
79α/β in 53% yield (Entry 1). The reaction adding n-BuLi 1.6M to 76 at −78 oC and then 5 equiv 
of diisopropyldichlorosilane instead provided 79α/β in 69% yield (Entry 2).   
In another typical reaction, a mixture of 2.5 equiv of diisopropylbis-(3-methoxyprop-1-
ynyl)-silane and 1.2 equiv of 76 in hexanes reacted with 10 mol% of NaH for 1 h. The 
monosilane was then mixed with 1 equiv of 77α/β in hexanes followed by the addition of 10 
mol% of NaH. After 3 h, the crude product was purified by silica gel flash chromatography to 
provide silaketal 79α/β in 46% yield (Entry 3).47 Silaketal bearing phenyl groups was made by 
coupling 76 and 77α/β using diphenyldichlorosilane and n-BuLi/imidazole to provide 80α/β in 
28% yield (Entry 4). When the coupling was done using diphenylbis-(3-methoxyprop-1-ynyl)-
silane and NaH, 80α was obtained in 75% yield (Entry 5). Silaketal 74α/β (bearing methyl 
groups) was obtained by coupling 76 and 77α/β using dimethyldichlorosilane and n-
BuLi/imidazole in 91% yield. In contrast, coupling using dimethylbis-(3-methoxyprop-1-ynyl)-
silane and NaH provided 74α/β in 49% yield (Entries 6 and 7). Silaketals 74α/β, 79α/β and 
80α/β were isolated as a 5:1 mixtures of epimers at C9. 
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Table 18. Silaketal synthesis 
R' R Base Time Yield
Cl i-Pr Imid. 24h 53%
CH2OMe
CH2OMe
i-Pr NaH 4h 46%
Ph NaH 4h 75%
Cl Me BuLi/Imid. 16h 91%
Cl i-Pr BuLi/Imid. 16h 69%
Cl Ph BuLi/Imid. 16h 28%
CH2OMe Me NaH 4h 49%
MeOOC
Me
O
OTBS
O
TBSO
SiR2
COOMe
Me
OH OTBSOH
TBSO
76 77α/β (α:β/5:1)
+ R2SiR'2
Base
74α/β, R = Me
79α/β, R = iPr
80α/β, R = Ph
a) all products were isolated as 5:1 α:β mixtures after silica gel flash chromatography
Producta
79α/β
79α/β
80α/β
74α/β
79α/β
80α/β
74α/β
Entry
1
3
2
5
4
6
7
9
9
     
 
With the three different silaketals in hand, we tested the RCM reactions with the different 
catalysts (Grubbs second generation and first generation, Hoveyda-and Grubbs catalyst), as 
summarized in Table 19. In a typical experiment silaketal, 74α/β was dissolved in benzene at 
0.01 M concentration. At reflux, was added 10 mol% of Grubbs II catalyst. After 24 h, the crude 
product was purified by silica gel chromatography to provide 75α/β in 63% yield (Entry 1). 
However, isolation of 75α/β was cumbersome and the 1H NMR spectrum of the product showed 
small unidentified impurities. The reaction of silaketal 74α/β with 10 mol% of Hoveyda-Grubbs 
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catalyst in benzene for 24 h provided impure 75α/β in 25% yield. Moreover, when 74α/β reacted 
under the same conditions for only 4 h, 75α/β was isolated in 43% yield (entries 2 and 3). 
Furthermore, reaction of silaketal 74α/β with 25 mol% of Grubbs I catalyst in benzene for 3 h 
provided 75α/β in 44% yield together with 40% of unreacted 74α/β (Entry 4). Reaction of 74α/β 
under the same conditions for 48 h in refluxing CH2Cl2 provided 75α/β and recovered 74α/β in 
31 and 50% yield, respectively (Entry 5). In turn, the reaction of 74α/β under the same 
conditions for 1 h in refluxing toluene provided 75α/β in 59% yield along with 15% of recovered 
74α/β (Entry 6).    
Finally, in an attempt to reach a complete conversion of silaketal, we reacted 74α/β with 
10 mol% of Hoveyda-Grubbs catalyst in benzene for 1 h. We isolated 75α/β in 61% yield 
without significant amounts of 74α/β (Entry 7). Reaction of diisopropylsilaketal 79α with the last 
conditions (Entry 7) provided 81α/β in 30% along with other unidentified impurities (Entry 8). 
The reaction of diphenylsilaketal 80α/β with the last conditions provided 82α/β in 45% yield 
with 15% of recovered 80α/β (Entry 9). The combination of silaketal formation using 
dimethyldichlorosilane with n-BuLi/imidazole and RCM reaction using dimethylsilaketal 74α/β 
and 10 mol% of Grubbs-Hoveyda catalyst is the best reaction sequence for the coupling of 
fragments 76 and 77α/β (Table 19).  
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Table 19. RCM reaction of silaketals 74α/β, 79α/β and 80α/β 
Catalyst Substrate Solvent Time Yield % PDT(RSM)a
24h
74α/β
48h
Grubbs II 10%
Hoveyda-Grubbs 10%
Benzene
Benzene 24h
69
25b
Grubbs I 25% DCM
Grubbs I 25% Toluene 1h 59 (15)
30 (ND)
45 (15)
MeOOC
Me
O
OTBS
O
TBSO
SiR2
74α/β, R = Me
79α/β, R = iPr
80α/β, R = Ph MeOOC
Me
O
OTBS
O
TBSO
SiR2
75α/β, R = Me
81α/β, R = iPr
82α/β, R = Ph
RCM catalyst
Productd
74α/βHoveyda-Grubbs 10% Benzene 4h 43b
3hGrubbs I 25% Benzene
Hoveyda-Grubbs 10% Toluene 1h 61 (0)
Hoveyda-Grubbs 10%
Hoveyda-Grubbs 10%
Toluene 1h
Toluene 1h
Entry
1
2
3
4
5
6
7
8
9
9 9
31 (50)
refluxing solvent
0.01M
44 (40)
a) mixture of epimers at C9 in 5:1 ratio. Yields of product (PDT) and
in () yield of recovered starting material (RSM)
b) Isolated yields with small unidentified impurities
79α/β
80α/β
74α/β
74α/β
74α/β
74α/β
74α/β
75α/β
75α/β
81α/β
82α/β
75α/β
75α/β
75α/β
75α/β
75α/β
 
 
Because of the promising results in the RCM reaction, we investigated a more direct 
route of 41 to a suitable bottom fragment alcohol. The current 3-step sequence could, in 
principle, be replaced by a single step via an asymmetric addition to 41.  Wipf has shown that 
vinyl-zirconium species added to aldehydes to provide internal allylic alcohols in high yields and 
high levels of stereoselectivity if promoted by a chiral ligand (Scheme 26).48 
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The application of internal olefins, bearing a silyl ether in the allylic position, as suitable 
substrates for the RCM reaction, led us to investigate a reductive addition of 1-hexyne and 
aldehyde 41 using chiral ligands 83, 84, and 85. The diastereoselectivities were measured the 
same way as for the synthesis of bottom fragment 77α/β. The results for this reaction are 
summarized in Scheme 26. 
In a typical experiment, 1.2 equiv of 1-hexyne was added to 1.2 equiv of Cp2ZrHCl in 
CH2Cl2.The solvent was then removed under vacuum. At −78 oC, toluene was added followed by 
1.2 equiv of Me2Zn 2M. Then, 10 mol% of chiral ligand 8549 was added. At −30 oC, aldehyde 41 
was added and the resulting solution was stirred for 15 h. The crude mixture was purified by 
silica gel flash chromatography to provide 86 in 81% yield and 6:1 dr of 86α:86β (Entry 1). 
Reaction of 41 with 10 mol% of ligand 83 provided alcohol 86 in 75% yield and 4:1 dr of 
86α:86β (Entry 2). However, reaction using 10 mol % of ligand 8450 provided 86 in 87% yield 
and 7:1 dr of 86α:86β (Entry 3). In an attempt to optimize the diastereoselectivity, we changed 
the ligand loading using conditions for Entry 3. When we used 5 mol % of 84, we obtained 86 in 
79% yield and 5:1 dr of 86α:86β. While, the reaction with 20 mol% of 84 provided 86 in 75% 
yield and 2.5:1 dr of 86α:86β. Ligand 84 was easily synthesized from L-proline in 3 steps and 
85% overall yield and provided the best yields and diastereoselectivities for the asymmetric 
reductive addition of 1-hexyne and aldehyde 41. From here on, all the compounds made with the 
mixture (86α/β) will be labeled as α/β; although, we will only show the α-epimer. 
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CpZrHCl, 1-Hexyne, CH2Cl2
Me2Zn, Toluene
-30 oC
OTBSHO
COOMe
C4H9
NMe2
SH
NMe2
SH
COOMe
OTBSO
41
86α (anti)
Ligand Mol% Yielda
85 10 81%
84
83
10 87%
10 75%
84 5 76%
84 20 79%
a) isolated yields after silica gel f lash chromatography. b) ratios determined by 1H NMR.
ratio (86α:86β)b
6:1
4:1
7:1
5:1
2.5:1
Entry
1
3
2
4
5
N
Me
Ph
Ph
OH
8583 84
OTBSHO
COOMe
C4H9
86β (syn)
+
9
9
 
Scheme 26. Reductive alkyne coupling reaction for the synthesis of fragment 86α 
 
Because of the isolation problems found in the RCM reaction using middle fragment 76 
and bottom fragment 77α/β, we next investigated alternative protecting groups for the middle 
fragment. RCM catalysts are known to have low reactivity towards olefins bearing a methyl 
group in the allylic position (fragment 76).51 Similarly, alkenes bearing free hydroxyl groups or 
chelating protecting groups (PMB, MOM) have enhanced reactivity towards RCM catalysts.52 
We hypothesized that changing the primary TBS ether (76) to a primary PMB ether (87) in the 
middle fragment will increase the reactivity of the more hindered alkene, as well as, decrease 
formation of the undesired byproducts during the RCM reaction. The synthesis of middle 
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fragment 87 started with the reaction of primary alcohol 78 with PMB trichloroimidiate in 
cyclohexane/CH2Cl2 and 0.05 equiv of BF3·OEt2 to provide PMB ether. This product was then 
reacted with TBAF in THF at 50 oC to provide 87 in 84% yield for 2 steps (Scheme 27).  
 
HO
PMBO
TBSO
HO
a) PMBOCNHCCl3
b) TBAF, THF, 50 oC,
84% 2 steps
78 87  
Scheme 27. Synthesis of middle fragment 87 
 
The availability of new fragments 86α/β and 87 with previous fragments 76 and 77α/β, 
allowed us to investigate the RCM reaction of all possible dimethylsilaketals obtained by 
coupling the fragments (Scheme 28). The coupling reaction of bottom fragment 86α/β (internal 
allylic alcohol) with middle fragment 76 (primary TBS ether) using dimethyldichlorosilane and 
n-BuLi/imidazole (see Entry 6, Table 18), provided silaketal 88α/β in 73% yield (7:1 mixture of 
epimers 86α/β at C9). The combination of bottom fragment 86α/β (internal allylic alcohol) and 
middle fragment 87 (primary PMB ether) under the same coupling conditions provided silaketal 
89α/β in 69% yield along with 15% of recovered 86α/β.  The last coupling combination with 
77α/β (terminal allylic alcohol) and 87 (primary PMB ether) under the same conditions provided 
silaketal 90α/β in 92% yield. The ratio of C9 epimers 89α/β and 90α/β was not measured 
because PMB ether proton resonance overlapped with C9 proton resonance from the minor β-
isomer in the 1H NMR spectrum. However, we presume that it is similar to the ratio from the 
respective bottom fragment.    
RCM reaction of silaketal 88α/β with 10 mol% of Hoveyda-Grubbs catalyst in refluxing 
toluene (see Entry 7, Table 19) provided 75α/β in 58% yield after 2 purifications by silica gel 
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flash chromatography (no recovered 88α/β was isolated). Reaction of silaketal 89α/β under the 
same conditions provided 91α/β in 63% yield along with 10% of recovered 89α/β. Finally, RCM 
reaction of silaketal 90α/β and Hoveyda-Grubbs catalyst under previous conditions provided 
91α/β in 68% yield along with 15% of recovered 90α/β.  The results showed that the RCM, as 
well as, the silaketal formation reactions were higher yielding with middle fragment 87. In turn, 
bottom fragment 86α/β was produced in a better 7:1 ratio of epimers at C9 compared to bottom 
fragment 77α/β that was obtained in a 5:1 ratio of epimers. The good results from the 
optimization experiments for a better synthetic route to C9 stereocenter and C10-C11 Z-alkene 
led us to scale up the synthesis of bottom fragment 86α/β and middle fragment 87 for an 
approach using the silaketal formation/RCM reaction sequence for a multi-gram synthesis of 6-
epi-dictyostatin 36.  
 
COOMe
Me
O
OTBSO
RO Me2
Si
COOMe
Me
OH OTBSOH
RO
+
tBuLi/Imidazole
R'
R = TBS, 76
R = PMB, 87
R' = H, 77α/β (α:β/5:1)
R' = C4H9, 86α/β (α:β/7:1)
Me2SiCl2
R'
74α/β, R = TBS, R' = H, 91%
88α/β, R = TBS, R' = C4H9, 73%
89α/β, R = PMB, R' = C4H9, 69%
90α/β, R = PMB, R' = H, 92%
COOMe
Me
O
OTBSO
RO Me2
Si
R'
Hoveyda-Grubbs
10 mol%, Toluene
COOMe
Me
O
OTBSO
RO Me2
Si
74α/β, R = TBS, R' = H
88α/β, R = TBS, R' = C4H9
89α/β, R = PMB, R' = C4H9
90α/β, R = PMB, R' = H
75α/β, R = TBS, 61%
75α/β, R = TBS, 58%
91α/β, R = PMB, 63%
91α/β, R = PMB, 68%
9
9
9
9
1011
 
Scheme 28. Synthesis and RCM reaction of silaketals 
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4.2.3 Application of fifth generation fragment coupling for final steps in the 
synthesis of 6-epi-dictyostatin. 
Because of the success in the small-scale bottom fragment and middle fragment coupling 
reactions (silaketal reaction/RCM reaction), we followed up with a scale-up reductive addition 
reaction of 1-hexyne and bottom fragment 41 and obtained 3 g of 86α/β in 73% yield and 8:1 
ratio of diastereomers (Scheme 29). Similarly, we obtained 3 g of middle fragment 87 (This 
experiment was done by Mr. Jung). The coupling of 2.5 g of bottom fragment 86α/β and 2.2 g of 
middle fragment 87 with dimethyldichlorosilane provided 3 g of 89α/β in 65% yield. The RCM 
reaction of 1 g of 89α/β using 10 mol% of Hoveyda-Grubbs catalyst in refluxing toluene 
provided 552 mg of 91α/β in 62% yield along with 150 mg of recovered 89α/β.      
We next investigated the selective removal of the dimethylsilicon group. At the same 
time, we expected to remove the diastereomeric impurity in 91α/β. Small-scale reaction of 91α/β 
with Cl2CHCOOH in MeOH/CH2Cl2 produced diol 92 in 69% yield as a 8:1 ratio of 92α:92β 
(epimers at C9) after silica gel flash chromatography. After scanning different combinations of 
TLC solvents, Hexanes/EtOAc 4:1 with 2% of MeOH showed separation of the epimers on TLC. 
Silica gel flash chromatography of 92α/92β mixture eluting with hexanes/EtOAc 4:1 with 2% of 
MeOH provided 92α in 54% overall yield as a single diastereomer (Scheme 29). We identified 
the isolated product as the desired mayor epimer (92α) by comparing the C9 proton resonance in 
the 1H NMR spectrum with the C9 proton resonances from diastereomerically pure 52α (Scheme 
20) and 62α (Table 17). We then protected diol 92α in small-scale with TBSOTf to obtain 93α in 
78% yield. We then removed the PMB group with DDQ to obtain primary alcohol 94α in 65% 
yield. Initial attempts to oxidize 94α using Parikh-Doering conditions gave impure aldehyde 95α. 
However, the reaction with Dess-Martin reagent produced 95α in 86% yield after silica gel flash 
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chromatography. We next tried to scale-up the sequence of reactions up to aldehyde 95α. 
However, the results were unsuccessful.  
 
COOMe
Me
O
OTBSO
PMBO Me2
Si
COOMe
Me
OH
OTBSOH
PMBO
+
tBuLi/Imidazole
C4H9
87, 2.2 g 86α/β (86α:86β/8:1), 2.5 g
Me2SiCl2
C4H9
Hoveyda-Grubbs
10 mol%, Toluene
COOMe
Me
O
OTBSO
PMBO Me2
Si
9
9
9 9
1011COOMe
Me
O
OTBSO
PMBO Me2
Si
C4H9
COOMe
Me
O
OTBSO
PMBO Me2
Si CCl2HCOOH
MeOH/CH2Cl2
COOMe
Me
OR
OTBSRO
PMBO
91α 92α, R = H, 54%
93α, R = TBS, 78%
DDQ, THF
COOMe
Me
OTBS
OTBSTBSO
X
94α, X = OH,H, 65%
95α, X = O, 86%
b c
a) TBSOTf, 2,6-Lutidine, CH2Cl2, 78%; b) SO3Py, DMSO, Et3N, CH2Cl2; b) DMP, CH2Cl2.
a
93α
9
1011
9
1011
9
1011
89α/β, 3 g, 69%
89α/β, 1 g 91α/β, 552 mg, 63%
/β
 
Scheme 29. Synthesis of key intermediate 95α 
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TBSO
TBSO OTBS
CO2Me
HO
HO
HO OH
O O
OH
TBSO
TBSO OTBS
CO2Me
O
H1) Cl2CHCO2H, 65%2) TBSOTf, 85%
3) DDQ, 70%
4) DMP
1) [Ph3PCuH]6, 78%
2) DDQ, 87%
3) Et2BOMe,NaBH4
87%
OH
1) TBSOTf, 85%
2) KOH
3) (2,6-(NO2)Me-
PhCO)2O
DMAP, TEA
4) HCl, 45%, three
steps
O
OSi
PMBO
OTBS
CO2Me
30:1
6-epi-dicty ostatin, 30 mg
91α, 500 mg
95α
96
97
85α
34, Ba(OH)2
TBSO
TBSO OTBS
CO2Me
O
PMBO
89%, 2 steps
96
97
 
Scheme 30. Final steps for the synthesis of 6-epi-dictyostatin 36 
 
Mr. Jung was provided with the remaining material of 89α/β to attempt the scale-up 
synthesis of 95α. Mr. Jung’s results on the scale-up synthesis of 95α and the remaining steps to 
obtain 6-epi-dictyostatin are summarized in Scheme 30. He obtained 208 mg of primary alcohol 
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94α and did Dess-Martin oxidation to provide crude aldehyde 95α. The crude mixture was 
reacted with top fragment 34 in the presence of Ba(OH)2 to provide advanced intermediate 96 in 
89% yield for the 2 steps. Enone 96 was reduced with Stryker’s reagent, followed by removal of 
PMB with DDQ and syn-selective reduction. Intermedaite 97 was obtained in 59% yield after 3 
steps. Alcohol 97 was selectively protected as a TBS ether then the ester was transformed to the 
acid followed by macrolactonization under Yamaguchi’s conditions. The final global 
deprotection Yielded 30 mg 6-epi-dictyostatin 36 in 45% yield for the last 3 steps.   
4.3 CONCLUSIONS 
Effective construction of C9 chiral center and Z-alkene at C10-C11 using the 3 steps 
procedure of alkynilation, Noyori reduction, and selective reduction was unsuccessful due to the 
reactivity of dienyl ester moiety in bottom fragment 41 to selective reduction catalysts.  
The design of a Z-vinyl lithium addition reaction to aldehyde 41 for coupling of 
fragments proved to work in small scale. However, scale-up results showed that yields were not 
very reproducible. As a consequence, the route was not suitable for the synthesis of 6-epi-
dictyostatin 36 in big-scale. 
NHK reaction of middle fragment 42 and aldehyde 41 promoted by chiral sulfonamides 
(60, 62, 63) proved to provide coupling product 64 in good yield but moderate 
diastereoselectivity. However, the inherited toxicity of the reagents (especially if used in large 
scale) together with the poor results obtained with the catalytic NHK reaction made this 
approach not suitable for our goals. 
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We designed a quicker and more efficient approach for the synthesis of top fragment 34. 
We obtained fragment 34 in 11 steps from alcohol 54 derived from (S)-Roche ester in 9% overall 
yield. 
The coupling of middle fragments (76 and 87) and bottom fragments (77α/β and 86α/β) 
as a dimethylsilaketal and subsequent RCM reaction using Hoveyda-Grubbs catalyst in toluene 
was the best route to establish the desired C10-C11 Z-alkene. Substrates (79α/β and 80α/β) with 
bulkier groups on silicon center led to moderate yields together with multiple impurities that 
made purification very hard during the RCM reaction. 
The Wipf coupling of alkynes and aldehydes proved to work with high levels of dr (7:1 
for small-scale and 8:1 for big-scale) for the synthesis of C9 stereocenter in bottom fragment 
86α/β. Moreover, formation of silaketals and RCM reaction when using bottom fragment 86α/β 
gave intermediate 91α/β in good yields.  
Small-scale synthesis of aldehyde 95α allowed us to remove β-isomer impurity. 
However, when it was scale-up from 91α, the results were unsuccessful. Mr. Jung completed the 
scale-up and the final steps of the synthesis to obtain 30 mg of 6-epi-dictyostatin 36.   
4.4 EXPERIMENTAL 
All reactions were performed under an atmosphere of argon unless otherwise specified or 
the reaction solvent contained water. The reaction times reported are dictated by TLC analysis of 
the reaction mixture in comparison to the starting material. Reaction solvents were freshly dried 
either by distillation or passing through an activated alumina column. CH2Cl2 was distilled from 
CaH. Commercially available reagents were used a received from supplier. Reactions were 
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monitored using thin layer chromatography (TLC) using Kieselgel 60 F254 silica gel plates. Flash 
chromatography was performed over silica gel 60, 230-400 mesh, with the designated solvents. 
1H NMR and 13C NMR spectra were recorded on a Bruker DPX-300 or a Bruker DPX-500 
spectrometer using residual solvent peaks as internal standard: CDCl3 7.23 ppm (1H NMR) and 
77.00 ppm (13C NMR). Chemical shifts are reported in ppm (δ) downfield from tetramethylsilane 
and proton-proton coupling constants (J) in Hz. Infrared spectra (IR) were recorded on a ATI 
Mattson genesis series FTIR spectrometer and are reported in reciprocal centimetres (cm-1). 
Optical rotations were measured with Perkin-Elmer 241 digital polarimeter with a sodium lamp 
at ambient temperature. HPLC analysis was performed on a Waters 600E system with UV 
detector. Low and high resolution mass spectra were obtained on a VG 70-G or Micromass 
Autospec double focusing instrument using EI, ESI, or CI. 
 
                                                         OTBSO
CO2Me
   
(2Z,4E,6R,7S)-Methyl 7-(tert-butyldimethylsilyloxy)-6-methyl-9-oxonona-2,4-dienoate (32):  
To a solution of (2Z,4E,6R,7S)-methyl-7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-
methylnona-2,4-dienoate (5 g, 15.2 mmol) and Et3N (3.07 g, 30.4 mmol) in CH2Cl2 (20 mL) and 
DMSO (20 mL) was added a solution of PySO3 (3.60 g, 22.8 mmol) in DMSO (20 mL) at 0 oC 
under Ar atmosphere. The resulting mixture was stirred at 0 oC for 20 min and then quenched 
with aqueous HCl (0.1 M). The aqueous phase was extracted with CH2Cl2, and the combined 
organic phase was washed with brine and dried over MgSO4. The solution was concentrated and 
the crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl 
acetate 10:1 to yield aldehyde 32 (4.51 g, 91%) as a colorless oil: [α]D −10.7 (c = 0.97, CHCl3); 
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IR (thin film) 3421, 2953, 2857, 1760, 1719, 1412, 1190, 1167, 837 cm-1;  1H-NMR (300 MHz, 
CDCl3) δ 9.76 (t, J = 2.1 Hz, 1H), 7.37 (dd, J = 15.6, 11.4 Hz, 1H), 6.54 (t, J = 11.2 Hz, 1H), 
6.06 (dd, J = 15.6, 7.2 Hz, 1H), 5.60 (d, J = 11.4 Hz, 1H), 4.15 (dt, J = 6.6, 5.1 Hz, 1H), 3.77 (s, 
3H), 2.50 (m, 1H), 2.47 (d, J = 5.1 Hz, 2H), 1.05 (d,  J = 6.6 Hz, 3H), 0.96 (s, 9H), 0.04 (s, 6H); 
13C-NMR (75 MHz, CDCl3) δ 201.5, 166.8, 145.6, 144.9, 127.6, 116.3, 70.9, 51.1, 48.3, 43.8, 
25.7, 18.0, 15.1, −4.5, −4.6 ppm. 
 
                                                      OTBSOH
CO2Me
 
(2Z,4E,6R,7S)-Methyl-7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-methyl-12-phenyldodeca-
2,4-dien-10-ynoate (43):  
To a solution of prop-2-ynylbenzene (72 mg, 0.62 mmol) in diethyl ether (3 mL) was 
added dropwise n-BuLi (387 μL, 1.6 M) at -78 oC under argon atmosphere. The resulting 
mixture was stirred for 1 h and a solution of aldehyde 32 (100 mg, 0.31 mmol) in diethyl ether (1 
mL) was added. The resulting mixture was stirred at −78 oC for 3 h and then quenched at RT 
with sat. aqueous NH4Cl. The aqueous phase was extracted with CH2Cl2, and the combined 
organic phase was washed with brine and dried over MgSO4. The solution was concentrated and 
the crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl 
acetate 9:1 to yield alcohol 43 (110 mg, 80%) as a colorless oil. IR (thin film) 3399, 2954, 2857, 
1721, 1424, 1165, 1101, 830, 751 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.39-7.22 (m, 6H), 6.54 
(t, J = 11.3 Hz, 1H), 6.12 (dd, J = 15.0, 7.8 Hz, 1H), 5.56 (d, J = 11.3 Hz, 1H), 4.52-4.47 (m, 
1H), 3.85 (t, J = 6.7 Hz, 1H), 3.68 (s, 3H), 3.60 (s, 2H), 2.56-2.51 (m, 1H), 1.84-1.71 (m, 2H), 
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1.09 (d, J = 6.7 Hz, 3H), 0.90 (s, 9H), 0.03 (s, 3H), 0.02 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 
166.9, 146.4, 145.5, 128.5, 127.9, 126.9, 126.7, 115.6, 83.7, 74.2, 61.3, 51.1, 42.5, 41.3, 25.8, 
25.1, 18.1, 14.6, −4.2, −4.6 ppm. 
 
                                                             OTBSOH
CO2Me
 
(2Z,4E,6R,7S,9R,10Z)-Methyl-7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-methyl-12-
phenyldodeca-2,4,10-trienoate (44β):  
To a solution of (Z)-(2-iodovinyl)-benzene (107 mg, 0.47 mmol) in diethyl ether (3 mL) 
was added dropwise t-BuLi (547 μL, 1.7M) at −78 oC and under argon atmosphere. The resulting 
mixture was stirred for 1 h and a solution of aldehyde 32 (100 mg, 0.31 mmol) in diethyl ether (1 
mL) was added. The resulting mixture was stirred at −78 oC for 3 h and then quenched at RT 
with sat. aqueous NH4Cl. The aqueous phase was extracted with diethyl ether, and the combined 
organic phase was washed with brine and dried over MgSO4. The solution was concentrated and 
the crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl 
acetate 9:1 to provide a first less polar alcohol 44β (55 mg, 39%) as a colorless oil: [α]D −2.5 (c 
0.79, CHCl3); IR (thin film) 3431, 3053, 2955, 2930, 2857, 2254, 1713, 1637, 1463, 1439, 1265, 
1198, 1096, 909, 736 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.44 (dd, J = 15.0, 11.3 Hz, 1H), 7.29-
7.18 (m, 5H), 6.55 (t, J = 11.3 Hz, 1H), 5.98 (dd, J = 15.0, 7.8 Hz, 1H), 5.63-5.532 (m, 3H), 
4.70-4.65 (m, 1H), 3.97 (dt, J = 7.2, 6.8 Hz, 1H), 3.65 (s, 3H), 3.44 (t, J = 8.9 Hz, 2H), 2.67-2.64 
(m, 1H), 2.46 (s, 1H), 1.78-1.70 (m, 1H), 1.62-1.56 (m, 1H), 1.10 (d, J = 6.7 Hz, 3H), 0.93 (s, 
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9H), 0.14 (s, 3H), 0.09 (s, 3H);  13C-NMR (125.8 MHz, CDCl3) δ 166.7, 145.3, 144.9, 143.7, 
139.0, 135.1, 128.5, 127.5, 126.3, 116.0, 79.5, 70.7, 51.0, 48.3, 43.2, 39.1, 25.7, 18.0, 15.1, −4.6, 
−4.7 ppm; HRMS (ESI) calcd for C26H40O4Si =444.2696, found = 444.2683. 
  
                                    OTBSOH
CO2Me
 
(2Z,4E,6R,7S,9S,10Z)-Methyl-7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-methyl-12-
phenyldodeca-2,4,10-trienoate (44α):  
The crude product from 44 provided a second more polar alcohol 44α (55 mg, 40%) as a 
colorless oil. [α]D −16.1 (c 0.71, CHCl3); IR (thin film) 3421, 2953, 2857, 1719, 1412, 1190, 
1167, 837 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.35 (dd, J = 15.0, 11.3 Hz, 1H), 7.29-7.18 (m, 
5H), 6.57 (t, J = 11.3 Hz, 1H), 6.02 (dd, J = 15.0, 7.8 Hz, 1H), 5.63-5.53 (m, 3H), 4.80 (dt, J = 
8.1, 6.8 Hz, 1H), 3.95 (dt, J = 7.2, 6.8 Hz, 1H), 3.73 (s, 3H), 3.45 (t, J = 8.9 Hz, 2H), 2.52-2.58 
(m, 1H), 1.64-1.59 (m, 2H), 1.06 (d, J = 6.7 Hz, 3H), 0.92 (s, 9H), 0.14 (s, 3H), 0.09 (s, 3H); 
13C-NMR (75 MHz, CDCl3) δ 166.8, 145.6, 144.9, 143.2, 139.0, 135.7, 128.5, 127.5, 126.3, 
116.0, 78.1, 70.9, 51.0, 48.3, 43.8, 39.3, 25.7, 18.0, 15.1, −4.5, −4.6 ppm; HRMS (ESI) calcd for 
C26H40O4Si =444.2696, found = 444.2687. 
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                                                 OMOMOH
CO2Me
 
(2Z,4E,6R,7S,9R,10Z)-Methyl-9-hydroxy-7-(methoxymethoxy)-6-methyl-12-phenyldodeca-
2,4,10-trienoate (47β):  
Following the same procedure as 44β, aldehyde 45 (100 mg, 0.39 mmol) provided first a 
less polar alcohol 47β (39 mg, 26%) as a colorless oil. [α]D −24.1 (c 0.69, CHCl3); IR (thin film) 
3311, 3052, 2986, 2959, 2872, 2253, 1720, 1610, 1511, 1439, 1265, 1175, 909, 734 cm-1; 1H-
NMR (300 MHz, CDCl3) δ 7.37 (dd, J = 15.4, 11.3 Hz, 1H), 7.29-7.18 (m, 5H), 6.54 (t, J = 11.3 
Hz, 1H),  6.02 (dd, J = 15.4, 7.7 Hz, 1H), 5.57-5.52 (m, 3H), 4.68 (dt, J = 8.2, 6.5 Hz, 1H), 4.64 
(dd, J = 21.3, 6.8 Hz, 2H), 3.71 (s, 3H), 3.68-3.64 (m, 4H), 3.45 (t, J = 8.9 Hz, 2H), 3.36 (s, 3H), 
2.63-2.60 (m, 1H), 1.79-1.72 (m, 1H), 1.65-1.60 (m, 1H), 1.09 (d, J = 6.8 Hz, 3H); 13C-NMR 
(125.8 MHz, CDCl3) δ 166.7, 145.6, 144.8, 143.2, 139.1, 135.6, 128.5, 127.5, 126.3, 116.2, 96.9, 
79.1, 70.7, 55.7, 51.0, 48.3, 43.5, 39.3, 15.1 ppm; HRMS (ESI) calcd for C25H30O5 = 374.2093, 
found = 374.2068. 
 
OMOMOH
CO2Me
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The crude product from 47 provided a second more polar alcohol 47α (58 mg, 40%) as a 
colorless oil. [α]D −19.3 (c 0.64, CHCl3); IR (thin film) 3295, 3050, 2999, 2927, 2854, 1465, 
1390, 1421, 1265 cm-1;  1H-NMR (300 MHz, CDCl3) δ 7.36 (dd, J = 15.4, 11.3 Hz, 1H), 7.29-
7.18 (m, 5H), 6.54 (t, J = 11.3 Hz, 1H),  6.02 (dd, J = 15.4, 7.7 Hz, 1H), 5.59-5.53 (m, 3H), 4.72 
(dt, J = 8.1, 6.8 Hz, 1H), 4.64 (dd, J = 21.3, 6.8 Hz, 2H), 3.71 (s, 3H), 3.68-3.64 (m, 4H), 3.45 (t, 
J = 8.9 Hz, 2H), 3.36 (s, 3H), 2.63-2.60 (m, 1H), 1.67-1.58 (m, 2H), 1.10 (d, J = 6.8 Hz, 3H); 
13C-NMR (125.8 MHz, CDCl3) δ 166.9, 145.7, 144.9, 143.2, 139.1, 135.6, 128.5, 127.5, 126.3, 
116.2, 96.9, 78.4, 70.3, 55.7, 51.0, 48.3, 43.8, 39.3, 15.1 ppm; HRMS (ESI) calcd for C25H30O5 = 
374.2093, found = 374.2045. 
                     
                                                    OPMBOH
CO2Me
 
(2Z,4E,6R,7S,9R,10Z)-Methyl-9-hydroxy-7-(4-methoxybenzyloxy)-6-methyl-12-
phenyldodeca-2,4,10-trienoate (48β):  
Following the same procedure as 44β, aldehyde 46 (100 mg, 0.30 mmol) provided first a 
less polar alcohol 48β (31 mg, 23%) as a colorless oil. [α]D −7.5 (c 0.6, CHCl3); IR (thin film) 
3345, 3053, 2986, 2953, 2249, 1712, 1638, 1602, 1439, 1265, 1177, 908 cm-1; 1H-NMR (300 
MHz, CDCl3) δ 7.43 (dd, J = 15.1, 11.4 Hz, 1H), 7.15-1.05 (m, 7H), 6.81 (d, J = 6.7 Hz, 2H), 
6.53 (t, J = 11.4 Hz, 1H), 6.11 (dt, J = 15.2, 7.2 Hz, 1H), 5.59-5.51 (m, 3H), 4.75-4.71 (m, 3H), 
3.77-3.75 (m, 1H), 3.72 (s, 3H), 3.47 (t, J = 8.9 Hz, 2H), 3.41 (s, 3H), 2.55-2.47 (m, 1H), 1.81-
1.76 (m, 1H), 1.70-1.66 (m, 1H), 1.04 (d, J = 6.9 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 166.8, 
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145.3, 144.8, 143.5, 143.3, 139.0, 135.6, 129.5, 128.5, 127.5, 126.3, 116.0, 113.8, 78.9, 70.6, 
55.6, 51.2, 49.6, 48.3, 43.8, 39.3, 25.7, 18.0, 15.1; HRMS (ESI) calcd for C28H34O5 = 450.2406, 
found = 450.2423. 
 
                             OPMBOH
CO2Me
 
(2Z,4E,6R,7S,9S,10Z)-Methyl-9-hydroxy-7-(4-methoxybenzyloxy)-6-methyl-12-
phenyldodeca-2,4,10-trienoate (48α):  
The crude product from 48 provided a second more polar alcohol 48α (54 mg, 40%) as a 
colorless oil. [α]D +4.3 (c 0.9, CHCl3); IR (thin film) 3321, 3053, 2985, 2959, 2928, 2253, 1717, 
1456, 1265, 909, 735 cm-1;  1H-NMR (300 MHz, CDCl3) δ 7.44 (dd, J = 15.1, 11.4 Hz, 1H), 
7.16-1.07 (m, 7H), 6.80 (d, J = 6.7 Hz, 2H), 6.53 (t, J = 11.4 Hz, 1H), 6.11 (dt, J = 15.2, 7.2 Hz, 
1H), 5.59-5.51 (m, 3H), 4.82 (dt, J = 8.1, 6.8 Hz, 1H), 4.72 (d, J = 6.7 Hz, 1H), 3.77-3.75 (m, 
1H), 3.72 (s, 3H), 3.47 (t, J = 8.9 Hz, 2H), 3.41 (s, 3H), 2.55-2.47 (m, 1H), 1.60-1.50 (m, 2H), 
1.03 (d,  J = 6.9 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 166.8, 145.6, 144.9, 143.7, 143.2, 139.0, 
135.7, 129.5, 128.5, 127.5, 126.3, 116.0, 113.8, 77.8, 70.7, 55.6, 51.0, 49.6, 48.3, 43.8, 39.3, 
25.7, 18.0, 15.1; HRMS (ESI) calcd for C28H34O5 = 450.2406, found = 450.2379. 
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OO
CO2Me
 
(R,2Z,4E)-Methyl-6-((4S,6S)-2,2-dimethyl-6-((Z)-3-phenylprop-1-enyl)-1,3-dioxan-4-
yl)hepta-2,4-dienoate (49):  
To a solution of vinyl alcohol 44α (20 mg, 0.05 mmol) in THF (1 mL) was added TBAF 
(75 μL, 1M), and the resulting mixture was stirred for 1 h. The reaction was quenched with sat. 
aqueous NH4Cl. The aqueous phase was extracted with diethyl ether, and the combined organic 
phase was washed with brine and dried over MgSO4. The solution was concentrated and the 
crude mixture was dissolved in acetone (1 mL) and then was added Et3N (10 mg, 0.1 mmol) and 
2,2-dimethoxypropoane (26 mg, 0.25 mmol) at RT. The resulting mixture was stir for 30 min 
then the solution was concentrated and the crude product was purified by silica gel flash 
chromatography eluting with hexanes/ethyl acetate 5:1 to yield acetonide 49 (14 mg, 78% for 2 
steps) as a colorless oil. [α]D −29.3 (c 0.52, CHCl3); IR (thin film) 3053, 2986, 2955, 2872, 2254, 
1739, 1648, 1607, 1438, 1377, 1265, 1232, 909, 735 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.40 
(dd, J = 15.0, 11.3 Hz, 1H), 7.32-7.17 (m, 5H), 6.60 (t, J = 11.3 Hz, 1H), 6.11 (dd, J = 15.0, 7.8 
Hz, 1H), 5.75-5.66 (m, 1H), 5.61 (d, J = 11.3 Hz, 1H), 5.56 (dd, 10.8, 8.1 Hz, 1H),  4.76 (dt, J = 
8.5, 6.3 Hz, 1H), 3.77 (dt, J = 7.2, 6.8 Hz, 1H), 3.73 (s, 3H), 3.45 (t, J = 8.3 Hz, 2H), 2.43 (m, 
1H), 1.79-1.1.72 (m, 2H), 1.41 (s, 3H), 1.26 (s, 3H), 1.09 (d, J = 6.7 Hz, 3H); 13C-NMR (75 
MHz, CDCl3) δ 166.8, 145.6, 144.9, 143.2, 139.0, 135.7, 128.5, 127.5, 126.3, 116.0, 100.3, 78.3, 
69.1, 51.0, 48.3, 43.8, 39.3, 25.2, 24.9, 18.0, 15.1 ppm; HRMS (ESI) calcd for C23H30O4 = 
370.2144, found = 370.2119. 
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OO
CO2Me
 
(R,2Z,4E)-Methyl-6-((4S,6R)-2,2-dimethyl-6-((Z)-3-phenylprop-1-enyl)-1,3-dioxan-4-
yl)hepta-2,4-dienoate (50):  
Following the same procedure for acetonide 49, alcohol 44β (20 mg, provided acetonide 
50 (13 mg, 75% for 2 steps) as a colorless oil. [α]D −11.8 (c 0.94, CHCl3); IR (thin film) 3052, 
2986, 2959, 2872, 2254, 1720, 1610, 1511, 1439, 1265, 1175, 909, 734 cm-1; 1H-NMR (300 
MHz, CDCl3) δ 7.39 (dd, J = 15.0, 11.3 Hz, 1H), 7.30-7.18 (m, 5H), 6.60 (t, J = 11.3 Hz, 1H), 
6.13 (dd, J = 15.0, 7.8 Hz, 1H), 5.74-5.68 (m, 1H), 5.62 (d, J = 11.3 Hz, 1H), 5.53 (dd, 10.8, 8.1 
Hz, 1H),  4.70 (dt, J = 8.5, 6.3 Hz, 1H), 3.82 (dt, J = 7.2, 6.8 Hz, 1H), 3.74 (s, 3H), 3.47 (t, J = 
8.3 Hz, 2H), 2.41 (m, 1H), 1.64-1.59 (m, 2H), 1.43 (s, 3H), 1.26 (s, 3H), 1.09 (d, J = 6.7 Hz, 
3H); 13C-NMR (75 MHz, CDCl3) δ 166.8, 145.4, 144.5, 143.3, 139.2, 135.9, 128.5, 127.5, 126.3, 
116.0, 98.3, 79.1, 69.7, 51.0, 48.3, 43.8, 39.3, 31.5, 20.1, 18.0, 15.1 ppm; HRMS (ESI) calcd for 
C23H30O4 = 370.2144, found = 370.2164. 
 
                                                       
PMBO
OTBS
I  
tert-Butyl((2S,3S,4S,Z)-6-iodo-1-(4-methoxybenzyloxy)-2,4-dimethylhex-5-en-3-
yloxy)dimethylsilane (31):  
To a suspension of IPh3PCH3 (3.49 g, 8.65 mmol) in THF (15 mL) was added n-BuLi 
(5.15 mL, 1,6 M). The resulting mixture was transferred via cannula to a solution of I2 (2.09 g, 
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8.24 mmol) in THF (5 mL) at −78 oC. The resulting brown suspension was stirred for ½ hour, 
and then NaHMDS (7.07 mL, 1M) was added dropwise at −78 oC. The red suspension was 
stirred for 15 min at −20 oC and then cooled back to −78 oC, followed by addition of a solution 
of aldehyde 51 (1.68 g, 4.42 mmol) in THF (5 mL). The resulting mixture was stirred at −78oC 
for 30 min and at −20 oC for 1 h. The reaction was quenched with sat. aqueous NH4Cl, and the 
aqueous phase was extracted with diethyl ether, and the combined organic phase was washed 
with brine and dried over MgSO4. The solution was concentrated and the crude product was 
purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 4:1 to yield vinyl 
iodide 31 (1.8 g, 81%) as a colorless oil. [α]D +18.4 (c 0.35, CHCl3); IR (thin film) 2955, 2929, 
2855, 1513, 1249, 1039, 837, 773 cm-1;  1H-NMR (300 MHz, CDCl3) δ 7.27 (d, J = 8.5 Hz, 2H), 
6.87 (d, J = 8.6 Hz, 2H), 5.90 (dd, J = 8.8, 7.3 Hz, 1H), 5.13 (d, J = 7.3 Hz, 1H), 4.61 (s, 2H), 
3.81 (s, 3H), 3.74 (t, J = 3.8 Hz, 2H), 3.40 (dd, J = 9.0, 5.8 Hz, 1H), 3.21 (dd, J = 9.0, 7.1 Hz, 
1H), 2.71-2.67 (m, 1H), 1.00 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.90 (s, 9H), 0.07 (s, 
3H), 0.05 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 159.2, 144.0, 130.9, 129.3, 113.8, 81.8, 76.0, 
72.7, 55.3, 43.8, 38.9, 26.3, 18.5, 17.7, 13.4, −3.5, −3.7 ppm; HRMS (EI) calcd for C22H37IO3Si 
= 504.1557, found = 504.1563. 
 
                                                    
PMBO
OTBS
 
tert-Butyl((2S,3S,4S)-1-(4-methoxybenzyloxy)-2,4-dimethylhex-5-en-3-yloxy)dimethylsilane 
(53):  
To a solution (Z)-vinyl iodide 31 (200 mg, 0.40 mmol) in diethyl ether (3 mL) was added 
dropwise t-BuLi (470 μL, 1.7M) at −78 oC and under argon atmosphere. The resulting mixture 
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was stirred for 1 h and a solution of aldehyde 32 (90 mg, 0.27 mmol) in diethyl ether (1 mL) was 
added. The resulting mixture was stirred at −78 oC for 3 h and then quenched at RT with sat. 
aqueous NH4Cl. The aqueous phase was extracted with diethyl ether, and the combined organic 
phase was washed with brine and dried over MgSO4. The solution was concentrated and the 
crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 
9:1 to provide a first less polar olefin 53 (59 mg, 39%) as a colorless oil: [α]D −5.0 (c 0.20, 
CHCl3); IR (thin film) 2957, 2929, 2856, 1513, 1249, 1039, 836 cm-1;  1H-NMR (300 MHz, 
CDCl3) δ 7.27 (d, J = 8.2 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H), 5.86 (ddd, J = 17.8, 10.2, 7.7 Hz, 
1H), 4.97 (dd, J = 17.7, 10.2 Hz, 2H), 4.43 (d, J = 11.5 Hz, 1H), 4.38 (t, J = 11.2 Hz, 1H), 3.81 
(s, 3H), 3.65 (dd, J = 4.6, 3.4 Hz, 1H), 3.37 (dd, J = 9.0, 6.6 Hz, 1H), 3.22 (dd, J = 6.8, 8.8 Hz, 
1H), 2.37-2.33 (m 1H), 1.96-1.92 (m, 1H), 1.01 (d, J = 6.8 Hz, 3H), 0.91-0.89 (m, 12H), 0.04 (s, 
3H), 0.02 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 159.1, 142.0, 130.9, 129.2, 114.1, 113.8, 76.0, 
73.4, 72.5, 55.3, 42.9, 37.2, 26.2, 18.5, 17.4, 12.4, −3.5, −3.9 ppm; HRMS (ESI) calcd for 
C22H38O3Si = 378.2590, found = 378.2587. 
                                     
                                                 OTBS
CO2Me
OH
TBSO
OPMB
 
(2Z,4E,6R,7S,9R,10Z,12S,13S,14S)-Methyl-7,13-bis(tert-butyldimethylsilyloxy)-9-hydroxy-
15-(4-methoxybenzyloxy)-6,12,14-trimethylpentadeca-2,4,10-trienoate (52β):  
The crude product from 52 provided a second more polar alcohol 52β (72 mg, 38%) as a 
colorless oil: [α]D −2.2 (c 0.39, CHCl3); IR (thin film) 3367, 3053, 2991, 2959, 2929, 2872, 
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2253, 1710, 1626, 1453, 1265, 903, 735 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.38 (dd, J = 15.4, 
11.3 Hz, 1H), 7.29 (d, J = 8.6 Hz, 2H), 6.93 (d, J = 8.6 Hz, 2H), 6.58 (t, J = 11.3 Hz, 1H), 6.05 
(dd, J = 15.4, 8.0 Hz, 1H), 5.61 (d, J = 11.3 Hz, 1H), 5.33 (dd, J = 10.1, 9.3 Hz, 1H), 5.27 (t, J = 
10.6 Hz, 1H), 4.45 (s, 2H), 4.44-4.41 (m, 1H),  3.83 (s, 3H), 3.80-3.76 (m, 1H), 3.75 (s, 3H), 
3.67 (dd, J = 9.0, 7.1 Hz, 1H), 3.38 (dd, J = 7.5, 3 Hz, 1H), 3.21 (dd, J = 9, 6 Hz, 1H), 2.89 (ddq, 
J = 10, 7, 6.6 Hz, 1H), 2.53-2.49 (m, 1H), 2.11 (m, 1H), 1.70 (m, 1H), 1.646 (bs, 1H), 1.48 (m, 
1H), 1.05 (d, J = 6.7 Hz, 3H), 0.91-0.86 (m, 24H), 0.09 (s, 3H), 0.08 (s, 3H),  0.06 (s, 3H), 0.04 
(s, 3H); 13C-NMR (75 MHz, CDCl3) δ 166.7, 159.1, 147.1, 145.5, 135.6, 132.3, 130.3, 129.5, 
127.0, 115.1, 113.8, 79.4, 73.5, 72.9, 72.2, 64.4, 55.2, 51.2, 42.2, 41.3, 37.2, 37.0, 26.2, 25.9, 
18.4, 18.0, 16.4, 15.7, −3.6, −4.4 ppm; HRMS (ESI) calcd for C39H68O7Si2 = 704.4505, found = 
704.4531. 
 
OTBS
CO2Me
OH
TBSO
OPMB
 
(2Z,4E,6R,7S,9S,10Z,12S,13S,14S)-Methyl-7,13-bis(tert-butyldimethylsilyloxy)-9-hydroxy-
15-(4-methoxybenzyloxy)-6,12,14-trimethylpentadeca-2,4,10-trienoate (52α):  
The crude product from 52 provided a third more polar alcohol 52α (57 mg, 30%) as a 
colorless oil: [α]D +8.8 (c 0.45, CHCl3); IR (thin film) 3367, 3051, 2991, 2879, 2872, 1720, 
1610, 1512, 1439, 1265, 1175, 912, 734 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.38 (dd, J = 15.3, 
11.2 Hz, 1H), 7.27 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 6.57 (t, J = 11.2 Hz, 1H), 6.04 
(dd, J = 15.3, 7.6 Hz, 1H), 5.62 (d, J = 11.3 Hz, 1H), 5.38 (t, J = 11 Hz, 1H), 5.32 (dd, J = 11, 
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8.5 Hz, 2H), 4.66 (dt, J = 8.5, 6.0 Hz, 1H), 4.38 (d, J = 4.5 Hz, 2H), 3.96 (dt, J = 6, 5 Hz, 1H), 
3.82 (s, 3H), 3.76 (s, 3H), 3.48 (dd, J = 9.5, 5.5 Hz, 1H), 3.45 (t, J = 5.5 Hz, 1H), 3.24 (t, J = 8.5 
Hz, 1H),  2.74 (m, 1H),  2.56 (m, 1H), 2.02-1.97 (m, 1H), 1.57 (t, J = 6 Hz, 2H), 1.08 (d, J = 6.5 
Hz, 3H), 1.00 (d, J = 6.5 Hz, 3H), 0.98 (d, J = 6.5 Hz, 3H), 0.94 (s, 9H), 0.91 (s, 9H), 0.16 (s, 
3H), 0.11 (s, 3H),  0.06 (s, 3H), 0.05 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 166.9, 159.1, 147.2, 
145.6, 135.7, 131.3, 131.1, 129.1, 126.8, 115.7, 113.7, 77.9, 72.7, 72.6, 72.2, 64.4, 55.2, 51.1, 
42.7, 40.1, 38.6, 35.6, 26.1, 26.0, 25.9, 25.4, 18.4, 18.0, 17.1, 14.8, 14.7, −3.9, −4.1, −4.5 ppm; 
HRMS (ESI) calcd for C39H68O7Si2 = 704.4505, found = 704.4519. 
                                     
                                                      
OTBS
TBSO
I  
(5R,6S,8R)-5-((S,Z)-4-Iodobut-3-en-2-yl)-2,2,3,3,6,8,11,11,12,12-decamethyl-4,10-dioxa-
3,11-disilatridecane (42):  
Following the same procedure for vinyl iodide 31, (2R,3R,4S,6R)-3,7-bis(tert-
butyldimethylsilyloxy)-2,4,6-trimethylheptanal (1.84 g, 4.42 mmol) provided vinyl iodide 42 
(1.65 g, 69%) as a colorless oil. [α]D +18.4 (c 0.35, CHCl3); IR (thin film) 2955, 2929, 2855, 
1513, 1249, 1039, 837, 773 cm-1;  1H-NMR (300 MHz, CDCl3) δ 6.24 (dd, J = 8.7, 7.2 Hz, 1H), 
6.07 (d, J = 7.2 Hz, 1H), 3.49-3.43 (m, 2H), 3.20 (dd, J = 9.9, 7.5 Hz, 1H), 2.65 (ddq, J = 9.9, 
6.8, 6.6 Hz, 1H), 1.63-1.57 (m, 3H), 1.39-1.31 (m, 1H) 0.92 (d, J = 6.6 Hz, 3H), 0.93-0.89 (m, 
24H), 0.06 (s, 3H), 0.05 (s, 3H), 0.01 (s, 6H); 13C-NMR (75 MHz, CDCl3) δ 144.2,  80.9, 78.8, 
68.1, 43.2, 37.5, 35.7, 33.4, 25.9, 18.2, 17.8, 16.0, −3.8, −4.0, −5.5 ppm; HRMS (EI) calcd for 
C23H49IO2Si2 = 540.2317, found = 540.2304.                                                        
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N O
OPMB
OH
MeO
 
(2R,3S,4S)-5-Hydroxy-N-methoxy-3-(4-methoxybenzyloxy)-N,2,4-trimethylpentanamide 
(57):  
To a solution of TBS ether 55 (2 g, 4.55 mmol) in DMF (10 mL) under argon 
atmosphere, was added portion wise solid TBAF·3H2O (2.54 g, 9.10 mmol) and the resulting 
solution was stirred for 8 h. The reaction mixture was quenched by addition of aqueous solution 
of HCl 1N. The aqueous phase was extracted with diethyl ether, and the combined organic phase 
was washed with brine and dried over MgSO4. The solution was concentrated and the crude 
product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate to 
provide alcohol 57 (754 mg, 51%) as a colorless oil: IR (thin film) 3367, 3063, 2991, 2986, 
2872, 1769, 1688, 1607, 1438, 1377, 1265, 1232, 909, 745 cm-1; 1H-NMR (300 MHz, CDCl3) δ 
7.28 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 4.57 (d, J = 10.3 Hz, 1H), 4.51 (d, J = 10.3 Hz, 
1H), 3.8 (s, 3H), 3.79-3.69 (m ,4H), 3.42 (dd, J = 9.6, 6.8 Hz, 1H), 3.21 (s, 3H),  2.85 (dq,  J = 
6.9, 5.7 Hz, 1H), 1.95-1.88 (m, 1H), 1.27 (d, J = 6.9 Hz, 3H), 1.01 (d, J = 6.9 Hz, 3H); 13C-NMR 
(75 MHz, CDCl3) δ 164.1, 159.1, 130.6, 129.6, 113.6, 79.0, 72.1, 66.1, 61.2, 55.4, 39.6, 29.7, 
26.0, 16.1, 11.3 ppm; HRMS (ESI) calcd for C17H27NO5 = 325.1889, found = 325.1870. 
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(2R,3S,4S,Z)-N-Methoxy-3-(4-methoxybenzyloxy)-N,2,4-trimethylocta-5,7-dienamide (58):  
 To a -78 oC solution of freshly distilled allyldiphenyl phospine (1.17 mL, 5.43 mmol) in 
THF (17 mL), was added t-BuLi (3.2 mL, 1.7M) and stirred for 5 min. The solution was warmed 
to 0 oC, stirred for 30 min and cooled to −78 oC. The solution was treated with Ti(i-PrO)4 (1.6 
mL, 5.43 mmol) and stirred for 30 min. A precooled solution of (2R,3S,4R)-N-methoxy-3-(4-
methoxybenzyloxy)-N,2,4-trimethyl-5-oxopentanamide (879 mg, 2.72 mmol) in THF (10 mL) 
was added via cannula and stirred for 1 h, then warmed to 0 oC. Iodomethane (1.69 mL, 27.2 
mmol) was added, and the solution was warmed to ambient temperature and stirred for 16 h. The 
solution was quenched with pH 7 buffer and the aqueous layer was extracted with CH2Cl2.  The 
combined organic phase was washed with brine and dried over MgSO4 and the solution was 
concentrated and the crude product was purified by silica gel flash chromatography eluting with 
hexanes/ethyl acetate to provide 58 (586 mg, 62%) as a 11:1 mixture of Z:E olefin isomers. To a 
solution of 58 (586 mg, 1.67 mmol) in THF (6 mL) at −78 oC was added phenyl triazole dione 
(87 mg, 0.5 mmol) and the resulting solution was stirred for 3 h. The reaction mixture was 
quenched with water and the aqueous layer was extracted with CH2Cl2.  The combined organic 
phase was washed with brine and dried over MgSO4 and the solution was concentrated and the 
crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 
to provide 58 (504 mg, 86%) as a single olefin isomer: [α]D20 +60.6° (c 11.2, CHCl3); IR (thin 
film) 2962, 2937, 1657, 1612, 1514, 1462, 1250, 1061 cm–1; 1H NMR (300 MHz, CDCl3) δ 7.31 
(d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 6.50 (dt, J = 16.8, 10.6 Hz, 1H), 6.02 (t, J = 11.0 
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Hz, 1H), 5.62 (t, J = 10.7 Hz, 1H), 5.15 (d, J = 16.8 Hz, 1H), 5.06 (d, J = 10.2 Hz, 1H), 4.63 (d, J 
= 10.6 Hz, 1H), 4.59 (d, J = 10.6 Hz, 1H), 3.81 (s, 3H), 3.70-3.66 (m, 1H), 3.59 (s, 3H), 3.13 (s, 
3H), 2.97-2.90 (m, 2H), 1.25 (d, J = 6.9 Hz, 3H), 1,14 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 176.7,159.5, 134.4, 132.9, 131.3, 129.9, 129.6 (2C), 117.4, 114.1 (2C), 84.8, 76.1, 
61.2, 55.6, 40.9, 36.5, 32.4, 19.4, 15.1; HRMS (EI) calcd for C20H29NO4 = 347.2097, found = 
347.2099. 
 
                                                       
(MeO)2OP
O
OPMB  
Dimethyl-(3R,4S,5S,Z)-4-(4-methoxybenzyloxy)-3,5-dimethyl-2-oxonona-6,8-
dienylphosphonate (34):  
To a solution of dimethoxy methylphosphonate (4.71 g, 38.0 mmol) in THF (24 mL) was 
added n-BuLi (21.6 mL, 1.6 M) at –78°C. The resulting solution was stirred for 1 h and a 
solution of Weinreb amide 58 (2.40 g, 6.91 mmol) in THF (12 mL) was added over 15 min. The 
resulting mixture was stirred at –78°C for 2 h. The mixture was quenched with sat. aqueous 
NH4Cl solution and the aqueous phase was extracted with diethyl ether. The combined organic 
extracts were washed with brine and dried over MgSO4. The solution was concentrated and the 
crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 
1:1 to yield phosphonate 34 (1.65 g, 69%) as a colorless oil. [α]D20 –1.7° (c 1.50, CHCl3); IR 
(thin film) 2958, 2873, 1709, 1612, 1514, 1462, 1248, 1032, 810 cm–1; 1H NMR (300 MHz, 
CDCl3) δ 7.29-7.24 (m, 2H), 6.89-6.84 (m, 2H), 6.50 (dt, J = 16.8, 11.0 Hz, 1H), 6.03 (t, J = 11.0 
Hz, 1H), 5.51 (t, J = 10.4 Hz, 1H), 5.22 (d, J = 16.8 Hz, 1H), 5.13 (d, J = 10.1 Hz, 1H), 4.57 (d, J 
= 11.9 Hz, 1H), 4.52 (d, J = 11.9 Hz, 1H), 3.81 (s, 3H), 3.78 (d, J = 5.9 Hz, 3H), 3.74 (d, J = 5.9 
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Hz, 3H), 3.60-3.57 (m, 1H), 3.31 (dd, J = 22.0, 14.4 Hz, 1H), 3.04-2.91 (m, 2H), 2.86-2.75 (m, 
1H), 1.21 (d, J = 7.0 Hz, 3H), 1,07 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ; 204.7 (d, 
JPC = 6.3 Hz), 159.4, 133.7, 132.2, 130.6, 130.0, 129.5, 118.2, 113.8, 83.6, 74.3, 55.3, 53.1 (d, 
JPC = 6.5 Hz), 52.9 (d, JPC = 6.1 Hz), 50.7, 41.0 (d, JPC = 129.3 Hz), 36.0, 19.0, 12.7; HRMS (EI) 
calcd for C21H31O6P = 410.1858, found 410.1857. 
 
                                             
HN
Me
O
N
SO2
Me  
(S)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)methanesulfonamide (60):  
To a solution of aniline 61 (5 g, 21.2 mmol) in pyridine (100 mL) was added DMAP (145 
mg) and mesityl chloride (11.42 mL, 146 mmol) at 0 oC. The resulting mixture was stirred for 1 
h and then overnight at RT. The reaction mixture was evaporated and the residue dissolved in 
EtOAc (150 mL) and sat. aqueous NH4Cl (60 mL). The organic phase was washed with brine 
and dried over MgSO4. The solution was concentrated and the crude product was purified by 
silica gel flash chromatography eluting with 2% MeOH/CH2Cl2 to yield sulfonamide 60 (3.15 g, 
58%) as a pale yellow solid. [α]D −5.8 (c 1.00, MeOH); 1H-NMR (300 MHz, CDCl3) δ 10.49 (br 
s, 1H), 7.40 (d, J = 7.5 Hz, 1H), 7.23 (d, J = 7.5 Hz, 1H), 7.20 (dd, J = 7.5, 7.5 Hz, 1H), 4.47-
4.40 (m, 1H), 4.12-4.06 (m, 2H), 2.82 (s, 3H), 2.55 (s, 3H), 1.84-1.74 (m 1H), 1.09 (d, J = 7.0 
Hz, 3H),  0.94 (d, J = 7.0 Hz, 3H); 13C-NMR (75 MHz, CDCl3) δ 164.3, 137.4, 136.3, 135.2, 
127.2, 125.8, 120.5, 72.9, 69.7, 38.6, 33.2, 19.9, 19.1, 18.5 ppm; HRMS (ESI) calcd for 
C14H20N2O3S = 296.1194, found = 296.1170. 
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(S)-2-Amino-N-(1-hydroxy-3-methylbutan-2-yl)-3-methylbenzamide (61):  
To a solution of 3-methyl-2-nitrobenzoic acid (30.0 g, 166 mmol) in CH2Cl2 (300 mL) 
was added DMF (1.2 mL) and oxalyl chloride (24.0 mL, 275 mmol) at 0 oC, and the suspension 
was sitrred for 5 h. The resulting clear mixture was stirred overnight at RT and then concentrated 
to give a crude yellow solid acid chloride. The crude mixture was dissolved in CH2Cl2 (250 mL) 
and treated with (L)-valinol (14.3 g, 138 mmol) at 0 oC, followed by Et3N (42 mL, 300 mol), and 
the resulting mixture was stirred for ½ hour. The reaction mixture was stirred at RT for 6 h and 
then diluted with CH2Cl2 (150 mL) and quenched with sat. aqueous NH4Cl (150 mL). The 
combined organic phases were washed with brine and dried over MgSO4. The resulting solution 
was concentrated to provide crude alcohol that was dissolved in a mixture of MeOH (160 mL) 
and THF (64 mL). The solution was treated with 10% Pd-C (500 mg) and after 3 operations of 
evacuation-hydrogen fill, the reaction mixture was stirred under H2 (balloon) at RT for 2 days. 
The reaction mixture was filtered through Celite and the filtrate was concentrated and the crude 
product was purified by silica gel flash chromatography eluting with 2% MeOH/CH2Cl2 to yield 
aniline 61 ( 17.6 g, 45%) as a white solid: [α]D −23.8 (c 1.00, MeOH); IR (thin film) 3494, 3090, 
3024, 2996, 2959, 2929, 2872, 1710, 1626, 1453, 1265, 903, 775 cm-1; 1H-NMR (500 MHz, 
CDCl3) δ 7.43-7.37 (m, 3H), 6.08 (d, J = 8.5 Hz, 1H), 4.05 (ddt, J = 8.5, 5.0, 3.5 Hz, 1H), 3.75 
(t, J = 3.5 Hz, 2H ), 2.41 (s, 3H), 1.98 (dq, J = 6.5, 5.0 Hz, 1H), 1.59 (bs, 1H), 1.00 (t, J = 6.5 Hz, 
6H); 13C-NMR (75 MHz, CDCl3) δ 165.2, 133.7, 131.4, 130.6, 125.5, 55.7, 46.4, 29.4, 19.3, 
18.9, 17.7 ppm; HRMS (ESI) calcd for C13H20N2O2 = 236.1525, found = 236.1512. 
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(S)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)-1-
phenylmethanesulfonamide (63):  
Following the same procedure for sulfonamide 60, aniline 61 (5 g, 21.2 mmol) and α-
toluenesulfonyl chloride (25 g, 146 mmol) provided sulfonamide 63 (3.15 g, 40%) as a clear 
solid: [α]D +14.0 (c 1.2, CHCl3); 1H-NMR (300 MHz, CDCl3) δ 12.1 (br s, 1H), 7.62-7.15 (m, 
8H), 4.49-4.34 (m, 2H), 4.26-4.21 (m, 1H), 4.12-4.08 (m, 1H), 3.86 (dd, J = 10.0, 8.5 Hz, 1H), 
2.33 (s, 3H), 1.86-1.79 (m 1H), 1.03 (d, J = 7.0 Hz, 3H),  0.97 (d, J = 7.0 Hz, 3H); 13C-NMR (75 
MHz, CDCl3) δ 163.0, 133.6, 132.0, 130.9, 130.0, 129.1, 128.8, 128.7, 117.3, 75.7, 67.9, 57.9, 
33.8, 2.60, 20.8, 18.5 ppm; HRMS (ESI) calcd for C14H20N2O3S = 372.1508, found = 372.1542. 
                                            
                                                      
OTBS
OTBS
OTBS
CO2Me
OH  
(2E,4E,6S,7S,9R,10Z,12S,13R,14S,16R)-Methyl-7,13,17-tris(tert-butyldimethylsilyloxy)-9-
hydroxy-6,12,14,16-tetramethylheptadeca-2,4,10-trienoate (64β):  
In a glove box a round bottom flask (RBF) was weighted with CrCl2 (151 mg, 1.24 
mmol) and NiCl2 (8 mg, 0.06mmol). The capped RBF was removed from the glove box and 
DMF (1 mL) was added and then stirred for 10 min. Vinyl iodide 42 (334 mg, 0.62 mmol) in 
DMF (1 mL) was added to the reaction mixture an stirred for 30 min at RT, then aldehyde 41 
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(100 mg, 0.31 mmol) in DMF (1 mL) was added and the resulting mixture was stirred for 6 h at 
RT. The mixture was filtered through celite and washed with THF. The solution was 
concentrated and the crude product was purified by silica gel flash chromatography eluting with 
hexanes/ethyl acetate 6:1 to provide a first less polar alcohol 64β (71 mg, 31%) as a colorless oil. 
[α]D −17.2 (c 0.56, CHCl3); IR (thin film) 3365, 3059, 2986, 2968, 2904, 2872, 2253, 1710, 
1626, 1453, 1265, 903, 735 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.31 (dd, J = 15.3, 11.2 Hz, 
1H), 6.50 (t, J = 11.2 Hz, 1H), 6.17 (dd, J = 15.3, 8.0 Hz, 1H), 5.51 (d, J = 11.2 Hz, 1H), 5.39-
5.24 (m, 2H), 4.40-4.36 (m, 1H),  3.87-3.81 (m, 1H), 3.65 (s, 3H), 3.42 (dd, J = 9.0, 7.1 Hz, 1H), 
3.34 (dd, J = 7.5, 3 Hz, 1H), 3.25 (dd, J = 9, 6 Hz, 1H), 2.65-2.54 (m, 2H), 1.65-1.59 (m, 2H), 
1.54-1.45 (m, 2H), 1.39-1.32 (m, 2H), 0.99 (d, J = 6.7 Hz, 3H), 0.96 (d, J = 6.8 Hz, 3H), 0.89-
0.86 (m, 12H), 0.85-0.83 (m, 17H), 0.75 (d, J = 6.8 Hz, 3H), 0.13 (s, 3H),  0.09 (s, 3H), -0.03 (s, 
12H); 13C-NMR (75 MHz, CDCl3) δ 166.9, 147.2, 145.8, 133.9, 132.3, 127.0, 115.8, 79.7, 73.5, 
68.9, 66.5, 52.3, 43.5, 42.7, 38.3, 35.7, 36.0, 33.5, 26.8, 26.6, 26.5, 25.9, 20.3, 18.3, 18.0, 16.2, 
15.2, −2.1, −3.6, −3.9, -4.1, -4.4 ppm; HRMS (ESI) calcd for C40H80O6Si3 = 740.5263, found = 
740.5279. 
  
                                                       
OTBS
OTBS
OTBS
CO2Me
OH  
(2E,4E,6S,7S,9S,10Z,12S,13R,14S,16R)-Methyl-7,13,17-tris(tert-butyldimethylsilyloxy)-9-
hydroxy-6,12,14,16-tetramethylheptadeca-2,4,10-trienoate (62α):  
The crude product from 62 provided a second more polar alcohol 62α (69 mg, 30%) as a 
colorless oil. [α]D −11.1 (c 0.35, CHCl3); IR (thin film) 3365, 3055, 2986, 2959, 2929, 2872, 
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1710, 1626, 1453, 1265, 903, 735 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.35 (dd, J = 15.4, 11.3 
Hz, 1H), 6.51 (t, J = 11.3 Hz, 1H), 6.12 (dd, J = 15.4, 8.0 Hz, 1H), 5.54 (d, J = 11.3 Hz, 1H), 
5.46 (t, J = 10.5 Hz, 1H), 5.28 (dd, J = 10.5, 8.5 Hz, 1H), 4.57 (t, J = 8.5 Hz, 1H),  3.90-3.86 (m, 
1H), 3.68 (s, 3H), 3.44 (dd, J = 9.0, 7.1 Hz, 1H), 3.31 (dd, J = 7.5, 3 Hz, 1H), 3.19 (dd, J = 9, 6 
Hz, 1H), 2.62-2.59 (m, 2H), 2.08 (bs, 1H), 1.65-1.59 (m, 2H), 1.54-1.50 (m, 1H), 1.49-1.45 (m, 
1H), 1.38-1.32 (m, 2H), 0.95 (d, J = 6.7 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H), 0.89-0.86 (m, 12H), 
0.85-0.83 (m, 17H), 0.79 (d, J = 6.8 Hz, 3H), 0.11 (s, 3H),  0.08 (s, 3H), -0.04 (s, 12H); 13C-
NMR (75 MHz, CDCl3) δ 167.1, 147.3, 145.9, 133.9, 132.4, 126.9, 115.7, 80.2, 73.1, 68.6, 66.2, 
52.1, 43.5, 42.7, 38.0, 35.9, 36.0, 33.8, 26.8, 26.6, 26.5, 25.9, 20.3, 18.9, 18.6, 16.2, 15.2, −2.9, 
−3.5, −3.9, -4.1, -4.2 ppm; HRMS (ESI) calcd for C40H80O6Si3 = 740.5263, found = 740.5224. 
  
HO
TBSO
 
(3S,4R,5S,7R)-8-(tert-Butyldimethylsilyloxy)-3,5,7-trimethyloct-1-en-4-ol (76):  
To a solution of alcohol 78 (1.24 g, 4.13 mmol) in THF (5 mL) was added HCl 3N in 
THF (5 mL). The resulting mixture was stirred for 3 h at RT and then quenched with sat. 
aqueous NaHCO3. The aqueous phase was extracted with diethyl ether, and the combined 
organic phase was washed with brine and dried over MgSO4. The solution was concentrated and 
the crude mixture dissolved in CH2Cl2 (20 mL) and then reacted with TBSCl (747 mg, 4.96 
mmol), imidazole (309 mg, 4.54 mmol) and DMAP (26 mg, 0.21 mmol). The resulting mixture 
was stirred for 6 h at RT and then quenched with sat. aqueous NH4Cl. The aqueous phase was 
extracted with diethyl ether, and the combined organic phase was washed with brine and dried 
over MgSO4. The solution was concentrated and the crude product was purified by silica gel 
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flash chromatography eluting with hexanes/ethyl acetate 3:1 to yield alcohol 76 (930 mg, 75%) 
as a colorless oil. [α]D +14.3 (c 1.3, CHCl3); IR (thin film) 3325, 3015, 2993, 2968, 2872, 1769, 
1648, 1623, 1438, 1395, 1265, 1232, 909, 735 cm-1; 1H-NMR (600 MHz, CDCl3) δ 5.60 (ddd, J 
= 17.0, 10.2, 8.1 Hz, 1H) 4.95 (dd, J = 16.8, 10.2 Hz, 2H), 3.46 (dd, J = 9.6, 4.8 Hz, 1H), 3.35 
(dd, J = 9.9, 6.6 Hz, 1H), 3.09 (dd, J = 8.1, 6.3 Hz, 1H), 2.18 (m, 1H), 1.77 (m, 1H), 1.71 (m, 
1H), 1.66 (m, 1H) 1.60-1.56 (m, 1H) 0.98 (s, 9H), 0.95 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 Hz, 
3H), 0.85 (d, J = 6.6 Hz, 3H),  0.06 (s, 3H), 0.04 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 141.7, 
116.1, 68.2, 42.0, 37.9, 32.8, 31.5, 25.9, 18.3, 17.7, 16.5, 13.2, −5.4 ppm; HRMS (ESI) calcd for 
C17H132O2Si = 300.2485, found = 300.2464. 
 
                                                      
COOMe
OTBSOH  
(2Z,4E,6S,7S,9S)-Methyl-7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-methylundeca-2,4,10-
trienoate (77α/β):  
To a solution of aldehyde 41 (326 mg, 1 mmol) in THF (5 mL) was added vinylMgBr 
(1.5 mL, 1M in THF) at −78 oC. The resulting mixture was stirred for 4 h and for another 2 h at 
−30 oC. The mixture was quenched with sat. aqueous NH4Cl and then the aqueous phase was 
extracted with diethyl ether, and the combined organic phase was washed with brine and dried 
over MgSO4. The solution was concentrated and the crude product was dissolved in CH2Cl2 (5 
mL) and reacted with Dess-Martin reagent (509 mg, 1.2 mmol) at RT. The resulting mixture was 
stirred for 2 h and then quenched with sat. aqueous Na2S2O3. The aqueous phase was extracted 
with diethyl ether, and the combined organic phase was washed with brine and dried over 
MgSO4. The solution was concentrated and the crude product was dissolved in toluene (5 mL) 
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and was added (R)-CBS (272 mg, 1 mmol) at RT. The resulting mixture was cooled to −78 oC 
and BH3·SMe2 (2 mL, 2 M) was added and then the mixture was stirred for 12 h and another 1 h 
at −30 oC. The resulting mixture was quenched at −78 oC with MeOH (200 μL) and then at RT 
was added sat. aqueous NaHCO3. The aqueous phase was extracted with diethyl ether, and the 
combined organic phase was washed with brine and dried over MgSO4. The solution was 
concentrated and the crude product was purified by silica gel flash chromatography eluting with 
hexanes/diethyl ether 4:1 to yield alcohol 77α/β (261 mg, 74% for 3 steps as a 5:1 mixture of 
77α:77β) as a pale yellow oil. IR (thin film) 3398, 3052, 2986, 2959, 2872, 1720, 1610, 1511, 
1439, 1265, 1175, 909, 734 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.39 (dd, J = 15.3, 11.4 Hz, 
1H), 6.57 (t, J = 11.3 Hz, 1H), 6.12 (dd, J = 15.3, 6.9 Hz, 1H), 5.86 (ddd, J = 17.1, 10.4, 8.1 Hz, 
1H), 5.62 (dd, J = 11.4 Hz, 1H), 5.23 (d, J = 17.1 Hz, 1H), 5.07 (d, J = 10.4 Hz, 1H), 4.36 (dt, J 
= 8.1, 5.4 Hz, 1H), 3.85 (dt, J = 7.2, 5.4 Hz, 1H),  3.72 (s, 3H), 2.56 (m, 1H),  2.28 (d, J = 3.6 
Hz, 1H), 1.57 (t, J = 5.4 Hz, 2H), 1.09 (d, J = 6.6 Hz, 3H), 0.92 (s, 9H), 0.13 (s, 3H), 0.11 (s, 
3H); 13C-NMR (75 MHz, CDCl3) δ 167.2, 147.6, 145.9, 142.3, 127.2, 116.0, 114.1, 73.5, 69.7, 
51.4, 43.0, 40.8, 26.4, 26.3, 18.5, 15.5, −3.8, −4.0 ppm. 
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(6R,8S,9R,13S,15S,16S,17E,19Z)-Methyl-9-((S)-but-3-en-2-yl)-15-(tert-
butyldimethylsilyloxy)-2,2,3,3,6,8,11,11,16-nonamethyl-13-vinyl-4,10,12-trioxa-3,11-
disilahenicosa-17,19-dien-21-oate (74α/β):  
To a solution of alcohol 76 (1.24 g, 4.13 mmol) in THF (40 mL) was added dropwise 
nBuLi (2.84 mL, 1.6 M) at −78 oC. The resulting mixture was stirred for 20 min and then was 
added dropwise dimethyldichlorosilane (2.49 mL, 20.65 mmol). The resulting mixture was warm 
up to RT and stirred for 2 h and then the solvent was removed under high vacuum until dryness 
for 4 h. A solution of 77α/β (1.61 g, 4.54 mmol) in THF (10 mL) and imidazole (930 mg, 13.65 
mmol) was added under argon atmosphere and the resulting solution was stirred for 16 h. The 
resulting mixture was quenched with sat. aqueous NaHCO3. The aqueous phase was extracted 
with diethyl ether, and the combined organic phase was washed with brine and dried over 
MgSO4. The solution was concentrated and the crude product was purified by silica gel flash 
chromatography eluting with hexanes/ethyl acetate 9:1 to yield silaketal 74α/β (2.67 g, 91%) as a 
colorless oil. [α]D −12.9 (c 0.88, CHCl3); IR (thin film) 3023, 2998, 2974, 2931, 2872, 1710, 
1626, 1453, 1265, 9043, 735 cm-1;  1H-NMR (300 MHz, C6D6) δ 7.74 (dd, J = 15.3, 11.1 Hz, 
1H), 6.28 (t, J = 11.1 Hz, 1H), 6.09-5.97 (m, 2H), 5.80 (ddd, J = 17.0, 10.2, 7.7 Hz, 1H), 5.56 (d, 
J = 11.1 Hz, 1H), 5.13-4.90 (m 4H), 4.38-4.36 (m, 1H), 3.88 (dt, J = 11.1 Hz, 1H),  3.50-3.47 
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(m, 2H), 3.37 (s, 3H), 3.14 (dd, J = 8.1, 6.3 Hz, 1H), 2.50 (m, 1H) 2.40 (m, 1H),  1.78-1.74 (m, 
3H), 1.64-1.54 (m ,3H), 1.05-0.086 (m, 30H), 0.17-0.02 (m, 18H); 13C-NMR (75 MHz, C6D6) δ 
166.4, 147.6, 145.6, 142.4, 142.0, 127.3, 116.1, 114.6, 114.4, 80.8, 73.2, 72.2, 68.2, 62.3, 50.6, 
44.8, 43.2, 42.7, 42.3, 38.6, 33.9, 33.6, 30.2, 29.6, 26.2, 26.1, 18.6, 17.9, 15.3, 14.0, −0.3, −0.7, 
−3.6, −4.4 ppm; HRMS (ESI) calcd for C38H74O6Si3 = 710.4793, found = 710.4786.  
 
                                             MeOOC
Me
O
OTBS
O
TBSO
SiiPr2
 
(6R,8S,9R,13S,15S,16S,17E,19Z)-Methyl-9-((S)-but-3-en-2-yl)-15-(tert-
butyldimethylsilyloxy)-11,11-diisopropyl-2,2,3,3,6,8,16-heptamethyl-13-vinyl-4,10,12-
trioxa-3,11-disilahenicosa-17,19-dien-21-oate (79α/β):  
Following the same procedure for 74α/β, alcohol 57  (124 mg, 0.41 mmol), 
diisopropyldichlorosilane (249 μL, 2.07 mmol) and alcohol 58 (161 mg, 0.45 mmol) provided 
silaketal 79α/β (217 mg, 69%) as a colorless oil. [α]D −55.6 (c 0.31, CHCl3); IR (thin film) 3050, 
2981, 2959, 2929, 2843, 1710, 1620, 1453, 1265, 903, 735 cm-1;  1H-NMR (300 MHz, C6D6) δ 
7.73 (dd, J = 15.3, 11.1 Hz, 1H), 6.27 (t, J = 11.1 Hz, 1H), 6.09-5.97 (m, 2H), 5.80 (ddd, J = 
17.0, 10.2, 7.7 Hz, 1H), 5.56 (d, J = 11.1 Hz, 1H), 5.13-4.90 (m 4H), 4.38-4.36 (m, 1H), 3.88 (dt, 
J = 11.1 Hz, 1H),  3.50-3.47 (m, 2H), 3.37 (s, 3H), 3.14 (dd, J = 8.1, 6.3 Hz, 1H), 2.50 (m, 1H), 
2.40 (m, 1H),  1.78-1.74 (m, 3H), 1.64-1.54 (m ,3H), 1.05-0.082 (m, 37H), 0.12-0.02 (m, 12H); 
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13C-NMR (75 MHz, C6D6) δ 166.4, 147.6, 145.6, 142.4, 142.0, 127.3, 116.1, 114.6, 114.4, 80.8, 
73.2, 72.2, 68.2, 62.3, 50.6, 44.8, 43.2, 42.7, 42.3, 38.6, 33.9, 33.6, 30.2, 29.6, 26.2, 26.1, 18.6, 
17.9, 15.3, 14.0, −0.3, −0.7, −3.6, −4.4 ppm; HRMS (ESI) calcd for C42H82O6Si3 = 766.5419, 
found = 766.5402.  
 
                                                 MeOOC
Me
O
OTBS
O
TBSO
SiPh2
 
(6R,8S,9R,13S,15S,16S,17E,19Z)-Methyl-9-((S)-but-3-en-2-yl)-15-(tert-
butyldimethylsilyloxy)-2,2,3,3,6,8,16-heptamethyl-11,11-diphenyl-13-vinyl-4,10,12-trioxa-
3,11-disilahenicosa-17,19-dien-21-oate (80α/β):  
To a solution of bis(3-methoxyprop-1-ynyl)diphenylsilane (150 mg, 0.49 mmol) and 
alcohol 76 (60 mg, 0.20 mmol) in hexanes (1.5 mL) was added sodium hydride (60% dispersion 
in mineral oil, 1 mg, 0.02 mmol). The resulting mixture wad stirred for 10 min and then filtered 
through celite. The solution was concentrated and the crude product was purified on silica gel 
eluting with hexanes/diethyl ether 9:1 to yield silane (100 mg, 91%) as a colorless oil. To a 
solution of silane (100 mg, 0.18 mmol) and alcohol 77α/β (64 mg, 0.18 mmol) in hexanes (1 mL) 
was added sodium hydride (60% dispersion in mineral oil, 1 mg, 0.02 mmol). The resulting 
mixture was stirred for 20 min and then filtered through celite. The solution was concentrated 
and the crude product was purified by silica gel flash chromatography eluting with 
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hexanes/diethyl ether 9:1 to yield silaketal 80α/β (123 mg, 82%) as a colorless oil. [α]D −8.4 (c 
0.31, CHCl3); IR (thin film) 3053, 2986, 2959, 2929, 2872, 2253, 1710, 1626, 1453, 1265, 903, 
735 cm-1;  1H-NMR (300 MHz, C6D6) δ 7.73 (dd, J = 15.3, 11.1 Hz, 1H), 7.65 (dd, J = 7.6, 1.5 
Hz, 4H), 7.40-7.30 (m, 6H), 6.27 (t, J = 11.1 Hz, 1H), 6.09-5.97 (m, 2H), 5.80 (ddd, J = 17.0, 
10.2, 7.7 Hz, 1H), 5.56 (d, J = 11.1 Hz, 1H), 5.13-4.90 (m 4H), 4.38-4.36 (m, 1H), 3.88 (dt, J = 
11.1 Hz, 1H),  3.50-3.47 (m, 2H), 3.37 (s, 3H), 3.14 (dd, J = 8.1, 6.3 Hz, 1H), 2.50 (m, 1H), 2.40 
(m, 1H),  1.78-1.74 (m, 3H), 1.64-1.54 (m ,3H), 1.05-0.082 (m, 30H), 0.12-0.02 (m, 12H); 13C-
NMR (75 MHz, C6D6) δ 166.4, 147.6, 145.6, 142.4, 142.0, 127.3, 116.1, 114.6, 114.4, 80.8, 
73.2, 72.2, 68.2, 62.3, 50.6, 44.8, 43.2, 42.7, 42.3, 38.6, 33.9, 33.6, 30.2, 29.6, 26.2, 26.1, 18.6, 
17.9, 15.3, 14.0, −0.3, −0.7, −3.6, −4.4 ppm; HRMS (ESI) calcd for C48H78O6Si3 = 834.5106, 
found = 834.5138.  
 
                                       MeOOC
Me
O
OTBS
O
TBSO
SiMe2
                                  
(2Z,4E,6S,7S)-Methyl-7-(tert-butyldimethylsilyloxy)-8-((4S,7S,8R,Z)-8-((2S,4R)-5-(tert-
butyldimethylsilyloxy)-4-methylpentan-2-yl)-2,2,7-trimethyl-7,8-dihydro-4H-1,3,2-
dioxasilocin-4-yl)-6-methylocta-2,4-dienoate (75α/β):  
To a solution of silaketal 74α/β (100 mg, 0.14 mmol) in toluene (13 mL, 0.01M) was 
added dropwise a solution of Hoveyda-Grubbs II (9 mg, 0.014 mmol) in toluene (1 mL) at 120 
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oC. The resulting mixture was stirred for 1 h at 120 oC and then the solution was concentrated 
and the crude product was purified by silica gel flash chromatography eluting with hexanes/ethyl 
acetate 15:1 to yield compound 75α/β (68 mg, 61%) as a pale brown oil: [α]D −18.4 (c = 0.57, 
CHCl3); 1H-NMR (300 MHz, C6D6) δ 7.76 (dd, J = 15.3, 11.1 Hz, 1H), 6.26 (t, J = 11.1 Hz, 1H), 
6.05 (dd, J = 15.4, 8.0 Hz, 1H), 5.61 (d, J = 11.3 Hz, 1H), 5.33 (t, J = 10.6 Hz, 1H), 5.27 (dd, J = 
10.1, 9.3 Hz, 1H), 4.38-4.36 (m, 1H), 3.86 (dt, J = 11.1 Hz, 1H), 3.50-3.47 (m, 2H), 3.37 (s, 3H), 
3.16 (dd, J = 8.1, 6.3 Hz, 1H), 2.57-2.52 (m, 1H), 2.46-2.40 (m, 1H),  1.78-1.78-1.74 (m, 3H), 
1.64-1.54 (m, 3H), 1.05-0.086 (m, 30H), 0.17-0.02 (m, 18H); 13C-NMR (75 MHz, C6D6) δ 166.4, 
147.6, 145.6, 142.0, 127.3, 116.1, 114.4, 80.9, 73.4, 72.5, 68.2, 62.3, 50.7, 44.6, 43.1, 42.9, 42.8, 
38.7, 33.9, 33.6, 30.2, 29.6, 26.2, 26.1, 18.6, 17.9, 15.3, 14.0, −0.3, −0.7, −3.6, −4.4 ppm. 
 
                                           OTBSHO
COOMe
C4H9
 
(2Z,4E,6S,7S,9S,10E)-Methyl-7-(tert-butyldimethylsilyloxy)-9-hydroxy-6-methylpentadeca-
2,4,10-trienoate (86α/β):   
To a suspension of zirconocene hydrochloride (500 mg, 1.93 mmol) in CH2Cl2 (4 mL) 
was added 1-hexyne (175 μL, 1.52 mmol) at RT and under argon atmosphere. The resulting 
mixture was stirred for 5 min and more 1-hexyne (80 μL, 0.7 mmol) was added. The resulting 
clear red solution was stirred for 10 min and then concentrated under high vacuum for ½ hour. 
To the resulting orange solid/oil was added toluene (4 mL) and then at −78 oC was added Me2Zn 
(650 μL, 2M). The resulting mixture was stirred for 10 min and was added ligand 84 (50 mg, 
0.19 mmol) and the mixture was allowed to warm up to −30 oC in 1 h. To the resulting mixture 
was added a solution of aldehyde 41 (421 mg, 1.29 mmol) in toluene (1 mL). The resulting 
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mixture was stirred for 12 h at −30 oC and then quenched with sat. aqueous NaHCO3. The 
aqueous phase was extracted with EtOAc and the combined organic phase was washed with 
brine and dried over MgSO4. The solution was concentrated and the crude product was purified 
by silica gel flash chromatography eluting with hexanes/diethyl ether 8:1 to yield alcohol 86α/β 
(460 mg, 87% as a 5:0.75 mixture of epimers 86α:86β) as a pale yellow oil. [α]D −2.4 (c = 1.00, 
CHCl3); IR (thin film) 3326, 2998, 2976, 1760, 1625, 1490, 1315, 1242, 1215, 1115, 752 cm-1;  
1H-NMR (300 MHz, CDCl3) δ 7.34 (dd, J = 15.3, 11.4 Hz, 1H), 6.53 (t, J = 11.3 Hz, 1H), 6.09 
(dd, J = 15.3, 6.9 Hz, 1H), 5.63-5.54 (m, 2H), 5.33 (dd, J = 15.3, 6.6 Hz, 1H), 5.27 (t, J = 10.6 
Hz, 1H), 4.23 (dt, J = 8.1, 6.8 Hz, 1H), 3.85 (dt, J = 7.2, 6.8 Hz, 1H),  3.68 (s, 3H), 2.56 (m, 1H),  
2.31 (bs, 1H), 1.99-1.95 (m, 2H), 1.54-1.43 (m, 2H), 1.29-1.27 (m, 4H), 1.03 (d, J = 6.6 Hz, 3H), 
0.84 (s, 12H), 0.08 (s, 3H), 0.05 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 166.7, 147.0, 145.4, 
133.0, 131.2, 126.6, 115.4, 73.3, 69.2, 50.9, 42.3, 40.4, 31.7, 31.2, 25.8, 26.7, 22.1, 18.0, 15.2, 
13.8, −4.4, −4.6 ppm;; MS (ESI) m/z 353(100), 395(64), 410(12); HRMS (ESI) calcd for 
C23H42O4Si = 410.2852, found = 410.2871. 
 
                                                      
HO
PMBO
 
(3S,4R,5S,7R)-8-(4-Methoxybenzyloxy)-3,5,7-trimethyloct-1-en-4-ol (87):  
To a solution of alcohol 78 (295 mg, 0.96 mmol) and 4-methoxybenzyl 2,2,2-
trichloroacetimidate (413 mg, 1.45 mmol) in a mixture of CH2Cl2 (1 mL) and cyclohexane (2 
mL) at 0 oC was added BF3·Et2O (6 μL). The resulting mixture was stirred for 2 h and for another 
6 h at RT. The mixture was quenched with sat. aqueous NaHCO3 and then the aqueous phase 
was extracted with CH2Cl2 and the combined organic phase was washed with brine and dried 
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over MgSO4. The solution was concentrated and the crude product was purified on silica gel 
eluting with hexanes/diethyl ether 7:1 to yield PMB ether (355 mg, 88%) as a colorless oil. To a 
solution of PMB ether (355 mg, 0.85 mmol) in THF (1 mL) was added TBAF (2.55 mL, 1M). 
The resulting pale brown solution was heated to 50 oC and stirred at that temperature for 24 h. 
The mixture was quenched with sat. aqueous NH4Cl and then the aqueous phase was extracted 
with CH2Cl2 and the combined organic phase was washed with brine and dried over MgSO4. The 
solution was concentrated and the crude product was purified by silica gel flash chromatography 
eluting with hexanes/diethyl ether 3:1 to yield alcohol 87 (219 mg, 84%) as a colorless oil. [α]D  
+28.8 (c = 1.6, CHCl3); IR (thin film) 3310, 2954, 2857, 1721, 1424, 1165, 1101, 830, 751 cm-1; 
1H-NMR (600 MHz, CDCl3) δ 5.74 (ddd, J = 14.7, 10.5, 8.4 Hz, 1H), 5.13 (dd, J = 15.1, 10.5 
Hz, 2H), 4.43 (s, 2H), 3.81 (s, 3H), 3.33 (dd, J = 9.0, 5.4 Hz, 1H), 3.24-3.18 (m, 2H), 2.27 (m, 
1H), 1.92-1.84 (m, 1H), 1.80-1.73 (m, 1H), 1.59 (t, J = 5.4 Hz, 2H), 0.97 (d, J = 6.8 Hz, 3H), 
0.95 (d, J = 6.7 Hz, 3H) 0.88 (d, J = 6.8 Hz, 3H); 13C-NMR (75.5 MHz, CDCl3) δ 159.7, 142.4, 
131.4, 129.7, 116.4, 114.4, 76.8, 76.3, 73.3, 55.7, 42.5, 39.0, 32.5, 31.3, 18.8, 17.2, 14.1 ppm; 
HRMS (ESI) calcd for C19H30O3 = 306.2195, found = 306.2192. 
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C4H9  
(6R,8S,9R,13S,15S,16S,17E,19Z)-Methyl-9-((S)-but-3-en-2-yl)-15-(tert-
butyldimethylsilyloxy)-13-((E)-hex-1-enyl)-2,2,3,3,6,8,11,11,16-nonamethyl-4,10,12-trioxa-
3,11-disilahenicosa-17,19-dien-21-oate (88α/β):  
Following the same procedure for silaketal 84α, alcohol 76 (124 mg, 0.41 mmol) and 
alcohol 77α/β (186 mg, 0.45 mmol) provided 88α/β (231 mg, 73%) as a colorless oil. [α]D −23.2 
(c 0.76, CHCl3); IR (thin film) 3053, 2986, 2959, 2929, 2872, 1710, 1626, 1453, 1265, 903, 735 
cm-1; 1H-NMR (300 MHz, C6D6) δ 7.74 (dd, J = 15.3, 11.1 Hz, 1H), 6.28 (t, J = 11.1 Hz, 1H), 
6.09-5.97 (m, 2H), 5.80 (ddd, J = 17.0, 10.2, 7.7 Hz, 1H), 5.56 (d, J = 11.1 Hz, 1H), 5.13-4.90 
(m 4H), 4.38-4.36 (m, 1H), 3.88 (dt, J = 11.1 Hz, 1H),  3.50-3.47 (m, 2H), 3.37 (s, 3H), 3.14 (dd, 
J = 8.1, 6.3 Hz, 1H), 2.50 (m, 1H), 2.40 (m, 1H),  1.78-1.74 (m, 3H), 1.64-1.54 (m ,3H), 1.05-
0.086 (m, 30H), 0.17-0.02 (m, 18H); 13C-NMR (125 MHz, CDCl3) δ 166.9, 148.6, 145.8, 142.0, 
133.3, 131.5, 126.1, 115.2, 114.1, 80.5, 72.6, 71.3, 67.9. 51.0, 42.9, 42.1, 41.7, 38.2, 33.5, 33.2, 
31.8, 31.3, 29.7, 25.9, 22.3, 18.3, 17.8, 15.0, 13.9, 13.6, −4.2, −5.4 ppm; HRMS (ESI) calcd for 
C42H82O6Si3 = 766.5420, found = 766.5429. 
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(4R,6S,7R,11S,13S,14S,15E,17Z)-Methyl-7-((S)-but-3-en-2-yl)-13-(tert-
butyldimethylsilyloxy)-11-((E)-hex-1-enyl)-1-(4-methoxyphenyl)-4,6,9,9,14-pentamethyl-
2,8,10-trioxa-9-silanonadeca-15,17-dien-19-oate (89α/β):  
Following the same procedure for silaketal 74α/β, alcohol 87 (126 mg, 0.41 mmol) and 
alcohol 77α/β (186 mg, 0.45 mmol) provided silaketal 89α/β (218 mg, 69%) as a colorless oil. 
[α]D −16.8 (c 0.88, CHCl3); IR (thin film) 3053, 2986, 2959, 2929, 2872, 2253, 1710, 1626, 
1453, 1265, 903, 735 cm-1; 1H-NMR (300 MHz, C6D6) δ 7.88 (dd, J = 15.0, 11.3 Hz, 1H), 7.29 
(d, J = 8.4 Hz, 2H), 6.84 (d, J = 8.4 Hz, 2H), 6.34 (t, J = 11.3 Hz, 1H), 6.18 (dd, J = 15.1, 6.6 Hz, 
1H), 6.09 (ddd, J = 14.7, 10.5, 8.4 Hz, 1H), 5.62-5.59 (m ,2H) 5.11-5.09 (m, 3H), 4.49 (dt, J = 
8.1, 6.8 Hz, 1H), 4.40 (d, J = 10.2 Hz, 2H), 4.15 (dt, J = 7.2, 6.8 Hz, 1H),  3.56 (dd, J = 8.5, 5.4 
Hz, 1H), 3.39-3.37 (m, 4H), 3.32 (s, 3H), 3.23 (t, J = 7.2 Hz, 1H), 2.60 (m, 1H), 2.47 (m, 1H), 
1.99-1.96 (m, 4H), 1.88-1.85 (m, 2H), 1.73-1.1.70 (m, 1H), 1.69-1.65 (m ,1H), 1.33-1.29 (m, 
2H), 1.28-1.25 (m, 2H), 1.12 (d, J = 6.6 Hz, 3H), 1.10 (d, J = 6.6 Hz, 3H), 1.07 (d, J = 6.6 Hz, 
3H), 1.05 (d, J = 6.6 Hz, 3H), 1.02 (s, 9H), 0.87 (t, J = 7.2 Hz, 3H)  0.41 (s, 3H), 0.29 (s, 3H), 
0.17 (s, 3H), 0.12 (s, 3H); 13C-NMR (75 MHz, C6D6) δ 166.7, 159.9, 148.3, 145.9, 142.8, 134.3, 
132.0, 131.8, 129.6, 127.5, 116.3, 114.7, 114.3, 75.8, 73.6, 73.3, 72.1, 55.0, 50.9, 43.8, 42.9, 
42.7, 39.4, 34.2, 32.5, 31.9, 31.8, 26.5, 22.9, 19.1, 18.2, 15.5, 14.4, 0.2, −0.3, −3.7 ppm.  
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(4R,6S,7R,11S,13S,14S,15E,17Z)-Methyl-7-((S)-but-3-en-2-yl)-13-(tert-
butyldimethylsilyloxy)-1-(4-methoxyphenyl)-4,6,9,9,14-pentamethyl-11-vinyl-2,8,10-trioxa-
9-silanonadeca-15,17-dien-19-oate (90α/β):  
Following the same procedure for silaketal 74α/β; alcohol 87  (126 mg, 0.41 mmol)  and 
alcohol 77α/β (159 mg, 0.45 mmol) provided 90α/β (270 mg, 92%) as a colorless oil: IR (thin 
film) 3021, 2991, 2879, 2872, 1720, 1610, 1512, 1439, 1265, 1175, 912, 734 cm-1; 1H-NMR 
(300 MHz, CDCl3) δ 7.34 (dd, J = 15.6, 11.4 Hz, 1H), 7.26 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.4 
Hz, 2H), 6.57 (t, J = 11.4 Hz, 1H), 6.14 (dd, J = 15.6, 6.9 Hz, 1H), 5.92-5.75 (m, 2H), 5.58 (d, J 
= 11.4 Hz, 1H)  5.16-4.95 (m ,4H), 4.42 (d, J = 4.8 Hz, 2H), 4.49 (dt, J = 7.8, 4.5 Hz, 1H), 3.83-
3.79 (m, 4H), 3.72 (s, 3H), 3.39 (dd, J = 5.7, 4.5 Hz, 1H),  3.34 (t, J = 4.5 Hz, 1H), 3.14 (dd, J = 
8.5, 7.5 Hz, 1H), 2.51 (m, 1H), 2.34 (m, 1H), 1.87-1.80 (m, 1H), 1.74-1.67 (m, 3H), 1.48-1.41 
(m, 2H), 1.04 (d, J = 6.6 Hz, 3H), 0.97 (d, J = 6.6 Hz, 3H), 0.95 (d, J = 6.6 Hz, 3H), 1.02 (s, 9H), 
0.87 (d, J = 6.7 Hz, 3H)  0.1 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.05 (s, 3H); 13C-NMR (75 MHz, 
CDCl3) δ 166.7, 159.0, 148.0, 145.6, 142.0, 141.6, 130.9, 129.0, 126.4, 115.4, 114.4, 114.1, 
113.6, 80.2, 75.3, 72.6, 71.6, 55.1, 50.9, 42.7, 42.3, 41.8, 38.6, 33.4, 31.0, 25.9, 18.5, 18.1, 17.5, 
14.8, 13.8, 1.0, −0.6, −1.0, −4.1 ppm.  
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(2Z,4E,6S,7S)-Methyl-7-(tert-butyldimethylsilyloxy)-8-((4S,7S,8R,Z)-8-((2S,4R)-5-(4-
methoxybenzyloxy)-4-methylpentan-2-yl)-2,2,7-trimethyl-7,8-dihydro-4H-1,3,2-
dioxasilocin-4-yl)-6-methylocta-2,4-dienoate (91α/β):  
Following the same procedure for 75α/β. Silaketal 89α/β (1 g, 1.30 mmol) provided 
91α/β (624 mg, 65%) as a pale brown oil: [α]D −48.3 (c 0.08, CHCl3); 1H-NMR (600 MHz, 
C6D6) δ 7.88 (dd, J = 15.4, 11.3 Hz, 1H), 7.28 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 6.35 
(t, J = 11.4 Hz, 1H), 6.20 (dd, J = 15.3, 6.7 Hz, 1H), 5.59 (d, J = 11.4 Hz, 1H), 5.40 (t, J = 10.8 
Hz, 1H), 5.23 (dd, J = 10.8, 8.4 Hz, 1H), 4.52 (t, J = 8.0 Hz, 1H), 4.41 (d, J = 6 Hz, 2H), 3.92-
3.81 (m, 4H), 3.74 (s, 3H), 3.38-3.36 (m, 1H),  3.31 (dd, J = 9, 4.4 Hz, 1H), 3.17 (t, J = 8.4 Hz, 
1H), 2.56-2.51  (m, 2H), 1.76-1.73 (m, 1H), 1.67-1.62 (m, 1H), 1.51-1.46 (m, 1H), 1.42-1.36 (m, 
1H), 1.33-1.27 (m, 2H), 1.09 (d, J = 6.6 Hz, 3H), 0.99 (d, J = 6.6 Hz, 3H), 0.94 (d, J = 6.6 Hz, 
3H), 1.02 (s, 12H),  0.87 (d, J = 6.7 Hz, 3H),  0.10 (s, 3H), 0.08 (s, 6H), 0.05 (m, 3H); 13C-NMR 
(151.1 MHz, C6D6) δ 166.8, 159.2, 146.9, 145.6, 132.8, 132.0, 130.8, 129.4, 126.7, 115.2, 112.9, 
79.7, 75.5, 72.9, 72.1, 66.2, 55.4, 50.2, 42.1, 42.0, 38.2, 35.2, 35.3, 31.6, 31.2, 26.3, 26.2, 26.0, 
25.9, 25.8, 25.7, 19.5, 18.5, 18.1, 17.5, 14.8, 13.8, 1.0, −0.6, −1.0, −4.1 ppm.  
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(2Z,4E,6S,7S,9S,10Z,12S,13R,14S,16R)-Methyl-7-(tert-butyldimethylsilyloxy)-9,13-
dihydroxy-17-(4-methoxybenzyloxy)-6,12,14,16-tetramethylheptadeca-2,4,10-trienoate 
(92α):  
To a solution of compound 91α/β (600 mg, 0.87 mmol) in a mixture of CH2Cl2 (30 mL) 
and MeOH (30 mL) was added a solution of Cl2CHCO2H (361 μL, 4.35 mmol)  in MeOH (5 
mL) at 0 oC. The resulting mixture was stirred for 2 h and then quenched with sat. aqueous 
NaHCO3. The aqueous phase was extracted with diethyl ether and the combined organic phase 
was washed with brine and dried over MgSO4. The solution was concentrated and the crude 
product was purified by silica gel flash chromatography eluting with hexanes/ethyl acetate 4:1 
and 2% of MeOH to yield diol 92α ( 303 mg, 54%) as a colorless oil. [α]D −27.8 (c 0.1, CHCl3); 
IR (thin film) 3406, 2983, 2971, 1765, 1684, 1641, 1512, 1422, 1265, 1160, 1128, 948, 738 cm-1; 
1H-NMR (600 MHz, CDCl3) δ 7.40 (dd, J = 15.6, 11.4 Hz, 1H), 7.25 (d, J = 8.4 Hz, 2H), 6.87 
(d, J = 8.4 Hz, 2H), 6.58 (t, J = 11.4 Hz, 1H), 6.16 (dd, J = 15.6, 6.9 Hz, 1H), 5.59 (d, J = 11.4 
Hz, 1H), 5.51 (dd, J = 10.8, 7.8 Hz, 1H), 5.29 (t, J = 10.8 Hz, 1H), 4.65 (dt, J = 7.8, 4.5 Hz, 1H), 
4.42 (d, J = 6 Hz, 2H), 3.90 (dt, J = 6.8, 4.5 Hz, 1H), 3.8 (s, 3H), 3.71 (s, 3H), 3.39 (dd, J = 9, 6 
Hz, 1H),  3.21 (t, J = 6.6 Hz, 1H), 3.17 (dd, J = 7.2, 6.6 Hz, 1H), 2.72  (m, 1H), 2.65 (m, 1H), 
1.86-1.83 (m, 1H), 1.76-1.73 (m, 1H), 1.65-1.59 (m, 2H), 1.54-1.49 (m, 2H), 1.09 (d, J = 6.6 Hz, 
3H), 1.06 (d, J = 6.6 Hz, 3H), 0.94 (d, J = 6.6 Hz, 3H), 1.02 (s, 9H), 0.85 (d, J = 6.7 Hz, 3H)  
0.14 (s, 3H), 0.10 (s, 3H);  13C-NMR (151.1 MHz, CDCl3) δ 166.9, 159.1, 147.1, 145.6, 134.7, 
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133.9, 130.7, 129.1, 126.7, 115.5, 113.7, 76.2, 75.8, 72.6, 65.2, 55.2, 51.1, 42.2, 40.3, 38.4, 36.1, 
31.4, 30.6, 25.9, 18.0, 17.9, 17.4, 15.5, 13.1, −4.4, −4.5 ppm. 
 
                   COOMe
Me
OTBS
OTBSTBSO
PMBO
 
(2Z,4E,6S,7S,9S,10Z,12S,13R,14S,16R)-Methyl-7,9,13-tris(tert-butyldimethylsilyloxy)-17-(4-
methoxybenzyloxy)-6,12,14,16-tetramethylheptadeca-2,4,10-trienoate (93α):  
To a solution of diol 92α (300mg, 0.47 mmol) in CH2Cl2 (6 mL) was added 2,6-lutidine 
(199 μL, 1.69 mmol) and TBSOTf (216 μL, 0.94 mmol) at −78 oC. The resulting mixture was 
warmed up to 0 oC and stirred for 2 h. The resulting mixture was quenched with water and the 
aqueous phase was extracted with diethyl ether. The combined organic phase was washed with 
brine and dried over MgSO4. The solution was concentrated and the crude product was purified 
by silica gel flash chromatography eluting with hexanes/ethyl acetate 10:1 yield TBS ether 93α ( 
315 mg, 78%) as a colorless oil. [α]D −72.2 (c 0.1, CHCl3); IR (thin film) 2965, 2953, 2899, 
1694, 1625, 1490, 1315, 1242, 1215, 1115, 720 cm-1; 1H-NMR (600 MHz, CDCl3) δ 7.34 (dd, J 
= 15.6, 11.4 Hz, 1H), 7.25 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 6.54 (t, J = 11.4 Hz, 1H), 
6.21 (dd, J = 15.6, 6.9 Hz, 1H), 5.54 (d, J = 11.4 Hz, 1H), 5.38 (t, J = 10.8 Hz, 1H), 5.25 (dd, J = 
10.8, 8.4 Hz, 1H), 4.54 (t, J = 8.6 Hz, 1H), 4.42 (d, J = 6 Hz, 2H), 3.92 (d, J = 7.2 Hz, 1H), 3.81 
(s, 3H), 3.72 (s, 3H), 3.36-3.34 (m, 1H),  3.31 (dd, J = 9, 4.4 Hz, 1H), 3.17 (t, J = 8.4 Hz, 1H), 
2.58-2.53  (m, 2H), 1.76-1.73 (m, 1H), 1.67-1.62 (m, 1H), 1.51-1.47 (m, 1H), 1.41-1.36 (m, 1H), 
1.33-1.31 (m, 1H), 1.29-1.27 (m, 1H), 1.04 (d, J = 6.6 Hz, 3H), 0.95 (d, J = 6.6 Hz, 3H), 0.92 (d, 
J = 6.6 Hz, 3H), 1.02 (s, 27H), 0.84 (d, J = 6.7 Hz, 3H),  0.10 (s, 3H), 0.9 (s, 3H), 0.05 (s, 6H), 
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0.02 (s, 3H), 0.01 (s, 3H);  13C-NMR (151.1 MHz, CDCl3) δ 166.8, 159.1, 146.8, 145.7, 132.7, 
132.4, 130.8, 129.0, 126.6, 115.1, 113.6, 79.8, 75.4, 72.8, 72.6, 66.4, 55.1, 50.8, 42.9, 42.2, 37.8, 
35.6, 35.4, 31.6, 31.2, 26.3, 26.2, 26.0, 25.9, 25.8, 25.7, 19.5, 18.8, 18.4, 18.1, 15.5, 14.7, −2.8, 
−3.5, −3.8, −4.1, −4.2 ppm.  
 
                                      COOMe
Me
OTBS
OTBSTBSO
HO
 
(2Z,4E,6S,7S,9S,10Z,12S,13R,14S,16R)-Methyl-7,9,13-tris(tert-butyldimethylsilyloxy)-17-
hydroxy-6,12,14,16-tetramethylheptadeca-2,4,10-trienoate (94α):  
To a solution TBS ether 93α (200 mg, 0.23 mmol) in CH2Cl2 (4 mL) and PH 7 buffer 
(200 μL) was added DDQ (63 mg, 0.28 mmol). The resulting mixture was stirred for 2 h and 
then quenched with with sat. aqueous NaHCO3. The aqueous phase was extracted with diethyl 
ether and the combined organic phase was washed with brine and dried over MgSO4. The 
solution was concentrated and the crude product was purified by silica gel flash chromatography 
eluting with hexanes/ethyl acetate 3:1 t yield alcohol 94α ( 111 mg, 65%) as a colorless oil. [α]D 
−96.1 (c 0.1, CHCl3); IR (thin film) 3355, 2984, 2857, 1721, 1656, 1424, 1165, 1101, 830, 751 
cm-1; 1H-NMR (600 MHz, CDCl3) δ 7.35 (dd, J = 15.6, 11.4 Hz, 1H), 6.56 (t, J = 11.4 Hz, 1H), 
6.22 (dd, J = 15.6, 6.9 Hz, 1H), 5.57 (d, J = 11.4 Hz, 1H), 5.44 (t, J = 10.8 Hz, 1H), 5.28 (dd, J = 
10.8, 8.4 Hz, 1H), 4.56 (t, J = 8.6 Hz, 1H), 3.94 (d, J = 7.2 Hz, 1H), 3.72 (s, 3H), 3.52-3.48 (m, 
1H),  3.37 (t, J = 7.2 Hz, 1H), 3.34-3.31 (m, 1H), 2.58-2.53  (m, 2H), 1.76-1.73 (m, 1H), 1.67-
1.62 (m, 1H), 1.51-1.47 (m, 1H), 1.41-1.36 (m, 1H), 1.33-1.31 (m, 1H), 1.29-1.27 (m, 1H), 1.04 
(d, J = 6.6 Hz, 3H), 0.95 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H), 1.02 (s, 27H), 0.84 (d, J = 
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6.7 Hz, 3H),  0.10 (s, 3H), 0.9 (s, 3H), 0.05 (s, 6H), 0.02 (s, 3H), 0.01 (s, 3H);  13C-NMR (151.1 
MHz, CDCl3) δ 167.4, 147.5, 146.3, 133.4, 132.8, 127.1, 115.7, 80.5, 73.4, 68.1, 66.9, 51.5, 
43.5, 42.7, 37.9, 36.1, 36.0, 33.9, 26.8, 26.7, 26.5, 26.4, 20.1, 19.0, 18.7, 16.2, 15.2, -2.8, -3.5, -
3.8, −4.1, −4.2 ppm. 
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